{ "schema_version": "1.0", "target_id": "e-exac", "language": "en", "nodes": [ { "id": "e-exac", "name": "Exactech, Inc.", "type": "organization", "role": "", "period": "", "group": "subject", "claim_ids": [ "c-identity", "c-founding", "c-pre-ipo", "c-early-suits", "c-2010-holders", "c-2010-board", "c-brighton", "c-exhibit21", "c-intl-llc", "c-exus", "c-barbados", "c-operations", "c-portfolio-2016", "c-dpa-2010", "c-donofrio", "c-trust-kickbacks", "c-deal-background", "c-merger-agreement", "c-independent-directors", "c-board-2018", "c-rollover", "c-holders-2018", "c-deal-suits", "c-arbitrage", "c-closing", "c-trust-deal", "c-chain-petition", "c-trust-chain", "c-sponsor-loans", "c-debt", "c-trust-fees", "c-board-2019", "c-board-2023", "c-executives", "c-officers-2024", "c-binder-tpg", "c-tpg-people", "c-trust-exit", "c-recalls-overview", "c-fda-sc-2023", "c-fda-sc-shoulder", "c-recall-records", "c-recalls-other", "c-warning-2024", "c-warning-2025", "c-fda-registration", "c-trust-recall-strategy", "c-trust-tpg-recall-role", "c-trust-packaging", "c-trust-inspections", "c-trust-knee", "c-trust-hss", "c-trust-recall-scale", "c-registry-revisions", "c-mdl", "c-mdl-tpg-dismissal", "c-trust-mdl", "c-suit-counts", "c-trust-suits", "c-florida-suits", "c-arkansas", "c-australia-class", "c-australia-settlement", "c-quitam-alabama", "c-trust-quitam", "c-quitam-maryland", "c-fca-settlement", "c-dischargeability", "c-petition", "c-advisers", "c-adhoc-rsa", "c-rsa-milestones", "c-apa", "c-bidding", "c-jointmedica", "c-case-parties", "c-plans", "c-tpg-release", "c-letter-ruling", "c-confirmation", "c-wind-down", "c-advita-launch", "c-advita-execs", "c-trademarks", "c-italy", "c-uk", "c-trust-suit", "c-ucc-allegations", "c-blueortho", "c-intercompany" ], "badges": [ { "label": "2010 deferred prosecution agreement on an anti-kickback conspiracy charge; complaint to be dismissed on 12 months of compliance", "claim_ids": [ "c-dpa-2010" ], "category": "CRIMINAL_PROCEEDINGS", "code": "A1", "subject_id": "e-exac" }, { "label": "Voluntary Class II device recalls, including the 2021–2024 polyethylene recalls over defective packaging", "claim_ids": [ "c-recalls-overview", "c-fda-sc-2023", "c-fda-sc-shoulder", "c-recall-records", "c-recalls-other" ], "category": "REGULATORY_ACTION", "code": "A2", "subject_id": "e-exac" }, { "label": "FDA warning letters of January 2024 (Gainesville) and December 2025 (Sarasota, addressed to 'Exactech, Inc. dba Advita Ortho')", "claim_ids": [ "c-warning-2024", "c-warning-2025" ], "category": "REGULATORY_ACTION", "code": "A3", "subject_id": "e-exac" }, { "label": "Defendant in product-liability litigation (MDL 3044 and the Florida master case); claims passed to the Settlement Trust under the 2025 plan", "claim_ids": [ "c-mdl", "c-suit-counts", "c-florida-suits" ], "category": "CIVIL_LITIGATION", "code": "A4", "subject_id": "e-exac" }, { "label": "Respondent in an Australian class action settled for about A$8.7 million without admission of liability (approved 13 November 2025)", "claim_ids": [ "c-australia-class", "c-australia-settlement" ], "category": "CIVIL_LITIGATION", "code": "A5", "subject_id": "e-exac" }, { "label": "Agreed in 2025 to pay $8 million to settle False Claims Act allegations, with no determination of liability; declined a Corporate Integrity Agreement", "claim_ids": [ "c-quitam-alabama", "c-fca-settlement" ], "category": "ENFORCEMENT", "code": "A6", "subject_id": "e-exac" }, { "label": "Chapter 11 debtor (D. Del. No. 24-12441); plan confirmed 17 September 2025 with the sale of the business", "claim_ids": [ "c-petition", "c-confirmation" ], "category": "FINANCIAL_DISTRESS", "code": "A7", "subject_id": "e-exac" } ], "jurisdiction": "us" }, { "id": "e-wpetty", "name": "William Petty", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-founding", "c-pre-ipo", "c-2010-holders", "c-2010-board", "c-brighton", "c-petty-companies", "c-barbados", "c-deal-background", "c-independent-directors", "c-board-2018", "c-rollover", "c-holders-2018", "c-deal-suits", "c-arbitrage", "c-closing", "c-form-d", "c-trust-deal", "c-board-2019", "c-board-2023", "c-executives", "c-trust-hss", "c-florida-suits", "c-trust-quitam", "c-case-parties", "c-trust-suit" ], "badges": [ { "label": "Defendant in the Settlement Trust's pending fiduciary-duty suit and earlier shareholder and product suits; allegations not adjudicated", "claim_ids": [ "c-trust-suit", "c-arbitrage", "c-florida-suits" ], "category": "CIVIL_LITIGATION", "code": "A10", "subject_id": "e-wpetty" } ] }, { "id": "e-miller", "name": "Gary J. Miller", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-founding", "c-pre-ipo", "c-2010-holders", "c-2010-board", "c-brighton", "c-barbados", "c-board-2018", "c-holders-2018", "c-board-2019", "c-trust-hss", "c-florida-suits", "c-case-parties" ], "badges": [ { "label": "Co-defendant in Florida product-liability suits; moved to dismiss; cases closed after the 2024 bankruptcy", "claim_ids": [ "c-florida-suits" ], "category": "CIVIL_LITIGATION", "code": "A12", "subject_id": "e-miller" } ] }, { "id": "e-bpetty", "name": "Betty Petty", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-founding", "c-pre-ipo", "c-2010-holders", "c-2010-board", "c-brighton", "c-petty-companies", "c-board-2018", "c-rollover", "c-holders-2018", "c-arbitrage", "c-board-2019", "c-florida-suits" ], "badges": [ { "label": "Defendant in a 2018 shareholder suit and in Florida product-liability suits closed after the bankruptcy; allegations not adjudicated", "claim_ids": [ "c-arbitrage", "c-florida-suits" ], "category": "CIVIL_LITIGATION", "code": "A11", "subject_id": "e-bpetty" } ] }, { "id": "e-dpetty", "name": "David W. Petty", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-founding", "c-pre-ipo", "c-2010-board", "c-brighton", "c-petty-companies", "c-barbados", "c-deal-background", "c-independent-directors", "c-board-2018", "c-rollover", "c-holders-2018", "c-deal-suits", "c-arbitrage", "c-form-d", "c-trust-deal", "c-board-2019", "c-board-2023", "c-executives", "c-officers-2024", "c-florida-suits", "c-case-parties", "c-uk", "c-trust-suit" ], "badges": [ { "label": "Defendant in the Settlement Trust's pending fiduciary-duty suit and earlier shareholder and product suits; allegations not adjudicated", "claim_ids": [ "c-trust-suit", "c-arbitrage", "c-florida-suits" ], "category": "CIVIL_LITIGATION", "code": "A10", "subject_id": "e-dpetty" } ] }, { "id": "e-kearney", "name": "R. Wynn Kearney, Jr.", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-pre-ipo", "c-2010-board" ], "badges": [] }, { "id": "e-seese", "name": "Timothy J. Seese", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-pre-ipo", "c-brighton", "c-barbados" ], "badges": [] }, { "id": "e-phillips", "name": "Joel C. Phillips", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-pre-ipo", "c-2010-board", "c-brighton", "c-board-2018", "c-rollover", "c-holders-2018", "c-board-2019", "c-uk" ], "badges": [] }, { "id": "e-hss", "name": "Hospital for Special Surgery", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-pre-ipo", "c-2010-board", "c-trust-exit", "c-trust-hss", "c-case-parties" ], "badges": [], "jurisdiction": "us" }, { "id": "e-accumed", "name": "Accumed, Inc.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-pre-ipo" ], "badges": [], "jurisdiction": "us" }, { "id": "e-jointmedical", "name": "Joint Medical", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-early-suits" ], "badges": [] }, { "id": "e-prima-lp", "name": "Prima Investments, Limited Partnership", "type": "organization", "role": "", "period": "", "group": "historical", "claim_ids": [ "c-2010-holders", "c-rollover", "c-holders-2018", "c-arbitrage" ], "badges": [], "jurisdiction": "us" }, { "id": "e-millerworks", "name": "Millerworks, Limited Partnership", "type": "organization", "role": "", "period": "", "group": "historical", "claim_ids": [ "c-2010-holders" ], "badges": [], "jurisdiction": "us" }, { "id": "e-gamco", "name": "GAMCO Investors, Inc.", "type": "organization", "role": "", "period": "", "group": "historical", "claim_ids": [ "c-2010-holders", "c-holders-2018" ], "badges": [], "jurisdiction": "us" }, { "id": "e-fmr", "name": "FMR LLC", "type": "organization", "role": "", "period": "", "group": "historical", "claim_ids": [ "c-2010-holders" ], "badges": [], "jurisdiction": "us" }, { "id": "e-thompson", "name": "Bruce Thompson", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-2010-board", "c-brighton", "c-exus", "c-deal-background", "c-board-2018", "c-rollover", "c-board-2019", "c-uk" ], "badges": [] }, { "id": "e-burstein", "name": "Albert H. Burstein", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-2010-board", "c-brighton", "c-deal-suits" ], "badges": [] }, { "id": "e-metts", "name": "Paul E. Metts", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-2010-board" ], "badges": [] }, { "id": "e-locander", "name": "William B. Locander", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-2010-board", "c-board-2018", "c-deal-suits", "c-arbitrage" ], "badges": [] }, { "id": "e-binch", "name": "James G. Binch", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-2010-board", "c-deal-background", "c-board-2018", "c-deal-suits", "c-arbitrage" ], "badges": [] }, { "id": "e-rsmith", "name": "Richard C. Smith", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-2010-board", "c-board-2018", "c-deal-suits", "c-arbitrage" ], "badges": [] }, { "id": "e-mcgladrey", "name": "McGladrey & Pullen, LLP", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-2010-board" ], "badges": [], "jurisdiction": "us" }, { "id": "e-brighton", "name": "Brighton Partners, Inc.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-brighton", "c-petty-companies" ], "badges": [], "jurisdiction": "us" }, { "id": "e-ahb", "name": "AH Burstein, Ph. D., Consulting Engineer, Inc.", "type": "organization", "role": "", "period": "", "group": "historical", "claim_ids": [ "c-brighton" ], "badges": [], "jurisdiction": "us" }, { "id": "e-exactortho", "name": "ExactOrtho, Inc.", "type": "organization", "role": "", "period": "", "group": "other", "claim_ids": [ "c-petty-companies" ], "badges": [], "jurisdiction": "us" }, { "id": "e-prima-inc", "name": "Prima Investments, Inc.", "type": "organization", "role": "", "period": "", "group": "historical", "claim_ids": [ "c-petty-companies", "c-holders-2018", "c-arbitrage" ], "badges": [], "jurisdiction": "us" }, { "id": "e-intl", "name": "Exactech International Corporation", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21", "c-intl-llc" ], "badges": [], "jurisdiction": "us" }, { "id": "e-shanghai", "name": "Exactech Medical (Shanghai), Ltd.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21", "c-portfolio-2016" ], "badges": [], "jurisdiction": "cn" }, { "id": "e-taiwan", "name": "Exactech Taiwan (Taiwan), Ltd.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21", "c-portfolio-2016" ], "badges": [], "jurisdiction": "tw" }, { "id": "e-uk", "name": "Exactech UK Limited", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21", "c-rsa-milestones", "c-uk", "c-intercompany" ], "badges": [], "jurisdiction": "gb" }, { "id": "e-kk", "name": "Exactech KK", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21", "c-intercompany" ], "badges": [], "jurisdiction": "jp" }, { "id": "e-altiva", "name": "Altiva Corporation", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21" ], "badges": [], "jurisdiction": "us" }, { "id": "e-exus", "name": "Exactech U.S., Inc.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21", "c-exus", "c-mdl", "c-florida-suits" ], "badges": [], "jurisdiction": "us" }, { "id": "e-eio", "name": "Exactech International Operation AG", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21", "c-rsa-milestones", "c-swiss", "c-intercompany" ], "badges": [], "jurisdiction": "ch" }, { "id": "e-fr", "name": "Exactech France SAS", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21", "c-france", "c-intercompany" ], "badges": [], "jurisdiction": "fr" }, { "id": "e-de", "name": "Exactech Deutschland GmbH", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21", "c-germany", "c-intercompany" ], "badges": [], "jurisdiction": "de" }, { "id": "e-iberica", "name": "Exactech Iberica, S.L.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-exhibit21", "c-spain", "c-intercompany" ], "badges": [], "jurisdiction": "es" }, { "id": "e-johnson", "name": "Darin Johnson", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-exus", "c-board-2023", "c-executives", "c-officers-2024", "c-warning-2024", "c-uk", "c-uk2" ], "badges": [] }, { "id": "e-edwards", "name": "Donna Edwards", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-exus", "c-board-2018", "c-rollover", "c-board-2019", "c-officers-2024", "c-adhoc-rsa" ], "badges": [] }, { "id": "e-collins", "name": "Tony Collins", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-exus", "c-officers-2024", "c-apa" ], "badges": [] }, { "id": "e-kleopfer", "name": "Stuart Kleopfer", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-exus" ], "badges": [] }, { "id": "e-bolukbasi", "name": "Kerem Bolukbasi", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-exus", "c-board-2023", "c-executives" ], "badges": [] }, { "id": "e-barbados", "name": "Exactech International, Inc. (Barbados)", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-barbados" ], "badges": [], "jurisdiction": "bb" }, { "id": "e-tecres", "name": "Tecres S.p.A.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-operations" ], "badges": [], "jurisdiction": "it" }, { "id": "e-rti", "name": "RTI Surgical, Inc.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-operations", "c-case-parties" ], "badges": [] }, { "id": "e-biomatlante", "name": "Biomatlante SARL", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-operations" ], "badges": [], "jurisdiction": "fr" }, { "id": "e-jpmchase", "name": "J.P. Morgan Chase Bank", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-portfolio-2016" ], "badges": [], "jurisdiction": "us" }, { "id": "e-au", "name": "Exactech Australia Pty Ltd", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-portfolio-2016", "c-australia-class", "c-australia-settlement", "c-rsa-milestones", "c-australia-sub", "c-intercompany" ], "badges": [ { "label": "Respondent in an Australian class action settled for about A$8.7 million without admission of liability (approved 13 November 2025)", "claim_ids": [ "c-australia-class", "c-australia-settlement" ], "category": "CIVIL_LITIGATION", "code": "A5", "subject_id": "e-au" } ], "jurisdiction": "au" }, { "id": "e-odna", "name": "Orthopedic Designs North America, Inc.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-portfolio-2016" ], "badges": [], "jurisdiction": "us" }, { "id": "e-biogend", "name": "BioGend Therapeutics Co., Ltd.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-portfolio-2016" ], "badges": [], "jurisdiction": "tw" }, { "id": "e-greenberg", "name": "Greenberg Traurig P.A.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-dpa-2010" ], "badges": [], "jurisdiction": "us" }, { "id": "e-donofrio", "name": "Douglas Donofrio", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-donofrio" ], "badges": [ { "label": "Pleaded guilty in 2010 to conspiring to violate the anti-kickback statute; sentence not in the record", "claim_ids": [ "c-donofrio" ], "category": "CRIMINAL_PROCEEDINGS", "code": "A8", "subject_id": "e-donofrio" } ] }, { "id": "e-tpg", "name": "TPG Inc.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-trust-kickbacks", "c-deal-background", "c-merger-agreement", "c-deal-suits", "c-arbitrage", "c-closing", "c-form-d", "c-trust-deal", "c-trust-chain", "c-trust-fees", "c-board-2023", "c-executives", "c-binder-tpg", "c-tpg-people", "c-trust-exit", "c-tpg-identity", "c-trust-recall-strategy", "c-trust-tpg-recall-role", "c-trust-packaging", "c-trust-inspections", "c-trust-hss", "c-mdl", "c-mdl-tpg-dismissal", "c-trust-mdl", "c-trust-quitam", "c-quitam-maryland", "c-tpg-release", "c-letter-ruling", "c-confirmation", "c-trust-suit", "c-ucc-allegations" ], "badges": [ { "label": "Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoing", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A13", "subject_id": "e-tpg" } ], "jurisdiction": "us" }, { "id": "e-binder", "name": "Jeffrey Binder", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-trust-kickbacks", "c-deal-background", "c-form-d", "c-trust-deal", "c-board-2019", "c-board-2023", "c-executives", "c-officers-2024", "c-binder-bio", "c-binder-tpg", "c-trust-tpg-recall-role", "c-trust-hss", "c-trust-suit", "c-ucc-allegations" ], "badges": [ { "label": "Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicated", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A14", "subject_id": "e-binder" } ] }, { "id": "e-hann", "name": "Daniel P. Hann", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-deal-background", "c-trust-deal", "c-board-2019", "c-board-2023" ], "badges": [] }, { "id": "e-sisitsky", "name": "Todd Sisitsky", "type": "person", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-deal-background", "c-form-d", "c-trust-deal", "c-board-2019", "c-board-2023", "c-tpg-people", "c-trust-suit" ], "badges": [ { "label": "Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicated", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A14", "subject_id": "e-sisitsky" } ] }, { "id": "e-garrison", "name": "Kendall Garrison", "type": "person", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-deal-background", "c-form-d", "c-trust-deal", "c-board-2019", "c-board-2023", "c-tpg-people", "c-trust-tpg-recall-role", "c-trust-suit" ], "badges": [ { "label": "Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicated", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A14", "subject_id": "e-garrison" } ] }, { "id": "e-tpg-global", "name": "TPG Global, LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-deal-background", "c-binder-tpg" ], "badges": [], "jurisdiction": "us" }, { "id": "e-osteon-lp", "name": "Osteon Holdings, L.P.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-merger-agreement", "c-rollover", "c-deal-suits", "c-closing" ], "badges": [], "jurisdiction": "us" }, { "id": "e-mergersub", "name": "Osteon Merger Sub, Inc.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-merger-agreement", "c-deal-suits", "c-closing", "c-mdl", "c-mdl-tpg-dismissal", "c-trust-mdl" ], "badges": [], "jurisdiction": "us" }, { "id": "e-tpg7", "name": "TPG Partners VII, L.P.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-merger-agreement", "c-rollover", "c-closing", "c-trust-chain", "c-mdl", "c-trust-suit" ], "badges": [ { "label": "Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoing", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A13", "subject_id": "e-tpg7" } ], "jurisdiction": "us" }, { "id": "e-jpm", "name": "J.P. Morgan Securities LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-merger-agreement" ], "badges": [], "jurisdiction": "us" }, { "id": "e-watts", "name": "Fern S. Watts", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-board-2018", "c-deal-suits", "c-arbitrage" ], "badges": [] }, { "id": "e-krusen", "name": "W. Andrew Krusen, Jr.", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-board-2018", "c-deal-suits", "c-arbitrage" ], "badges": [] }, { "id": "e-mfh-llc", "name": "Miller Family Holdings, LLC", "type": "organization", "role": "", "period": "", "group": "historical", "claim_ids": [ "c-rollover", "c-holders-2018", "c-florida-suits" ], "badges": [], "jurisdiction": "us" }, { "id": "e-roche", "name": "Chris Roche", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-rollover", "c-advita-execs" ], "badges": [] }, { "id": "e-szabo", "name": "Steve Szabo", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-rollover" ], "badges": [] }, { "id": "e-blackrock", "name": "BlackRock, Inc.", "type": "organization", "role": "", "period": "", "group": "historical", "claim_ids": [ "c-holders-2018" ], "badges": [], "jurisdiction": "us" }, { "id": "e-dfa", "name": "Dimensional Fund Advisors LP", "type": "organization", "role": "", "period": "", "group": "historical", "claim_ids": [ "c-holders-2018" ], "badges": [], "jurisdiction": "us" }, { "id": "e-mfh-inc", "name": "Miller Family Holdings, Inc.", "type": "organization", "role": "", "period": "", "group": "historical", "claim_ids": [ "c-holders-2018", "c-florida-suits" ], "badges": [], "jurisdiction": "us" }, { "id": "e-arbfund", "name": "The Arbitrage Fund", "type": "organization", "role": "", "period": "", "group": "other", "claim_ids": [ "c-arbitrage" ], "badges": [], "jurisdiction": "us" }, { "id": "e-osteon", "name": "Osteon Holdings, Inc.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-closing", "c-form-d", "c-trust-chain", "c-trust-fees", "c-board-2023", "c-executives", "c-tpg-people", "c-trust-exit", "c-mdl", "c-mdl-tpg-dismissal", "c-trust-mdl", "c-petition", "c-adhoc-rsa", "c-uk", "c-trust-suit" ], "badges": [ { "label": "Chapter 11 debtor jointly administered with Exactech, Inc. (D. Del. No. 24-12441)", "claim_ids": [ "c-petition" ], "category": "FINANCIAL_DISTRESS", "code": "A15", "subject_id": "e-osteon" } ], "jurisdiction": "us" }, { "id": "e-lagatta", "name": "Michael LaGatta", "type": "person", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-closing", "c-form-d" ], "badges": [] }, { "id": "e-tpg-genpar", "name": "TPG Genpar VII, L.P.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-closing", "c-mdl" ], "badges": [], "jurisdiction": "us" }, { "id": "e-tpg-genpar-adv", "name": "TPG Genpar VII Advisors, LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-closing", "c-mdl" ], "badges": [], "jurisdiction": "us" }, { "id": "e-nasdaq", "name": "Nasdaq", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-closing" ], "badges": [] }, { "id": "e-schilling", "name": "John Schilling", "type": "person", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-form-d", "c-trust-deal", "c-board-2019", "c-board-2023", "c-tpg-people", "c-trust-tpg-recall-role", "c-trust-hss", "c-trust-suit" ], "badges": [ { "label": "Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicated", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A14", "subject_id": "e-schilling" } ] }, { "id": "e-fliss", "name": "Adam Fliss", "type": "person", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-form-d" ], "badges": [] }, { "id": "e-tepatti", "name": "Michael Tepatti", "type": "person", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-trust-deal", "c-board-2023", "c-tpg-people", "c-trust-tpg-recall-role", "c-trust-suit" ], "badges": [ { "label": "Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicated", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A14", "subject_id": "e-tepatti" } ] }, { "id": "e-osteon2", "name": "Osteon Intermediate Holdings II, Inc.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-chain-petition", "c-trust-chain", "c-sponsor-loans", "c-trust-fees", "c-mdl", "c-mdl-tpg-dismissal", "c-trust-mdl", "c-petition", "c-advisers", "c-adhoc-rsa", "c-apa" ], "badges": [ { "label": "Chapter 11 debtor jointly administered with Exactech, Inc. (D. Del. No. 24-12441)", "claim_ids": [ "c-petition" ], "category": "FINANCIAL_DISTRESS", "code": "A15", "subject_id": "e-osteon2" } ], "jurisdiction": "us" }, { "id": "e-xpand", "name": "XpandOrtho, Inc.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-chain-petition", "c-trust-chain", "c-petition", "c-advisers", "c-adhoc-rsa", "c-apa" ], "badges": [ { "label": "Chapter 11 debtor jointly administered with Exactech, Inc. (D. Del. No. 24-12441)", "claim_ids": [ "c-petition" ], "category": "FINANCIAL_DISTRESS", "code": "A15", "subject_id": "e-xpand" } ], "jurisdiction": "us" }, { "id": "e-goldman", "name": "Goldman Sachs Bank USA", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-chain-petition" ], "badges": [], "jurisdiction": "us" }, { "id": "e-glas-us", "name": "GLAS Trust Company LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-chain-petition" ], "badges": [], "jurisdiction": "us" }, { "id": "e-osteon1", "name": "Osteon Intermediate Holdings I, Inc.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-trust-chain", "c-trust-fees", "c-petition", "c-adhoc-rsa" ], "badges": [ { "label": "Chapter 11 debtor jointly administered with Exactech, Inc. (D. Del. No. 24-12441)", "claim_ids": [ "c-petition" ], "category": "FINANCIAL_DISTRESS", "code": "A15", "subject_id": "e-osteon1" } ], "jurisdiction": "us" }, { "id": "e-sponsor", "name": "TPG VII Osteon Holdings, L.P.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-trust-chain", "c-sponsor-loans", "c-advisers", "c-jointmedica", "c-trust-suit" ], "badges": [ { "label": "Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoing", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A13", "subject_id": "e-sponsor" } ], "jurisdiction": "us" }, { "id": "e-tpg-mgmt", "name": "TPG VII Management, LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-trust-fees", "c-trust-suit" ], "badges": [ { "label": "Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoing", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A13", "subject_id": "e-tpg-mgmt" } ], "jurisdiction": "us" }, { "id": "e-trust", "name": "Exactech Settlement Trust", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-trust-fees", "c-letter-ruling", "c-confirmation", "c-trust-suit" ], "badges": [], "jurisdiction": "us" }, { "id": "e-nole", "name": "Diana Nole", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-board-2023" ], "badges": [] }, { "id": "e-bingham", "name": "Gwen Bingham", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-board-2023" ], "badges": [] }, { "id": "e-golz", "name": "Karen Golz", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-board-2023" ], "badges": [] }, { "id": "e-abrams", "name": "M. Elizabeth Abrams", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-board-2023", "c-officers-2024", "c-advisers" ], "badges": [] }, { "id": "e-yasskin", "name": "Bennett Yasskin", "type": "person", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-board-2023", "c-tpg-people", "c-trust-tpg-recall-role", "c-trust-suit" ], "badges": [ { "label": "Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicated", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A14", "subject_id": "e-yasskin" } ] }, { "id": "e-lin", "name": "John Lin", "type": "person", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-board-2023", "c-tpg-people", "c-trust-tpg-recall-role", "c-trust-suit" ], "badges": [ { "label": "Individual defendant in the Settlement Trust's pending suit (Del. Ch. 2026-0129); allegations not adjudicated", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A14", "subject_id": "e-lin" } ] }, { "id": "e-livingston", "name": "Jessica Livingston", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-officers-2024", "c-quitam-alabama", "c-advita-registry" ], "badges": [] }, { "id": "e-pohl", "name": "Timothy Pohl", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-officers-2024", "c-advisers" ], "badges": [] }, { "id": "e-biomet", "name": "Biomet, Inc.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-binder-bio" ], "badges": [], "jurisdiction": "us" }, { "id": "e-advita", "name": "Advita Ortho, LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-warning-2025", "c-fda-registration", "c-advita-launch", "c-advita-execs", "c-advita-registry", "c-trademarks" ], "badges": [], "jurisdiction": "us" }, { "id": "e-sahagun", "name": "Aurelio Sahagun", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-warning-2025", "c-confirmation", "c-advita-launch" ], "badges": [] }, { "id": "e-crader", "name": "Michael Crader", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-trust-tpg-recall-role" ], "badges": [] }, { "id": "e-hillman", "name": "Hillman Supply Company, Inc.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-trust-packaging", "c-florida-suits", "c-arkansas", "c-hillman-registry" ], "badges": [ { "label": "Co-defendant, as alleged packaging supplier, in Florida product-liability suits; filed answers and defences; cases closed after the 2024 bankruptcy", "claim_ids": [ "c-florida-suits" ], "category": "CIVIL_LITIGATION", "code": "A9", "subject_id": "e-hillman" } ], "jurisdiction": "us" }, { "id": "e-kirkland", "name": "Kirkland & Ellis LLP", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-trust-mdl", "c-jointmedica", "c-tpg-release", "c-letter-ruling" ], "badges": [], "jurisdiction": "us" }, { "id": "e-harrold", "name": "Simon Harrold", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-australia-class", "c-australia-settlement" ], "badges": [] }, { "id": "e-york", "name": "Jesse York", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-australia-class", "c-petition", "c-advisers" ], "badges": [] }, { "id": "e-wallace", "name": "Brooks Wallace", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-quitam-alabama", "c-fca-settlement", "c-dischargeability" ], "badges": [] }, { "id": "e-farley", "name": "Robert Farley", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-quitam-alabama", "c-fca-settlement", "c-dischargeability" ], "badges": [] }, { "id": "e-fuentes", "name": "Manuel Fuentes", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-quitam-alabama", "c-fca-settlement", "c-dischargeability" ], "badges": [] }, { "id": "e-petrera", "name": "Pasquale Petrera", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-quitam-maryland", "c-fca-settlement" ], "badges": [] }, { "id": "e-centerview", "name": "Centerview Partners", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-advisers", "c-bidding" ], "badges": [] }, { "id": "e-ropes", "name": "Ropes & Gray LLP", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-advisers", "c-bidding", "c-tpg-release", "c-letter-ruling" ], "badges": [] }, { "id": "e-riveron", "name": "Riveron RTS, LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-advisers" ], "badges": [], "jurisdiction": "us" }, { "id": "e-ycst", "name": "Young Conaway Stargatt & Taylor, LLP", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-advisers" ], "badges": [], "jurisdiction": "us" }, { "id": "e-whitecase", "name": "White & Case LLP", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-advisers" ], "badges": [] }, { "id": "e-milbank", "name": "Milbank LLP", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-adhoc-rsa", "c-apa" ], "badges": [], "jurisdiction": "us" }, { "id": "e-eibidco", "name": "EI Bidco, LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-adhoc-rsa", "c-apa", "c-bidding" ], "badges": [], "jurisdiction": "us" }, { "id": "e-watiga", "name": "Watiga Trust Ltd", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-apa", "c-watiga" ], "badges": [], "jurisdiction": "sg" }, { "id": "e-richards", "name": "Matthew Richards", "type": "person", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-apa", "c-watiga" ], "badges": [] }, { "id": "e-glas", "name": "Global Loan Agency Services Group", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-watiga" ], "badges": [] }, { "id": "e-jointmedica", "name": "JointMedica Limited", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-jointmedica", "c-intercompany" ], "badges": [], "jurisdiction": "gb" }, { "id": "e-jm-inv", "name": "JointMedica Investment Holdings, L.P.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-jointmedica" ], "badges": [] }, { "id": "e-ucc", "name": "Official Committee of Unsecured Creditors of Exactech, Inc.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-case-parties", "c-tpg-release", "c-confirmation", "c-ucc-allegations" ], "badges": [] }, { "id": "e-brownrudnick", "name": "Brown Rudnick LLP", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-tpg-release", "c-confirmation", "c-trust-suit" ], "badges": [], "jurisdiction": "us" }, { "id": "e-reisman", "name": "Ellen K. Reisman", "type": "person", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-confirmation", "c-trust-suit" ], "badges": [] }, { "id": "e-halperin", "name": "Alan D. Halperin", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-confirmation", "c-wind-down" ], "badges": [] }, { "id": "e-guc-trust", "name": "Exactech Commercial GUC Liquidating Trust", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-confirmation", "c-wind-down" ], "badges": [], "jurisdiction": "us" }, { "id": "e-svp", "name": "Strategic Value Partners, LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-confirmation", "c-advita-launch", "c-advita-registry" ], "badges": [], "jurisdiction": "us" }, { "id": "e-stellex", "name": "Stellex Capital Management LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-confirmation", "c-advita-launch" ], "badges": [] }, { "id": "e-greywolf", "name": "Greywolf Capital Management LP", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-confirmation", "c-advita-launch" ], "badges": [] }, { "id": "e-dundon", "name": "Matthew Dundon", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-wind-down" ], "badges": [] }, { "id": "e-coleschotz", "name": "Cole Schotz P.C.", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-wind-down" ], "badges": [], "jurisdiction": "us" }, { "id": "e-wright", "name": "Rick Wright", "type": "person", "role": "", "period": "", "group": "leadership", "claim_ids": [ "c-wind-down" ], "badges": [] }, { "id": "e-dundon-adv", "name": "Dundon Advisers LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-wind-down" ], "badges": [], "jurisdiction": "us" }, { "id": "e-ferrari", "name": "Luigi Ferrari", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-launch" ], "badges": [] }, { "id": "e-ekdahl", "name": "Andrew Ekdahl", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-launch" ], "badges": [] }, { "id": "e-demski", "name": "Dave Demski", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-launch" ], "badges": [] }, { "id": "e-debaca", "name": "Steve C de Baca", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-launch" ], "badges": [] }, { "id": "e-anderson", "name": "Clara Anderson", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-launch" ], "badges": [] }, { "id": "e-drichards", "name": "Dave Richards", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-launch" ], "badges": [] }, { "id": "e-demarco", "name": "Catherine DeMarco", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-launch" ], "badges": [] }, { "id": "e-cjames", "name": "Craig James", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-launch" ], "badges": [] }, { "id": "e-figg", "name": "Jeffrey Figg", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-execs" ], "badges": [] }, { "id": "e-lopes", "name": "Jorge Lopes", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-execs" ], "badges": [] }, { "id": "e-ryoung", "name": "Rebecca Young", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-execs" ], "badges": [] }, { "id": "e-haydock", "name": "Paul Haydock", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-advita-execs" ], "badges": [] }, { "id": "e-advita-h1", "name": "Advita Holdings LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-advita-registry" ], "badges": [] }, { "id": "e-advita-h2", "name": "Advita Holdings II LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-advita-registry" ], "badges": [] }, { "id": "e-italia", "name": "Exactech Italia S.p.A.", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-italy", "c-intercompany" ], "badges": [], "jurisdiction": "it" }, { "id": "e-kohtz", "name": "Alexander Kohtz", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-germany" ], "badges": [] }, { "id": "e-backhuss", "name": "David Timm Backhuß", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-germany", "c-austria" ], "badges": [] }, { "id": "e-hohl", "name": "Nicolas Hohl", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-germany", "c-uk", "c-uk2" ], "badges": [] }, { "id": "e-andrews", "name": "Richard Edmund Andrews Jr.", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-swiss", "c-uk", "c-uk2" ], "badges": [] }, { "id": "e-rognoni", "name": "Monica Rognoni", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-swiss" ], "badges": [] }, { "id": "e-mouillac", "name": "Laurent Mouillac", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-france" ], "badges": [] }, { "id": "e-eog", "name": "Exactech EÖG GmbH", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-austria", "c-intercompany" ], "badges": [], "jurisdiction": "at" }, { "id": "e-cintron", "name": "Elliot Ness Cintron", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-uk" ], "badges": [] }, { "id": "e-astoin", "name": "Eric Astoin", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-uk", "c-uk2" ], "badges": [] }, { "id": "e-beckley", "name": "Nathan Beckley", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-uk", "c-uk2" ], "badges": [] }, { "id": "e-ohare", "name": "Andrew O'Hare", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-uk", "c-uk2" ], "badges": [] }, { "id": "e-uk2", "name": "Exactech (UK) 2 Limited", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-uk2" ], "badges": [], "jurisdiction": "gb" }, { "id": "e-tpg-ops", "name": "TPG Operations, LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-trust-suit" ], "badges": [ { "label": "Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoing", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A13", "subject_id": "e-tpg-ops" } ] }, { "id": "e-tpg-h2", "name": "TPG Holdings II Sub, LP", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-trust-suit" ], "badges": [ { "label": "Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoing", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A13", "subject_id": "e-tpg-h2" } ] }, { "id": "e-tpg-fo", "name": "TPG Capital – FO, LLC", "type": "organization", "role": "", "period": "", "group": "counterparties", "claim_ids": [ "c-trust-suit" ], "badges": [ { "label": "Defendant in the Settlement Trust's pending alter-ego suit (Del. Ch. 2026-0129); TPG denies wrongdoing", "claim_ids": [ "c-trust-suit" ], "category": "CIVIL_LITIGATION", "code": "A13", "subject_id": "e-tpg-fo" } ] }, { "id": "e-blueortho", "name": "Blue Ortho SAS", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-blueortho", "c-intercompany" ], "badges": [], "jurisdiction": "fr" }, { "id": "e-boyer", "name": "Anthony Boyer", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-blueortho" ], "badges": [] }, { "id": "e-stiehl", "name": "James Stiehl", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-blueortho" ], "badges": [] }, { "id": "e-lavallee", "name": "Stéphane Lavallée", "type": "person", "role": "", "period": "", "group": "other", "claim_ids": [ "c-blueortho" ], "badges": [] }, { "id": "e-korea", "name": "Exactech Korea Jusik Hoesa", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-intercompany" ], "badges": [], "jurisdiction": "kr" }, { "id": "e-pt", "name": "Exactech Portugal, LDA", "type": "organization", "role": "", "period": "", "group": "group_companies", "claim_ids": [ "c-intercompany" ], "badges": [], "jurisdiction": "pt" } ], "edges": [ { "id": "r-wpetty-exac", "from": "e-wpetty", "to": "e-exac", "role": "Co-founder; chairman of the board since inception", "period": "From 1985", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-founding" ], "kind": "directs" }, { "id": "r-wpetty-exac-2", "from": "e-wpetty", "to": "e-exac", "role": "Chief executive officer", "period": "1985 – 2014", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-founding" ], "kind": "directs" }, { "id": "r-wpetty-exac-3", "from": "e-wpetty", "to": "e-exac", "role": "President", "period": "January 2002 – December 2007", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-founding" ], "kind": "directs" }, { "id": "r-miller-exac", "from": "e-miller", "to": "e-exac", "role": "Co-founder; vice president, later executive vice president, research and development", "period": "From 1986 (executive vice president from February 2000)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-founding" ], "kind": "employs" }, { "id": "r-miller-exac-2", "from": "e-miller", "to": "e-exac", "role": "Director", "period": "March 1989 – May 2003", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-founding" ], "kind": "directs" }, { "id": "r-bpetty-exac", "from": "e-bpetty", "to": "e-exac", "role": "Co-founder; company secretary since inception; treasurer and director until March 1996", "period": "From 1985", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-founding" ], "kind": "employs" }, { "id": "r-wpetty-bpetty", "from": "e-wpetty", "to": "e-bpetty", "role": "Spouse", "period": "As stated in the 1996 and 2018 filings", "status": "documented", "direction": "undirected", "role_group": "associations", "temporal_status": "unknown", "claim_ids": [ "c-founding" ], "kind": "family" }, { "id": "r-wpetty-dpetty", "from": "e-wpetty", "to": "e-dpetty", "role": "Father", "period": "As stated in the 2018 merger proxy", "status": "documented", "direction": "directed", "role_group": "associations", "temporal_status": "unknown", "claim_ids": [ "c-founding" ], "kind": "family" }, { "id": "r-wpetty-exac-4", "from": "e-wpetty", "to": "e-exac", "role": "Principal shareholder: 1,323,271 shares (44.6% before the 1996 offering), mostly held jointly with Betty Petty", "period": "Before the 1996 initial public offering", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "owns" }, { "id": "r-bpetty-exac-2", "from": "e-bpetty", "to": "e-exac", "role": "Joint holder with William Petty of 1,318,699 shares", "period": "Before the 1996 initial public offering", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "owns" }, { "id": "r-miller-exac-3", "from": "e-miller", "to": "e-exac", "role": "Shareholder: 285,002 shares (9.6% before the 1996 offering)", "period": "Before the 1996 initial public offering", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "owns" }, { "id": "r-wpetty-exac-5", "from": "e-wpetty", "to": "e-exac", "role": "Holder, with Betty Petty, of the first right to buy family members' shares under the family shareholders agreement", "period": "From before the 1996 offering", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "owns" }, { "id": "r-bpetty-exac-3", "from": "e-bpetty", "to": "e-exac", "role": "Holder, with William Petty, of the first right to buy family members' shares under the family shareholders agreement", "period": "From before the 1996 offering", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "owns" }, { "id": "r-seese-exac", "from": "e-seese", "to": "e-exac", "role": "President and chief operating officer; director", "period": "From March 1991 (director from April 1991)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "directs" }, { "id": "r-phillips-exac", "from": "e-phillips", "to": "e-exac", "role": "Treasurer", "period": "From March 1996", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "employs" }, { "id": "r-exac-hss", "from": "e-exac", "to": "e-hss", "role": "Licensee paying royalties on the Optetrak knee system", "period": "As described in 1996", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "business" }, { "id": "r-exac-accumed", "from": "e-exac", "to": "e-accumed", "role": "Licensee paying royalties on a bipolar hip prosthesis", "period": "As described in 1996", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "business" }, { "id": "r-wpetty-exac-6", "from": "e-wpetty", "to": "e-exac", "role": "Design-team member receiving royalties on products", "period": "As described in 1996 and 2010", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "business" }, { "id": "r-miller-exac-4", "from": "e-miller", "to": "e-exac", "role": "Design-team member receiving royalties on products", "period": "As described in 1996 and 2010", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-pre-ipo" ], "kind": "business" }, { "id": "r-jointmedical-exac", "from": "e-jointmedical", "to": "e-exac", "role": "Plaintiff in a 1995 patent-infringement action (dismissed without prejudice as to Exactech on 28 July 1995)", "period": "3 April 1995 – 28 July 1995", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "historical", "claim_ids": [ "c-early-suits" ], "kind": "legal" }, { "id": "r-wpetty-exac-7", "from": "e-wpetty", "to": "e-exac", "role": "Beneficial owner, with Betty Petty, of 29.5% (including 27.3% through Prima Investments, Limited Partnership)", "period": "Record date of the 2010 proxy statement", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-2010-holders" ], "kind": "owns" }, { "id": "r-prima-lp-exac", "from": "e-prima-lp", "to": "e-exac", "role": "Shareholder: 3,517,498 shares (27.3%)", "period": "Record date of the 2010 proxy statement", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-2010-holders" ], "kind": "owns" }, { "id": "r-miller-exac-5", "from": "e-miller", "to": "e-exac", "role": "Beneficial owner of 4.0% (including 3.2% through Millerworks, Limited Partnership)", "period": "Record date of the 2010 proxy statement", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-2010-holders" ], "kind": "owns" }, { "id": "r-millerworks-exac", "from": "e-millerworks", "to": "e-exac", "role": "Shareholder: 411,212 shares (3.2%)", "period": "Record date of the 2010 proxy statement", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-2010-holders" ], "kind": "owns" }, { "id": "r-miller-millerworks", "from": "e-miller", "to": "e-millerworks", "role": "Owner of the general partner (Millerworks, Inc.); his family holds all partnership interests", "period": "As of 2010", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-2010-holders" ], "kind": "owns" }, { "id": "r-gamco-exac", "from": "e-gamco", "to": "e-exac", "role": "Shareholder: 798,294 shares (6.2%)", "period": "Record date of the 2010 proxy statement", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-2010-holders" ], "kind": "owns" }, { "id": "r-fmr-exac", "from": "e-fmr", "to": "e-exac", "role": "Shareholder: 707,500 shares (5.5%)", "period": "Record date of the 2010 proxy statement", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-2010-holders" ], "kind": "owns" }, { "id": "r-dpetty-exac", "from": "e-dpetty", "to": "e-exac", "role": "President and director", "period": "As of March 2010 (president from November 2007)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "directs" }, { "id": "r-phillips-exac-2", "from": "e-phillips", "to": "e-exac", "role": "Chief financial officer and treasurer", "period": "As of March 2010", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "employs" }, { "id": "r-thompson-exac", "from": "e-thompson", "to": "e-exac", "role": "Senior vice president (general manager, biologics and spine division, in 2010; strategic initiatives by 2018)", "period": "2010 – 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "employs" }, { "id": "r-bpetty-exac-4", "from": "e-bpetty", "to": "e-exac", "role": "Vice president and corporate secretary", "period": "As of 2010; vice president, administration, in 2018–2019", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "employs" }, { "id": "r-burstein-exac", "from": "e-burstein", "to": "e-exac", "role": "Director", "period": "From March 1996", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "directs" }, { "id": "r-kearney-exac", "from": "e-kearney", "to": "e-exac", "role": "Director", "period": "From September 1989", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "directs" }, { "id": "r-metts-exac", "from": "e-metts", "to": "e-exac", "role": "Director", "period": "From April 1998", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "directs" }, { "id": "r-locander-exac", "from": "e-locander", "to": "e-exac", "role": "Director", "period": "As of 2010 and until the 2018 merger", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "directs" }, { "id": "r-binch-exac", "from": "e-binch", "to": "e-exac", "role": "Director", "period": "As of 2010 and until the 2018 merger", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "directs" }, { "id": "r-rsmith-exac", "from": "e-rsmith", "to": "e-exac", "role": "Director (nominated in 2010)", "period": "From 2010 until the 2018 merger", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "directs" }, { "id": "r-burstein-hss", "from": "e-burstein", "to": "e-hss", "role": "Senior scientist and associate attending orthopaedic surgeon (biomechanical engineering)", "period": "1976 – 1996", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "employs" }, { "id": "r-mcgladrey-exac", "from": "e-mcgladrey", "to": "e-exac", "role": "Independent registered public accounting firm", "period": "From 2007", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-2010-board" ], "kind": "business" }, { "id": "r-brighton-exac", "from": "e-brighton", "to": "e-exac", "role": "Supplier of raw materials, equipment and licences (related party)", "period": "Until its acquisition on 24 May 2010 (purchases reported for 2007–2009)", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "business" }, { "id": "r-burstein-brighton", "from": "e-burstein", "to": "e-brighton", "role": "Beneficial owner of 24%", "period": "As of 2010, until the sale of 24 May 2010", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "owns" }, { "id": "r-wpetty-brighton", "from": "e-wpetty", "to": "e-brighton", "role": "Joint owner with Betty Petty of 4.6%", "period": "As of 2010, until the sale of 24 May 2010", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "owns" }, { "id": "r-miller-brighton", "from": "e-miller", "to": "e-brighton", "role": "Beneficial owner of 2.8%", "period": "As of 2010, until the sale of 24 May 2010", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "owns" }, { "id": "r-exac-brighton", "from": "e-exac", "to": "e-brighton", "role": "Acquirer of all shares for $5,500,000", "period": "From 24 May 2010", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "owns" }, { "id": "r-burstein-exac-2", "from": "e-burstein", "to": "e-exac", "role": "Seller of Brighton Partners shares and sellers' representative", "period": "24 May 2010", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "business" }, { "id": "r-wpetty-exac-8", "from": "e-wpetty", "to": "e-exac", "role": "Seller of Brighton Partners shares and sellers' representative", "period": "24 May 2010", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "business" }, { "id": "r-miller-exac-6", "from": "e-miller", "to": "e-exac", "role": "Seller of Brighton Partners shares", "period": "24 May 2010", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "business" }, { "id": "r-seese-exac-2", "from": "e-seese", "to": "e-exac", "role": "Seller of Brighton Partners shares", "period": "24 May 2010", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "business" }, { "id": "r-burstein-exac-3", "from": "e-burstein", "to": "e-exac", "role": "Consultant under a verbal consulting agreement ($180,000 for 2009)", "period": "As of 2009", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "business" }, { "id": "r-ahb-exac", "from": "e-ahb", "to": "e-exac", "role": "Provider of transition services after the Brighton Partners purchase", "period": "From 24 May 2010", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "business" }, { "id": "r-burstein-ahb", "from": "e-burstein", "to": "e-ahb", "role": "Owner of the consulting company", "period": "As of 2010", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-brighton" ], "kind": "owns" }, { "id": "r-dpetty-brighton", "from": "e-dpetty", "to": "e-brighton", "role": "Listed officer (register index; no title or dates shown)", "period": "Date not recorded", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-petty-companies" ], "kind": "directs" }, { "id": "r-bpetty-brighton", "from": "e-bpetty", "to": "e-brighton", "role": "Listed officer (register index; no title or dates shown)", "period": "Date not recorded", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-petty-companies" ], "kind": "directs" }, { "id": "r-dpetty-exactortho", "from": "e-dpetty", "to": "e-exactortho", "role": "Chief executive officer", "period": "From 7 December 2017 until the dissolution of 27 September 2019", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-petty-companies" ], "kind": "directs" }, { "id": "r-wpetty-exactortho", "from": "e-wpetty", "to": "e-exactortho", "role": "Officer and registered agent", "period": "From 7 December 2017 until the dissolution of 27 September 2019", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-petty-companies" ], "kind": "directs" }, { "id": "r-bpetty-exactortho", "from": "e-bpetty", "to": "e-exactortho", "role": "Officer", "period": "From 7 December 2017 until the dissolution of 27 September 2019", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-petty-companies" ], "kind": "directs" }, { "id": "r-wpetty-prima-inc", "from": "e-wpetty", "to": "e-prima-inc", "role": "President and registered agent", "period": "As of the 2019 annual report", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-petty-companies" ], "kind": "directs" }, { "id": "r-exac-intl", "from": "e-exac", "to": "e-intl", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in the earlier exhibit and in 2013", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-shanghai", "from": "e-exac", "to": "e-shanghai", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in the earlier exhibit and in 2013; sold in September 2017", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-taiwan", "from": "e-exac", "to": "e-taiwan", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in the earlier exhibit and in 2013; majority sold in 2017", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-uk", "from": "e-exac", "to": "e-uk", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in the earlier exhibit and in 2013", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-kk", "from": "e-exac", "to": "e-kk", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in the earlier exhibit and in 2013", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-altiva", "from": "e-exac", "to": "e-altiva", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in the earlier exhibit only", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-exus", "from": "e-exac", "to": "e-exus", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in 2013", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-eio", "from": "e-exac", "to": "e-eio", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in 2013", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-fr", "from": "e-exac", "to": "e-fr", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in 2013", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-de", "from": "e-exac", "to": "e-de", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in 2013", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-iberica", "from": "e-exac", "to": "e-iberica", "role": "Parent (subsidiary listed in Exhibit 21.1)", "period": "Listed in 2013", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exhibit21" ], "kind": "owns" }, { "id": "r-exac-intl-2", "from": "e-exac", "to": "e-intl", "role": "Manager of the Florida LLC", "period": "Until the voluntary dissolution of 9 August 2016", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-intl-llc" ], "kind": "owns" }, { "id": "r-exac-exus-2", "from": "e-exac", "to": "e-exus", "role": "Parent of the United States sales and distribution subsidiary", "period": "Until the merger (effective 8 October 2020, filed 8 February 2023)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exus" ], "kind": "owns" }, { "id": "r-exac-exus-3", "from": "e-exac", "to": "e-exus", "role": "Surviving corporation of the merger of Exactech U.S., Inc. into Exactech, Inc.", "period": "Filed 8 February 2023, effective 8 October 2020", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-exus" ], "kind": "owns" }, { "id": "r-johnson-exus", "from": "e-johnson", "to": "e-exus", "role": "President", "period": "As of the 2022–2023 annual reports", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-exus" ], "kind": "directs" }, { "id": "r-edwards-exus", "from": "e-edwards", "to": "e-exus", "role": "Secretary", "period": "As of the 2022–2023 annual reports", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-exus" ], "kind": "directs" }, { "id": "r-collins-exus", "from": "e-collins", "to": "e-exus", "role": "Chief financial officer", "period": "As of the 2023 annual report", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-exus" ], "kind": "directs" }, { "id": "r-kleopfer-exus", "from": "e-kleopfer", "to": "e-exus", "role": "Director", "period": "As of the 2022–2023 annual reports", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-exus" ], "kind": "directs" }, { "id": "r-thompson-exus", "from": "e-thompson", "to": "e-exus", "role": "Director", "period": "As of the 2022–2023 annual reports", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-exus" ], "kind": "directs" }, { "id": "r-bolukbasi-exus", "from": "e-bolukbasi", "to": "e-exus", "role": "Treasurer", "period": "As of the 2022 West Virginia annual report", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-exus" ], "kind": "directs" }, { "id": "r-dpetty-barbados", "from": "e-dpetty", "to": "e-barbados", "role": "Director", "period": "From 29 January 1999 (company closed 24 October 2003)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-barbados" ], "kind": "directs" }, { "id": "r-wpetty-barbados", "from": "e-wpetty", "to": "e-barbados", "role": "Director", "period": "From 29 January 1999 (company closed 24 October 2003)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-barbados" ], "kind": "directs" }, { "id": "r-seese-barbados", "from": "e-seese", "to": "e-barbados", "role": "Director", "period": "From 29 January 1999 (company closed 24 October 2003)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-barbados" ], "kind": "directs" }, { "id": "r-miller-barbados", "from": "e-miller", "to": "e-barbados", "role": "Director", "period": "From 29 January 1999 (company closed 24 October 2003)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-barbados" ], "kind": "directs" }, { "id": "r-exac-tecres", "from": "e-exac", "to": "e-tecres", "role": "Distributor of its products under an exclusive agreement", "period": "As described in the 2016 annual report", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-operations" ], "kind": "business" }, { "id": "r-exac-rti", "from": "e-exac", "to": "e-rti", "role": "Distributor of its products under a non-exclusive agreement", "period": "As described in the 2016 annual report", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-operations" ], "kind": "business" }, { "id": "r-exac-biomatlante", "from": "e-exac", "to": "e-biomatlante", "role": "Distributor of its products under a non-exclusive agreement", "period": "As described in the 2016 annual report", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-operations" ], "kind": "business" }, { "id": "r-exac-jpmchase", "from": "e-exac", "to": "e-jpmchase", "role": "Borrower under a $150 million revolving credit facility led by the bank", "period": "From December 2015", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-portfolio-2016" ], "kind": "business" }, { "id": "r-exac-au", "from": "e-exac", "to": "e-au", "role": "Parent (acquired its independent Australian distributor)", "period": "From February 2016", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-portfolio-2016" ], "kind": "owns" }, { "id": "r-exac-odna", "from": "e-exac", "to": "e-odna", "role": "Holder of 24.55%", "period": "From October 2016", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-portfolio-2016" ], "kind": "owns" }, { "id": "r-biogend-taiwan", "from": "e-biogend", "to": "e-taiwan", "role": "Acquirer of 81% (31 July 2017); absorbed the company by merger on 31 December 2017", "period": "31 July 2017 – 31 December 2017", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-portfolio-2016" ], "kind": "owns" }, { "id": "r-exac-biogend", "from": "e-exac", "to": "e-biogend", "role": "Shareholder (about 5% reported in June 2019)", "period": "As reported in June 2019", "status": "reported", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-portfolio-2016" ], "kind": "owns" }, { "id": "r-exac-greenberg", "from": "e-exac", "to": "e-greenberg", "role": "Client: outside counsel authorised to sign the 2010 deferred prosecution agreement", "period": "December 2010", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-dpa-2010" ], "kind": "business" }, { "id": "r-donofrio-exac", "from": "e-donofrio", "to": "e-exac", "role": "Director of sales, Northeast region", "period": "About 2002 – 2010 (in post at the time of the plea)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-donofrio" ], "kind": "employs" }, { "id": "r-hann-tpg", "from": "e-hann", "to": "e-tpg", "role": "Representative of TPG at the first meeting with Exactech (1 May 2017)", "period": "2017", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-deal-background" ], "kind": "other" }, { "id": "r-binder-tpg", "from": "e-binder", "to": "e-tpg", "role": "Adviser (former Biomet chief executive) taking part in the 2017 approach", "period": "2017", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-deal-background" ], "kind": "other" }, { "id": "r-sisitsky-tpg", "from": "e-sisitsky", "to": "e-tpg", "role": "Managing partner of TPG Capital North America", "period": "As of 2017", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-deal-background" ], "kind": "employs" }, { "id": "r-garrison-tpg", "from": "e-garrison", "to": "e-tpg", "role": "Principal", "period": "As of 2017", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-deal-background" ], "kind": "employs" }, { "id": "r-binch-exac-2", "from": "e-binch", "to": "e-exac", "role": "Lead independent director", "period": "As of 2017", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-deal-background" ], "kind": "directs" }, { "id": "r-exac-tpg-global", "from": "e-exac", "to": "e-tpg-global", "role": "Party to the confidentiality agreement of 7 August 2017", "period": "7 August 2017", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-deal-background" ], "kind": "business" }, { "id": "r-osteon-lp-mergersub", "from": "e-osteon-lp", "to": "e-mergersub", "role": "Parent (100%) of the merger subsidiary", "period": "22 October 2017 – 14 February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-merger-agreement" ], "kind": "owns" }, { "id": "r-tpg7-osteon-lp", "from": "e-tpg7", "to": "e-osteon-lp", "role": "Fund that jointly owned Parent and committed up to $737,057,000 of equity", "period": "From 22 October 2017", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-merger-agreement" ], "kind": "owns" }, { "id": "r-tpg-osteon-lp", "from": "e-tpg", "to": "e-osteon-lp", "role": "Sponsor: Parent described as an affiliate of TPG Capital, L.P.", "period": "2017 – 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-merger-agreement" ], "kind": "other" }, { "id": "r-exac-osteon-lp", "from": "e-exac", "to": "e-osteon-lp", "role": "Target company under the merger agreement of 22 October 2017 (price $49.25 per share after the amendment)", "period": "22 October 2017 – 14 February 2018", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-merger-agreement" ], "kind": "business" }, { "id": "r-osteon-lp-exac", "from": "e-osteon-lp", "to": "e-exac", "role": "Agreed parent (100%) after the merger", "period": "Agreed 22 October 2017; at closing the parent was Osteon Holdings, Inc.", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-merger-agreement" ], "kind": "owns" }, { "id": "r-exac-jpm", "from": "e-exac", "to": "e-jpm", "role": "Client: financial adviser on the merger (engagement letter of 13 October 2017)", "period": "October 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-merger-agreement" ], "kind": "business" }, { "id": "r-wpetty-exac-9", "from": "e-wpetty", "to": "e-exac", "role": "Executive chairman and chairman of the board", "period": "As of January 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2018" ], "kind": "directs" }, { "id": "r-dpetty-exac-2", "from": "e-dpetty", "to": "e-exac", "role": "President", "period": "November 2007 – 2018 (president in 2019 annual report)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2018" ], "kind": "directs" }, { "id": "r-dpetty-exac-3", "from": "e-dpetty", "to": "e-exac", "role": "Chief executive officer", "period": "March 2014 – January 2020", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2018", "c-executives" ], "kind": "directs" }, { "id": "r-phillips-exac-3", "from": "e-phillips", "to": "e-exac", "role": "Executive vice president, chief financial officer and treasurer", "period": "As of 2015 – 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2018" ], "kind": "employs" }, { "id": "r-watts-exac", "from": "e-watts", "to": "e-exac", "role": "Independent director", "period": "As of January 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2018" ], "kind": "directs" }, { "id": "r-krusen-exac", "from": "e-krusen", "to": "e-exac", "role": "Independent director", "period": "As of January 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2018" ], "kind": "directs" }, { "id": "r-prima-lp-osteon-lp", "from": "e-prima-lp", "to": "e-osteon-lp", "role": "Rollover investor: 2,300,000 Exactech shares exchanged for 130,757,376 Class B Parent shares", "period": "December 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-wpetty-osteon-lp", "from": "e-wpetty", "to": "e-osteon-lp", "role": "Rollover investor: 102,400 shares exchanged for 5,821,546 Class B Parent shares", "period": "December 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-bpetty-osteon-lp", "from": "e-bpetty", "to": "e-osteon-lp", "role": "Rollover investor: 75,400 shares exchanged for 3,713,450 Class A Parent shares", "period": "December 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-dpetty-osteon-lp", "from": "e-dpetty", "to": "e-osteon-lp", "role": "Rollover investor: 50,000 shares exchanged for 2,462,500 Class A Parent shares", "period": "December 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-mfh-llc-osteon-lp", "from": "e-mfh-llc", "to": "e-osteon-lp", "role": "Rollover investor: 47,650 Exactech shares", "period": "December 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-phillips-osteon-lp", "from": "e-phillips", "to": "e-osteon-lp", "role": "Rollover investor: 82,000 Exactech shares", "period": "December 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-thompson-osteon-lp", "from": "e-thompson", "to": "e-osteon-lp", "role": "Rollover investor: 25,279 Exactech shares", "period": "December 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-edwards-osteon-lp", "from": "e-edwards", "to": "e-osteon-lp", "role": "Rollover investor: 18,052 Exactech shares", "period": "December 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-szabo-osteon-lp", "from": "e-szabo", "to": "e-osteon-lp", "role": "Rollover investor: 6,345 Exactech shares", "period": "December 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-roche-osteon-lp", "from": "e-roche", "to": "e-osteon-lp", "role": "Rollover investor: 4,458 Exactech shares", "period": "December 2017 – February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-tpg7-osteon-lp-2", "from": "e-tpg7", "to": "e-osteon-lp", "role": "Fund with drag-along rights; rollover investors vote in proportion with it", "period": "Agreed terms of December 2017", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-rollover" ], "kind": "owns" }, { "id": "r-wpetty-exac-10", "from": "e-wpetty", "to": "e-exac", "role": "Beneficial owner of 3,589,188 shares (24.3%), including 21.4% through Prima Investments, Limited Partnership", "period": "Record date of the merger vote (January 2018)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-prima-lp-exac-2", "from": "e-prima-lp", "to": "e-exac", "role": "Shareholder: 3,080,271 shares", "period": "Record date of the merger vote (January 2018)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-prima-inc-prima-lp", "from": "e-prima-inc", "to": "e-prima-lp", "role": "General partner", "period": "As of 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-wpetty-prima-inc-2", "from": "e-wpetty", "to": "e-prima-inc", "role": "Co-owner with Betty Petty (company wholly owned by the couple)", "period": "As of 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-bpetty-prima-inc", "from": "e-bpetty", "to": "e-prima-inc", "role": "Co-owner with William Petty (company wholly owned by the couple)", "period": "As of 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-wpetty-prima-lp", "from": "e-wpetty", "to": "e-prima-lp", "role": "Limited partner with Betty Petty and their children", "period": "As of 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-bpetty-prima-lp", "from": "e-bpetty", "to": "e-prima-lp", "role": "Limited partner with William Petty and their children", "period": "As of 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-gamco-exac-2", "from": "e-gamco", "to": "e-exac", "role": "Shareholder: 1,863,658 shares (12.9%) as investment adviser", "period": "As reported on 21 November 2017", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-blackrock-exac", "from": "e-blackrock", "to": "e-exac", "role": "Shareholder: 800,197 shares (5.5%)", "period": "Record date of the merger vote (January 2018)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-dfa-exac", "from": "e-dfa", "to": "e-exac", "role": "Shareholder: 751,750 shares (5.2%)", "period": "Record date of the merger vote (January 2018)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-mfh-llc-exac", "from": "e-mfh-llc", "to": "e-exac", "role": "Shareholder: 142,370 shares", "period": "Record date of the merger vote (January 2018)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-miller-exac-7", "from": "e-miller", "to": "e-exac", "role": "Shareholder: shares valued at $8,769,406 at the merger price", "period": "Record date of the merger vote (January 2018)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-phillips-exac-4", "from": "e-phillips", "to": "e-exac", "role": "Shareholder: shares valued at $5,559,143 at the merger price", "period": "Record date of the merger vote (January 2018)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-dpetty-exac-4", "from": "e-dpetty", "to": "e-exac", "role": "Shareholder: shares valued at $3,231,884 at the merger price", "period": "Record date of the merger vote (January 2018)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-mfh-inc-mfh-llc", "from": "e-mfh-inc", "to": "e-mfh-llc", "role": "Principal member", "period": "As of 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-miller-mfh-inc", "from": "e-miller", "to": "e-mfh-inc", "role": "Owner with his wife and children", "period": "As of 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-holders-2018" ], "kind": "owns" }, { "id": "r-arbfund-wpetty", "from": "e-arbfund", "to": "e-wpetty", "role": "Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)", "period": "From 2018; appellate decision of 22 July 2020", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-arbitrage" ], "kind": "legal" }, { "id": "r-arbfund-bpetty", "from": "e-arbfund", "to": "e-bpetty", "role": "Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)", "period": "From 2018; appellate decision of 22 July 2020", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-arbitrage" ], "kind": "legal" }, { "id": "r-arbfund-dpetty", "from": "e-arbfund", "to": "e-dpetty", "role": "Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)", "period": "From 2018; appellate decision of 22 July 2020", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-arbitrage" ], "kind": "legal" }, { "id": "r-arbfund-prima-inc", "from": "e-arbfund", "to": "e-prima-inc", "role": "Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)", "period": "From 2018; appellate decision of 22 July 2020", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-arbitrage" ], "kind": "legal" }, { "id": "r-arbfund-prima-lp", "from": "e-arbfund", "to": "e-prima-lp", "role": "Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)", "period": "From 2018; appellate decision of 22 July 2020", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-arbitrage" ], "kind": "legal" }, { "id": "r-arbfund-binch", "from": "e-arbfund", "to": "e-binch", "role": "Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)", "period": "From 2018; appellate decision of 22 July 2020", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-arbitrage" ], "kind": "legal" }, { "id": "r-arbfund-krusen", "from": "e-arbfund", "to": "e-krusen", "role": "Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)", "period": "From 2018; appellate decision of 22 July 2020", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-arbitrage" ], "kind": "legal" }, { "id": "r-arbfund-locander", "from": "e-arbfund", "to": "e-locander", "role": "Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)", "period": "From 2018; appellate decision of 22 July 2020", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-arbitrage" ], "kind": "legal" }, { "id": "r-arbfund-rsmith", "from": "e-arbfund", "to": "e-rsmith", "role": "Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)", "period": "From 2018; appellate decision of 22 July 2020", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-arbitrage" ], "kind": "legal" }, { "id": "r-arbfund-watts", "from": "e-arbfund", "to": "e-watts", "role": "Plaintiff in a shareholder suit for breach of fiduciary duty over the 2018 sale (Fla. 3d DCA No. 3D19-797 on class certification)", "period": "From 2018; appellate decision of 22 July 2020", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-arbitrage" ], "kind": "legal" }, { "id": "r-exac-mergersub", "from": "e-exac", "to": "e-mergersub", "role": "Surviving corporation of the merger with Osteon Merger Sub, Inc.", "period": "14 February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-closing" ], "kind": "owns" }, { "id": "r-tpg-exac", "from": "e-tpg", "to": "e-exac", "role": "Acquirer of all common stock through its affiliated fund and holding companies (Exactech's closing announcement)", "period": "14 February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-closing" ], "kind": "owns" }, { "id": "r-osteon-exac", "from": "e-osteon", "to": "e-exac", "role": "Indirect parent (100%) after the merger", "period": "From 14 February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-closing" ], "kind": "owns" }, { "id": "r-lagatta-mergersub", "from": "e-lagatta", "to": "e-mergersub", "role": "Vice president; signed the articles of merger", "period": "February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-closing" ], "kind": "directs" }, { "id": "r-tpg-genpar-tpg7", "from": "e-tpg-genpar", "to": "e-tpg7", "role": "General partner", "period": "As of February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-closing" ], "kind": "owns" }, { "id": "r-tpg-genpar-adv-tpg-genpar", "from": "e-tpg-genpar-adv", "to": "e-tpg-genpar", "role": "General partner", "period": "As of February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-closing" ], "kind": "owns" }, { "id": "r-lagatta-tpg-genpar-adv", "from": "e-lagatta", "to": "e-tpg-genpar-adv", "role": "Vice president; signed for TPG Partners VII, L.P. through its general-partner chain", "period": "February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-closing" ], "kind": "directs" }, { "id": "r-exac-nasdaq", "from": "e-exac", "to": "e-nasdaq", "role": "Listed issuer (ticker EXAC)", "period": "1996 – 15 February 2018", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-closing" ], "kind": "business" }, { "id": "r-garrison-osteon", "from": "e-garrison", "to": "e-osteon", "role": "Director", "period": "From February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-form-d" ], "kind": "directs" }, { "id": "r-sisitsky-osteon", "from": "e-sisitsky", "to": "e-osteon", "role": "Director", "period": "From February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-form-d" ], "kind": "directs" }, { "id": "r-schilling-osteon", "from": "e-schilling", "to": "e-osteon", "role": "Director", "period": "From February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-form-d" ], "kind": "directs" }, { "id": "r-binder-osteon", "from": "e-binder", "to": "e-osteon", "role": "Director", "period": "From February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-form-d" ], "kind": "directs" }, { "id": "r-dpetty-osteon", "from": "e-dpetty", "to": "e-osteon", "role": "Director", "period": "From February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-form-d" ], "kind": "directs" }, { "id": "r-wpetty-osteon", "from": "e-wpetty", "to": "e-osteon", "role": "Director", "period": "From February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-form-d" ], "kind": "directs" }, { "id": "r-lagatta-osteon", "from": "e-lagatta", "to": "e-osteon", "role": "Executive officer", "period": "As of February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-form-d" ], "kind": "directs" }, { "id": "r-fliss-osteon", "from": "e-fliss", "to": "e-osteon", "role": "Executive officer; signed the Form D as vice president", "period": "As of February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-form-d" ], "kind": "directs" }, { "id": "r-hann-tpg-2", "from": "e-hann", "to": "e-tpg", "role": "Consultant to TPG (per the complaint)", "period": "As of 2017", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-trust-deal" ], "kind": "other" }, { "id": "r-osteon2-exac", "from": "e-osteon2", "to": "e-exac", "role": "Sole shareholder (100%)", "period": "From 14 February 2018; as stated at the petition date (29 October 2024)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-chain-petition" ], "kind": "owns" }, { "id": "r-osteon2-exac-2", "from": "e-osteon2", "to": "e-exac", "role": "'Holdings' and guarantor under the first-lien credit agreement", "period": "From 14 February 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-chain-petition" ], "kind": "owns" }, { "id": "r-xpand-exac", "from": "e-xpand", "to": "e-exac", "role": "Guarantor of the first-lien loans", "period": "From 14 February 2018", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-chain-petition" ], "kind": "business" }, { "id": "r-exac-goldman", "from": "e-exac", "to": "e-goldman", "role": "Borrower under the first-lien credit agreement, for which the bank was agent", "period": "14 February 2018 – 28 October 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-chain-petition" ], "kind": "business" }, { "id": "r-exac-glas-us", "from": "e-exac", "to": "e-glas-us", "role": "Borrower under the first-lien credit agreement, for which the company became agent", "period": "From 28 October 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-chain-petition" ], "kind": "business" }, { "id": "r-osteon-osteon1", "from": "e-osteon", "to": "e-osteon1", "role": "Parent (100%)", "period": "2018 – 2024 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-trust-chain" ], "kind": "owns" }, { "id": "r-osteon1-osteon2", "from": "e-osteon1", "to": "e-osteon2", "role": "Parent (100%)", "period": "2018 – 2024 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-trust-chain" ], "kind": "owns" }, { "id": "r-exac-xpand", "from": "e-exac", "to": "e-xpand", "role": "Parent (100%)", "period": "As of the 2024 petition (per the complaint)", "status": "reported", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-trust-chain" ], "kind": "owns" }, { "id": "r-sponsor-osteon", "from": "e-sponsor", "to": "e-osteon", "role": "Majority shareholder (88%) and Majority Lead Investor under the shareholders agreement", "period": "2018 – 2024 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-trust-chain" ], "kind": "owns" }, { "id": "r-tpg7-sponsor", "from": "e-tpg7", "to": "e-sponsor", "role": "Holder of 95% and funder", "period": "From 2018 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-trust-chain" ], "kind": "owns" }, { "id": "r-tpg-tpg7", "from": "e-tpg", "to": "e-tpg7", "role": "Sponsor of the fund (one of TPG, Inc.'s funds)", "period": "Per the complaint", "status": "reported", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-trust-chain" ], "kind": "owns" }, { "id": "r-sponsor-exac", "from": "e-sponsor", "to": "e-exac", "role": "Sponsor: direct or indirect equityholder, manager, consultant and lender (restructuring support agreement definition)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-sponsor-loans" ], "kind": "owns" }, { "id": "r-sponsor-exac-2", "from": "e-sponsor", "to": "e-exac", "role": "Agent and sole lender under the sidecar credit agreement ($28,525,064.59 outstanding at the petition date)", "period": "From 19 September 2023", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-sponsor-loans" ], "kind": "business" }, { "id": "r-tpg-mgmt-exac", "from": "e-tpg-mgmt", "to": "e-exac", "role": "Manager under the Management Services Agreement (annual fee of $1 million)", "period": "From 14 February 2018 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-trust-fees" ], "kind": "business" }, { "id": "r-wpetty-exac-11", "from": "e-wpetty", "to": "e-exac", "role": "Director (co-executive chairman with Jeffrey Binder after the merger)", "period": "February 2018 – January 2020", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2019" ], "kind": "directs" }, { "id": "r-binder-exac", "from": "e-binder", "to": "e-exac", "role": "Director", "period": "From February 2018", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2019" ], "kind": "directs" }, { "id": "r-garrison-exac", "from": "e-garrison", "to": "e-exac", "role": "Director", "period": "February 2018 – 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2019" ], "kind": "directs" }, { "id": "r-schilling-exac", "from": "e-schilling", "to": "e-exac", "role": "Director", "period": "February 2018 – 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2019" ], "kind": "directs" }, { "id": "r-sisitsky-exac", "from": "e-sisitsky", "to": "e-exac", "role": "Director", "period": "February 2018 – 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2019" ], "kind": "directs" }, { "id": "r-dpetty-exac-5", "from": "e-dpetty", "to": "e-exac", "role": "Director", "period": "From February 2018 (also before the merger)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-board-2019" ], "kind": "directs" }, { "id": "r-edwards-exac", "from": "e-edwards", "to": "e-exac", "role": "Vice president, legal; later general counsel, senior vice president and secretary", "period": "From before 2018 to the 2024 bankruptcy filing", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2019" ], "kind": "employs" }, { "id": "r-miller-exac-8", "from": "e-miller", "to": "e-exac", "role": "Executive vice president, research and development", "period": "Listed in 2018 and 2019", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2019" ], "kind": "employs" }, { "id": "r-hann-exac", "from": "e-hann", "to": "e-exac", "role": "Senior vice president, business development", "period": "Listed in the 2019 annual report", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2019" ], "kind": "employs" }, { "id": "r-johnson-exac", "from": "e-johnson", "to": "e-exac", "role": "Director", "period": "From 2020", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2023" ], "kind": "directs" }, { "id": "r-nole-exac", "from": "e-nole", "to": "e-exac", "role": "Director", "period": "From January 2021 (per the complaint); listed in November 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2023" ], "kind": "directs" }, { "id": "r-bingham-exac", "from": "e-bingham", "to": "e-exac", "role": "Director", "period": "From January 2021 (per the complaint); listed in November 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2023" ], "kind": "directs" }, { "id": "r-golz-exac", "from": "e-golz", "to": "e-exac", "role": "Director and audit committee member", "period": "From January 2021 (per the complaint); listed in November 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2023" ], "kind": "directs" }, { "id": "r-golz-osteon", "from": "e-golz", "to": "e-osteon", "role": "Director and audit committee member", "period": "As described in 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2023" ], "kind": "directs" }, { "id": "r-garrison-exac-2", "from": "e-garrison", "to": "e-exac", "role": "Member of the audit and compliance committee", "period": "2018 – end of 2024 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2023" ], "kind": "directs" }, { "id": "r-schilling-exac-2", "from": "e-schilling", "to": "e-exac", "role": "Member of the audit and compliance committee", "period": "2018 – end of 2024 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2023" ], "kind": "directs" }, { "id": "r-tepatti-exac", "from": "e-tepatti", "to": "e-exac", "role": "TPG principal attending board and audit committee meetings", "period": "2019 – 2024 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-board-2023" ], "kind": "other" }, { "id": "r-wpetty-exac-12", "from": "e-wpetty", "to": "e-exac", "role": "Executive chairman (2014–2018); co-executive chairman with Jeffrey Binder", "period": "2014 – January 2020", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-executives" ], "kind": "directs" }, { "id": "r-dpetty-exac-6", "from": "e-dpetty", "to": "e-exac", "role": "Vice chairman", "period": "From January 2020 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-executives" ], "kind": "directs" }, { "id": "r-dpetty-osteon-2", "from": "e-dpetty", "to": "e-osteon", "role": "Director", "period": "14 February 2018 – October 2024 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-executives" ], "kind": "directs" }, { "id": "r-johnson-exac-2", "from": "e-johnson", "to": "e-exac", "role": "President and chief executive officer (interim chief executive from March 2023)", "period": "January 2020 – March 2022; March 2023 – 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-executives" ], "kind": "directs" }, { "id": "r-binder-exac-2", "from": "e-binder", "to": "e-exac", "role": "Co-executive chairman, then executive chairman", "period": "February 2018 – about September 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-executives" ], "kind": "directs" }, { "id": "r-binder-exac-3", "from": "e-binder", "to": "e-exac", "role": "Chief executive officer", "period": "March 2022 – March 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-executives" ], "kind": "directs" }, { "id": "r-binder-osteon-2", "from": "e-binder", "to": "e-osteon", "role": "Co-executive chairman, then executive chairman; director", "period": "February 2018 – about September 2023 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-executives" ], "kind": "directs" }, { "id": "r-bolukbasi-exac", "from": "e-bolukbasi", "to": "e-exac", "role": "Chief financial officer and executive vice president", "period": "From August 2020", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-executives" ], "kind": "employs" }, { "id": "r-bolukbasi-tpg", "from": "e-bolukbasi", "to": "e-tpg", "role": "Consultant; field operations adviser in TPG Capital's operations group", "period": "November 2014 – December 2018; January – August 2020 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-executives" ], "kind": "other" }, { "id": "r-collins-exac", "from": "e-collins", "to": "e-exac", "role": "Chief financial officer", "period": "As of 2023–2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-officers-2024" ], "kind": "employs" }, { "id": "r-livingston-exac", "from": "e-livingston", "to": "e-exac", "role": "Assistant secretary", "period": "As of August 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-officers-2024" ], "kind": "employs" }, { "id": "r-binder-exac-4", "from": "e-binder", "to": "e-exac", "role": "Chairman", "period": "As of August 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-officers-2024" ], "kind": "directs" }, { "id": "r-binder-biomet", "from": "e-binder", "to": "e-biomet", "role": "President, chief executive officer and director", "period": "February 2007 – June 2015 (end date per the Settlement Trust's complaint)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-binder-bio" ], "kind": "directs" }, { "id": "r-binder-tpg-global", "from": "e-binder", "to": "e-tpg-global", "role": "Senior adviser under an agreement of 29 June 2015 (amended 6 March 2018)", "period": "From June 2015 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-binder-tpg" ], "kind": "other" }, { "id": "r-binder-tpg-2", "from": "e-binder", "to": "e-tpg", "role": "Senior adviser and consultant", "period": "From 2015; reported as continuing in May 2025", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-binder-tpg" ], "kind": "other" }, { "id": "r-sisitsky-tpg-2", "from": "e-sisitsky", "to": "e-tpg", "role": "President and director of TPG Inc.", "period": "Until 6 September 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-tpg-people" ], "kind": "directs" }, { "id": "r-schilling-tpg", "from": "e-schilling", "to": "e-tpg", "role": "Partner and head of operations, TPG Capital", "period": "Per the complaint", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-tpg-people" ], "kind": "employs" }, { "id": "r-tepatti-tpg", "from": "e-tepatti", "to": "e-tpg", "role": "Principal, TPG Capital", "period": "Per the complaint", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-tpg-people" ], "kind": "employs" }, { "id": "r-yasskin-tpg", "from": "e-yasskin", "to": "e-tpg", "role": "Member of the TPG health-care team", "period": "Per the complaint", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-tpg-people" ], "kind": "employs" }, { "id": "r-lin-tpg", "from": "e-lin", "to": "e-tpg", "role": "Member of the TPG health-care team", "period": "Per the complaint", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-tpg-people" ], "kind": "employs" }, { "id": "r-exac-advita", "from": "e-exac", "to": "e-advita", "role": "510(k) applicant with Advita Ortho as correspondent (K260583)", "period": "20 February – 14 April 2026", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-fda-registration" ], "kind": "business" }, { "id": "r-crader-exac", "from": "e-crader", "to": "e-exac", "role": "Chief quality and regulatory clinical officer", "period": "As of July 2021 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-trust-tpg-recall-role" ], "kind": "employs" }, { "id": "r-hillman-exac", "from": "e-hillman", "to": "e-exac", "role": "Supplier of polyethylene vacuum bags (per the complaint)", "period": "2004 – 2021 (per the complaint)", "status": "reported", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-trust-packaging" ], "kind": "business" }, { "id": "r-exac-hss-2", "from": "e-exac", "to": "e-hss", "role": "Supplier of implants (HSS described as its largest domestic customer)", "period": "Until HSS stopped using the knee (February 2019) and shoulder (February 2021) products (per the complaint)", "status": "reported", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-trust-hss" ], "kind": "business" }, { "id": "r-osteon2-exac-3", "from": "e-osteon2", "to": "e-exac", "role": "Joint policyholder on a product-liability insurance certificate ($10 million limit)", "period": "As described in the March 2024 order", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-mdl-tpg-dismissal" ], "kind": "business" }, { "id": "r-kirkland-tpg", "from": "e-kirkland", "to": "e-tpg", "role": "Counsel to the TPG defendants in the MDL", "period": "From March 2023", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-trust-mdl" ], "kind": "business" }, { "id": "r-harrold-au", "from": "e-harrold", "to": "e-au", "role": "Lead applicant in class action NSD 1224 of 2024", "period": "5 September 2024 – 13 November 2025", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "historical", "claim_ids": [ "c-australia-class" ], "kind": "legal" }, { "id": "r-harrold-exac", "from": "e-harrold", "to": "e-exac", "role": "Lead applicant in class action NSD 1224 of 2024", "period": "5 September 2024 – 13 November 2025", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "historical", "claim_ids": [ "c-australia-class" ], "kind": "legal" }, { "id": "r-york-exac", "from": "e-york", "to": "e-exac", "role": "Foreign representative in the Australian recognition proceeding", "period": "From 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-australia-class" ], "kind": "other" }, { "id": "r-wallace-exac", "from": "e-wallace", "to": "e-exac", "role": "Relator (whistle-blower plaintiff) in qui tam No. 7:18-cv-1010 (N.D. Ala.)", "period": "29 June 2018 – 10 July 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "historical", "claim_ids": [ "c-quitam-alabama" ], "kind": "legal" }, { "id": "r-farley-exac", "from": "e-farley", "to": "e-exac", "role": "Relator (whistle-blower plaintiff) in qui tam No. 7:18-cv-1010 (N.D. Ala.)", "period": "29 June 2018 – 10 July 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "historical", "claim_ids": [ "c-quitam-alabama" ], "kind": "legal" }, { "id": "r-fuentes-exac", "from": "e-fuentes", "to": "e-exac", "role": "Relator (whistle-blower plaintiff) in qui tam No. 7:18-cv-1010 (N.D. Ala.)", "period": "29 June 2018 – 10 July 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "historical", "claim_ids": [ "c-quitam-alabama" ], "kind": "legal" }, { "id": "r-livingston-exac-2", "from": "e-livingston", "to": "e-exac", "role": "Counsel for Exactech in the Alabama qui tam case", "period": "2020 – 2021 filings", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-quitam-alabama" ], "kind": "business" }, { "id": "r-petrera-exac", "from": "e-petrera", "to": "e-exac", "role": "Relator in qui tam No. 21-cv-3325-SAG (D. Md.)", "period": "Until the September 2025 settlement", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "historical", "claim_ids": [ "c-quitam-maryland" ], "kind": "legal" }, { "id": "r-petrera-tpg", "from": "e-petrera", "to": "e-tpg", "role": "Relator in claims against TPG Capital, L.P. (dismissed voluntarily without prejudice on 23 April 2026)", "period": "Until 23 April 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "historical", "claim_ids": [ "c-quitam-maryland" ], "kind": "legal" }, { "id": "r-wallace-exac-2", "from": "e-wallace", "to": "e-exac", "role": "Plaintiff (with the United States) in adversary proceeding 1:25-ap-50076 on dischargeability", "period": "From 3 February 2025", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-dischargeability" ], "kind": "legal" }, { "id": "r-farley-exac-2", "from": "e-farley", "to": "e-exac", "role": "Plaintiff (with the United States) in adversary proceeding 1:25-ap-50076 on dischargeability", "period": "From 3 February 2025", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-dischargeability" ], "kind": "legal" }, { "id": "r-fuentes-exac-2", "from": "e-fuentes", "to": "e-exac", "role": "Plaintiff (with the United States) in adversary proceeding 1:25-ap-50076 on dischargeability", "period": "From 3 February 2025", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-dischargeability" ], "kind": "legal" }, { "id": "r-york-exac-2", "from": "e-york", "to": "e-exac", "role": "Chief restructuring officer; declarant in support of the Chapter 11 petitions", "period": "From 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-petition" ], "kind": "employs" }, { "id": "r-exac-centerview", "from": "e-exac", "to": "e-centerview", "role": "Client: investment banker", "period": "From July 2023", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "business" }, { "id": "r-exac-ropes", "from": "e-exac", "to": "e-ropes", "role": "Client: legal counsel (restructuring and Chapter 11)", "period": "From before 2023 through the Chapter 11 case", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "business" }, { "id": "r-exac-riveron", "from": "e-exac", "to": "e-riveron", "role": "Client: financial adviser", "period": "From 25 April 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "business" }, { "id": "r-exac-ycst", "from": "e-exac", "to": "e-ycst", "role": "Client: co-counsel", "period": "From 27 August 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "business" }, { "id": "r-york-riveron", "from": "e-york", "to": "e-riveron", "role": "Managing director (senior managing director)", "period": "As of 2024–2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-advisers" ], "kind": "employs" }, { "id": "r-abrams-exac", "from": "e-abrams", "to": "e-exac", "role": "Independent director; special committee member", "period": "From November 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "directs" }, { "id": "r-abrams-osteon2", "from": "e-abrams", "to": "e-osteon2", "role": "Independent director; special committee member", "period": "From November 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "directs" }, { "id": "r-abrams-xpand", "from": "e-abrams", "to": "e-xpand", "role": "Independent director; special committee member", "period": "From 24 July 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "directs" }, { "id": "r-pohl-exac", "from": "e-pohl", "to": "e-exac", "role": "Independent director; special committee member", "period": "From 24 July 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "directs" }, { "id": "r-pohl-osteon2", "from": "e-pohl", "to": "e-osteon2", "role": "Independent director; special committee member", "period": "From 24 July 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "directs" }, { "id": "r-pohl-xpand", "from": "e-pohl", "to": "e-xpand", "role": "Independent director; special committee member", "period": "From 24 July 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "directs" }, { "id": "r-exac-whitecase", "from": "e-exac", "to": "e-whitecase", "role": "Special committee's independent counsel", "period": "From July 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-advisers" ], "kind": "business" }, { "id": "r-edwards-exac-2", "from": "e-edwards", "to": "e-exac", "role": "Secretary (signed the restructuring support agreement for all five companies)", "period": "October 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-adhoc-rsa" ], "kind": "directs" }, { "id": "r-exac-au-2", "from": "e-exac", "to": "e-au", "role": "Parent of the Australian subsidiary (subject of restructuring milestones)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-rsa-milestones" ], "kind": "owns" }, { "id": "r-exac-uk-2", "from": "e-exac", "to": "e-uk", "role": "Parent of the UK subsidiary (subject of restructuring milestones)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-rsa-milestones" ], "kind": "owns" }, { "id": "r-exac-eio-2", "from": "e-exac", "to": "e-eio", "role": "Parent of the Swiss operating subsidiary (indirect subsidiaries referred to in the agreement)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-rsa-milestones" ], "kind": "owns" }, { "id": "r-exac-eibidco", "from": "e-exac", "to": "e-eibidco", "role": "Seller under the stalking-horse asset purchase agreement", "period": "From 29 October 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-apa" ], "kind": "business" }, { "id": "r-osteon2-eibidco", "from": "e-osteon2", "to": "e-eibidco", "role": "Seller under the stalking-horse asset purchase agreement", "period": "From 29 October 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-apa" ], "kind": "business" }, { "id": "r-xpand-eibidco", "from": "e-xpand", "to": "e-eibidco", "role": "Seller under the stalking-horse asset purchase agreement", "period": "From 29 October 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-apa" ], "kind": "business" }, { "id": "r-richards-eibidco", "from": "e-richards", "to": "e-eibidco", "role": "Authorised person; signed the asset purchase agreement", "period": "October 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-apa" ], "kind": "directs" }, { "id": "r-eibidco-watiga", "from": "e-eibidco", "to": "e-watiga", "role": "Notice address (c/o the trust company in Singapore)", "period": "As stated in the agreement of 29 October 2024", "status": "documented", "direction": "directed", "role_group": "infrastructure", "temporal_status": "historical", "claim_ids": [ "c-apa" ], "kind": "other" }, { "id": "r-milbank-eibidco", "from": "e-milbank", "to": "e-eibidco", "role": "Counsel receiving copies of the purchaser's notices", "period": "As stated in the agreement of 29 October 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-apa" ], "kind": "business" }, { "id": "r-collins-exac-2", "from": "e-collins", "to": "e-exac", "role": "Chief financial officer; signed the asset purchase agreement for the sellers", "period": "October 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-apa" ], "kind": "employs" }, { "id": "r-glas-watiga", "from": "e-glas", "to": "e-watiga", "role": "Acquirer and parent group", "period": "From December 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-watiga" ], "kind": "owns" }, { "id": "r-richards-watiga", "from": "e-richards", "to": "e-watiga", "role": "Founder and managing director (as described by GLAS)", "period": "As of December 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "unknown", "claim_ids": [ "c-watiga" ], "kind": "directs" }, { "id": "r-eibidco-exac", "from": "e-eibidco", "to": "e-exac", "role": "Stalking-horse bidder for substantially all assets", "period": "From 10 December 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "historical", "claim_ids": [ "c-bidding" ], "kind": "business" }, { "id": "r-exac-jointmedica", "from": "e-exac", "to": "e-jointmedica", "role": "Holder of membership interests; exclusive distributor under the agreement of 24 August 2023", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-jointmedica" ], "kind": "owns" }, { "id": "r-jm-inv-jointmedica", "from": "e-jm-inv", "to": "e-jointmedica", "role": "Co-venturer whose consent was required to transfer Exactech's interest", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-jointmedica" ], "kind": "owns" }, { "id": "r-jm-inv-exac", "from": "e-jm-inv", "to": "e-exac", "role": "Party whose consent was required to transfer Exactech's JointMedica interest", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-jointmedica" ], "kind": "business" }, { "id": "r-exac-jointmedica-2", "from": "e-exac", "to": "e-jointmedica", "role": "Plaintiff in adversary proceeding 1:24-ap-50297 (dismissed with prejudice on 5 November 2025)", "period": "13 December 2024 – 5 November 2025", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "historical", "claim_ids": [ "c-jointmedica" ], "kind": "legal" }, { "id": "r-exac-jm-inv", "from": "e-exac", "to": "e-jm-inv", "role": "Plaintiff in adversary proceeding 1:24-ap-50297 (dismissed with prejudice on 5 November 2025)", "period": "13 December 2024 – 5 November 2025", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "historical", "claim_ids": [ "c-jointmedica" ], "kind": "legal" }, { "id": "r-kirkland-jm-inv", "from": "e-kirkland", "to": "e-jm-inv", "role": "Counsel in the Chapter 11 case", "period": "As of 2025–2026", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-jointmedica" ], "kind": "business" }, { "id": "r-kirkland-sponsor", "from": "e-kirkland", "to": "e-sponsor", "role": "Counsel in the Chapter 11 case", "period": "As of 2025–2026", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-jointmedica" ], "kind": "business" }, { "id": "r-brownrudnick-ucc", "from": "e-brownrudnick", "to": "e-ucc", "role": "Counsel to the official committee of unsecured creditors", "period": "From 2024", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-tpg-release" ], "kind": "business" }, { "id": "r-kirkland-tpg-2", "from": "e-kirkland", "to": "e-tpg", "role": "Counsel to TPG in the Chapter 11 case", "period": "2025", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-tpg-release" ], "kind": "business" }, { "id": "r-exac-tpg", "from": "e-exac", "to": "e-tpg", "role": "Adverse party on alter-ego and veil-piercing claims (bankruptcy court ruling of 20 May 2025)", "period": "From 2025", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "unknown", "claim_ids": [ "c-letter-ruling" ], "kind": "legal" }, { "id": "r-trust-exac", "from": "e-trust", "to": "e-exac", "role": "Successor to the debtors' personal-injury and wrongful-death liabilities and estate causes of action under the plan", "period": "From the plan effective date", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-confirmation" ], "kind": "legal" }, { "id": "r-reisman-trust", "from": "e-reisman", "to": "e-trust", "role": "Settlement trustee", "period": "From the plan effective date", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-confirmation" ], "kind": "directs" }, { "id": "r-halperin-guc-trust", "from": "e-halperin", "to": "e-guc-trust", "role": "Commercial GUC trustee (named in the confirmation order)", "period": "From the plan effective date", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-confirmation" ], "kind": "directs" }, { "id": "r-halperin-exac", "from": "e-halperin", "to": "e-exac", "role": "Wind-down officer (named in the confirmation order)", "period": "From the plan effective date", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-confirmation" ], "kind": "directs" }, { "id": "r-svp-exac", "from": "e-svp", "to": "e-exac", "role": "Member of the ownership group acquiring substantially all operations and assets", "period": "Sale approved September 2025", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-confirmation" ], "kind": "other" }, { "id": "r-stellex-exac", "from": "e-stellex", "to": "e-exac", "role": "Member of the ownership group acquiring substantially all operations and assets", "period": "Sale approved September 2025", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-confirmation" ], "kind": "other" }, { "id": "r-greywolf-exac", "from": "e-greywolf", "to": "e-exac", "role": "Member of the ownership group acquiring substantially all operations and assets", "period": "Sale approved September 2025", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-confirmation" ], "kind": "other" }, { "id": "r-dundon-guc-trust", "from": "e-dundon", "to": "e-guc-trust", "role": "Trustee", "period": "As of 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-wind-down" ], "kind": "directs" }, { "id": "r-dundon-exac", "from": "e-dundon", "to": "e-exac", "role": "Wind-down officer; officer in the 2026 Florida annual report", "period": "As of 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-wind-down" ], "kind": "directs" }, { "id": "r-wright-exac", "from": "e-wright", "to": "e-exac", "role": "Listed with the title 'Other' in the 2026 Florida annual report", "period": "As of 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-wind-down" ], "kind": "other" }, { "id": "r-dundon-dundon-adv", "from": "e-dundon", "to": "e-dundon-adv", "role": "Managing member", "period": "As of 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-wind-down" ], "kind": "directs" }, { "id": "r-coleschotz-dundon", "from": "e-coleschotz", "to": "e-dundon", "role": "Counsel to the trustee and wind-down officer", "period": "As of October 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-wind-down" ], "kind": "business" }, { "id": "r-advita-exac", "from": "e-advita", "to": "e-exac", "role": "Acquirer of the product lines, product data, operations and staff in the restructuring", "period": "From 2025", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "other" }, { "id": "r-svp-advita", "from": "e-svp", "to": "e-advita", "role": "Owner (funds managed by affiliates)", "period": "From November 2025", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "owns" }, { "id": "r-stellex-advita", "from": "e-stellex", "to": "e-advita", "role": "Owner (funds managed by affiliates)", "period": "From November 2025", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "owns" }, { "id": "r-greywolf-advita", "from": "e-greywolf", "to": "e-advita", "role": "Owner (funds managed by affiliates)", "period": "From November 2025", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "owns" }, { "id": "r-ferrari-advita", "from": "e-ferrari", "to": "e-advita", "role": "Chair of the board", "period": "From November 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "directs" }, { "id": "r-ferrari-svp", "from": "e-ferrari", "to": "e-svp", "role": "Senior adviser", "period": "As of 2025–2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "other" }, { "id": "r-sahagun-advita", "from": "e-sahagun", "to": "e-advita", "role": "Chief executive officer and director", "period": "From November 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "directs" }, { "id": "r-ekdahl-advita", "from": "e-ekdahl", "to": "e-advita", "role": "Director", "period": "From November 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "directs" }, { "id": "r-demski-advita", "from": "e-demski", "to": "e-advita", "role": "Director", "period": "From November 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "directs" }, { "id": "r-demski-svp", "from": "e-demski", "to": "e-svp", "role": "Senior adviser", "period": "As of 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "other" }, { "id": "r-debaca-advita", "from": "e-debaca", "to": "e-advita", "role": "Director", "period": "From November 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "directs" }, { "id": "r-anderson-advita", "from": "e-anderson", "to": "e-advita", "role": "Director", "period": "As of October 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "directs" }, { "id": "r-anderson-svp", "from": "e-anderson", "to": "e-svp", "role": "Managing director", "period": "As of 2025–2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "employs" }, { "id": "r-drichards-advita", "from": "e-drichards", "to": "e-advita", "role": "Director", "period": "As of October 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "directs" }, { "id": "r-drichards-svp", "from": "e-drichards", "to": "e-svp", "role": "Managing director; co-head of the operations team", "period": "As of 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "employs" }, { "id": "r-demarco-advita", "from": "e-demarco", "to": "e-advita", "role": "Director", "period": "As of October 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "directs" }, { "id": "r-demarco-stellex", "from": "e-demarco", "to": "e-stellex", "role": "Principal", "period": "As of 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "employs" }, { "id": "r-cjames-advita", "from": "e-cjames", "to": "e-advita", "role": "Director", "period": "As of October 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "directs" }, { "id": "r-cjames-greywolf", "from": "e-cjames", "to": "e-greywolf", "role": "Managing director", "period": "As of 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-launch" ], "kind": "employs" }, { "id": "r-roche-exac", "from": "e-roche", "to": "e-exac", "role": "Employee (from 2003); senior vice president, extremities, from July 2021", "period": "2003 – 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-advita-execs" ], "kind": "employs" }, { "id": "r-roche-advita", "from": "e-roche", "to": "e-advita", "role": "Senior vice president, extremities", "period": "From November 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-execs" ], "kind": "employs" }, { "id": "r-figg-advita", "from": "e-figg", "to": "e-advita", "role": "Chief financial officer", "period": "From March 2026 (succeeded by September 2026)", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-advita-execs" ], "kind": "employs" }, { "id": "r-lopes-advita", "from": "e-lopes", "to": "e-advita", "role": "Chief operating officer", "period": "From March 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-execs" ], "kind": "employs" }, { "id": "r-ryoung-advita", "from": "e-ryoung", "to": "e-advita", "role": "Chief human resources officer", "period": "From March 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-execs" ], "kind": "employs" }, { "id": "r-haydock-advita", "from": "e-haydock", "to": "e-advita", "role": "Chief financial officer", "period": "From September 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-execs" ], "kind": "employs" }, { "id": "r-advita-h1-advita", "from": "e-advita-h1", "to": "e-advita", "role": "Member of the LLC", "period": "As of the 2026 Florida record", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "current", "claim_ids": [ "c-advita-registry" ], "kind": "owns" }, { "id": "r-advita-h2-advita", "from": "e-advita-h2", "to": "e-advita", "role": "Member of the LLC", "period": "As of the 2026 Florida record", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "current", "claim_ids": [ "c-advita-registry" ], "kind": "owns" }, { "id": "r-livingston-advita", "from": "e-livingston", "to": "e-advita", "role": "Authorised person", "period": "As of the 2026 Florida record", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-advita-registry" ], "kind": "other" }, { "id": "r-svp-advita-h1", "from": "e-svp", "to": "e-advita-h1", "role": "Same business address (100 West Putnam Avenue, Greenwich)", "period": "As of 2026", "status": "documented", "direction": "undirected", "role_group": "infrastructure", "temporal_status": "current", "claim_ids": [ "c-advita-registry" ], "kind": "other" }, { "id": "r-svp-advita-h2", "from": "e-svp", "to": "e-advita-h2", "role": "Same business address (100 West Putnam Avenue, Greenwich)", "period": "As of 2026", "status": "documented", "direction": "undirected", "role_group": "infrastructure", "temporal_status": "current", "claim_ids": [ "c-advita-registry" ], "kind": "other" }, { "id": "r-exac-advita-2", "from": "e-exac", "to": "e-advita", "role": "Assignor of the EXACTECH trade mark in Canada (date of change 31 October 2025)", "period": "From 31 October 2025", "status": "documented", "direction": "directed", "role_group": "business", "temporal_status": "unknown", "claim_ids": [ "c-trademarks" ], "kind": "business" }, { "id": "r-exac-italia", "from": "e-exac", "to": "e-italia", "role": "Direct parent (as recorded in the LEI register)", "period": "Recorded in the LEI register as of October 2026", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-italy" ], "kind": "owns" }, { "id": "r-kohtz-de", "from": "e-kohtz", "to": "e-de", "role": "Managing director", "period": "May 2010 – 3 August 2020", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-germany" ], "kind": "directs" }, { "id": "r-backhuss-de", "from": "e-backhuss", "to": "e-de", "role": "Managing director", "period": "3 August 2020 – 30 October 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-germany" ], "kind": "directs" }, { "id": "r-hohl-de", "from": "e-hohl", "to": "e-de", "role": "Managing director", "period": "From 30 October 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-germany" ], "kind": "directs" }, { "id": "r-andrews-eio", "from": "e-andrews", "to": "e-eio", "role": "Board member with signing authority", "period": "As of July 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-swiss" ], "kind": "directs" }, { "id": "r-rognoni-eio", "from": "e-rognoni", "to": "e-eio", "role": "Board member with signing authority", "period": "As of July 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-swiss" ], "kind": "directs" }, { "id": "r-mouillac-fr", "from": "e-mouillac", "to": "e-fr", "role": "President", "period": "From 13 January 2020", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-france" ], "kind": "directs" }, { "id": "r-backhuss-eog", "from": "e-backhuss", "to": "e-eog", "role": "Managing director", "period": "From 11 October 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-austria" ], "kind": "directs" }, { "id": "r-exac-uk-3", "from": "e-exac", "to": "e-uk", "role": "Person with significant control (more than 75%)", "period": "6 April 2016 – 21 December 2018", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-uk" ], "kind": "owns" }, { "id": "r-osteon-uk", "from": "e-osteon", "to": "e-uk", "role": "Person with significant control (more than 75%)", "period": "21 December 2018 – 31 October 2025", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "historical", "claim_ids": [ "c-uk" ], "kind": "owns" }, { "id": "r-dpetty-uk", "from": "e-dpetty", "to": "e-uk", "role": "Director", "period": "1 July 2005 – 1 February 2020", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk" ], "kind": "directs" }, { "id": "r-phillips-uk", "from": "e-phillips", "to": "e-uk", "role": "Director", "period": "1 July 2005 – 1 February 2020", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk" ], "kind": "directs" }, { "id": "r-johnson-uk", "from": "e-johnson", "to": "e-uk", "role": "Director", "period": "1 February 2020 – 21 October 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk" ], "kind": "directs" }, { "id": "r-thompson-uk", "from": "e-thompson", "to": "e-uk", "role": "Director", "period": "1 February 2020 – 31 March 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk" ], "kind": "directs" }, { "id": "r-cintron-uk", "from": "e-cintron", "to": "e-uk", "role": "Director", "period": "1 February 2020 – 30 April 2023", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk" ], "kind": "directs" }, { "id": "r-andrews-uk", "from": "e-andrews", "to": "e-uk", "role": "Director", "period": "From 1 April 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-uk" ], "kind": "directs" }, { "id": "r-hohl-uk", "from": "e-hohl", "to": "e-uk", "role": "Director", "period": "From 1 April 2024", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-uk" ], "kind": "directs" }, { "id": "r-astoin-uk", "from": "e-astoin", "to": "e-uk", "role": "Director", "period": "From 5 February 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-uk" ], "kind": "directs" }, { "id": "r-beckley-uk", "from": "e-beckley", "to": "e-uk", "role": "Director", "period": "From 5 February 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-uk" ], "kind": "directs" }, { "id": "r-ohare-uk", "from": "e-ohare", "to": "e-uk", "role": "Director", "period": "From 5 February 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-uk" ], "kind": "directs" }, { "id": "r-andrews-uk2", "from": "e-andrews", "to": "e-uk2", "role": "Director", "period": "From 25 June 2025 until dissolution", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk2" ], "kind": "directs" }, { "id": "r-hohl-uk2", "from": "e-hohl", "to": "e-uk2", "role": "Director", "period": "From 25 June 2025 until dissolution", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk2" ], "kind": "directs" }, { "id": "r-johnson-uk2", "from": "e-johnson", "to": "e-uk2", "role": "Director", "period": "25 June 2025 – 21 October 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk2" ], "kind": "directs" }, { "id": "r-astoin-uk2", "from": "e-astoin", "to": "e-uk2", "role": "Director", "period": "From 22 October 2025 until dissolution", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk2" ], "kind": "directs" }, { "id": "r-beckley-uk2", "from": "e-beckley", "to": "e-uk2", "role": "Director", "period": "From 22 October 2025 until dissolution", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk2" ], "kind": "directs" }, { "id": "r-ohare-uk2", "from": "e-ohare", "to": "e-uk2", "role": "Director", "period": "From 22 October 2025 until dissolution", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-uk2" ], "kind": "directs" }, { "id": "r-trust-tpg", "from": "e-trust", "to": "e-tpg", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-tpg7", "from": "e-trust", "to": "e-tpg7", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-tpg-mgmt", "from": "e-trust", "to": "e-tpg-mgmt", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-sponsor", "from": "e-trust", "to": "e-sponsor", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-tpg-ops", "from": "e-trust", "to": "e-tpg-ops", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-tpg-h2", "from": "e-trust", "to": "e-tpg-h2", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-tpg-fo", "from": "e-trust", "to": "e-tpg-fo", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (alter ego and aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-binder", "from": "e-trust", "to": "e-binder", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-garrison", "from": "e-trust", "to": "e-garrison", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-schilling", "from": "e-trust", "to": "e-schilling", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-sisitsky", "from": "e-trust", "to": "e-sisitsky", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-tepatti", "from": "e-trust", "to": "e-tepatti", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-yasskin", "from": "e-trust", "to": "e-yasskin", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-lin", "from": "e-trust", "to": "e-lin", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-wpetty", "from": "e-trust", "to": "e-wpetty", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-trust-dpetty", "from": "e-trust", "to": "e-dpetty", "role": "Plaintiff in Del. Ch. C.A. No. 2026-0129-MTZ (breach of fiduciary duty or aiding and abetting; pending)", "period": "From 30 January 2026", "status": "documented", "direction": "directed", "role_group": "legal", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "legal" }, { "id": "r-reisman-trust-2", "from": "e-reisman", "to": "e-trust", "role": "Trustee; plaintiff in her capacity as trustee", "period": "From 2025", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "directs" }, { "id": "r-brownrudnick-trust", "from": "e-brownrudnick", "to": "e-trust", "role": "Co-counsel in the suit against TPG", "period": "From January 2026", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-trust-suit" ], "kind": "business" }, { "id": "r-exac-blueortho", "from": "e-exac", "to": "e-blueortho", "role": "Parent (100%); buyer of goods and services from it", "period": "From 15 January 2015 (as of the 2024 declaration)", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-blueortho" ], "kind": "owns" }, { "id": "r-boyer-blueortho", "from": "e-boyer", "to": "e-blueortho", "role": "Co-founder; president", "period": "From 9 December 2008", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "current", "claim_ids": [ "c-blueortho" ], "kind": "directs" }, { "id": "r-stiehl-blueortho", "from": "e-stiehl", "to": "e-blueortho", "role": "Co-founder", "period": "From 2008", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-blueortho" ], "kind": "other" }, { "id": "r-lavallee-blueortho", "from": "e-lavallee", "to": "e-blueortho", "role": "Co-founder", "period": "From 2008", "status": "documented", "direction": "directed", "role_group": "people", "temporal_status": "historical", "claim_ids": [ "c-blueortho" ], "kind": "other" }, { "id": "r-exac-eio-3", "from": "e-exac", "to": "e-eio", "role": "Parent; buyer of goods and services from the international operating subsidiary", "period": "As of 2018 and 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-intercompany" ], "kind": "owns" }, { "id": "r-exac-italia-2", "from": "e-exac", "to": "e-italia", "role": "Parent group company (2024 group chart)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-intercompany" ], "kind": "owns" }, { "id": "r-exac-korea", "from": "e-exac", "to": "e-korea", "role": "Parent group company (2024 group chart)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-intercompany" ], "kind": "owns" }, { "id": "r-exac-de-2", "from": "e-exac", "to": "e-de", "role": "Parent group company (2024 group chart)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-intercompany" ], "kind": "owns" }, { "id": "r-exac-fr-2", "from": "e-exac", "to": "e-fr", "role": "Parent group company (2024 group chart)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-intercompany" ], "kind": "owns" }, { "id": "r-exac-iberica-2", "from": "e-exac", "to": "e-iberica", "role": "Parent group company (2024 group chart)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-intercompany" ], "kind": "owns" }, { "id": "r-exac-kk-2", "from": "e-exac", "to": "e-kk", "role": "Parent group company (2024 group chart)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-intercompany" ], "kind": "owns" }, { "id": "r-exac-eog", "from": "e-exac", "to": "e-eog", "role": "Parent group company (2024 group chart)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-intercompany" ], "kind": "owns" }, { "id": "r-exac-pt", "from": "e-exac", "to": "e-pt", "role": "Parent group company (2024 group chart)", "period": "As of October 2024", "status": "documented", "direction": "directed", "role_group": "ownership", "temporal_status": "unknown", "claim_ids": [ "c-intercompany" ], "kind": "owns" } ], "history": [], "claims": [ { "id": "c-identity", "kind": "fact", "text": "Exactech, Inc. is a Florida profit corporation registered with the Florida Division of Corporations under document number H85101 (filed 13 November 1985, effective 8 November 1985; federal employer identification number 59-2603930), with its operating address at 2320 NW 66th Court, Gainesville, Florida. The SEC's EDGAR system records it under Central Index Key 0000913165 with industry code 3842 (orthopedic, prosthetic and surgical appliances and supplies); after the 2018 take-private the record lists no ticker or exchange. Its Legal Entity Identifier, 549300B1BI1XN672F813, was issued on 3 October 2013; the global LEI register shows the entity as active but the identifier's registration as lapsed, with renewal due since 27 March 2022. In its 2024 bankruptcy petition the company gave Exactech U.S., Inc. as a name used in the previous eight years. A search of the Florida register for 'Exactech' returns H85101 as the only active record; other Exactech-named Florida records (Exactech International, LLC and Inc., Exactech Spine, Inc., Exactech U.S., Inc.) are inactive.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d4", "s-d19", "s-d114", "s-d20", "s-d18" ], "entity_ids": [ "e-exac" ] }, { "id": "c-founding", "kind": "fact", "text": "Exactech was founded in 1985 by William (Bill) Petty, an orthopaedic surgeon, Gary J. Miller, a biomedical engineer, and Betty Petty, according to the declaration filed by the company's chief restructuring officer in 2024. The company first made a cemented primary hip system, developed its first knee implant in 1992, went public on Nasdaq in 1996 to fund the knee business, entered the shoulder market in 2005 and in 2014 acquired the computer-assisted surgery business behind ExactechGPS; it was publicly listed for 21 years before TPG acquired it in 2018. SEC filings describe William Petty as a founder, chairman of the board since inception, chief executive officer from inception until 2014 and president from January 2002 to December 2007; in 1996 he was also a professor at the University of Florida College of Medicine (since July 1975) and had chaired its orthopaedic surgery department from 1981 to January 1996. Gary J. Miller, also a founder, was vice president of research and development from 1986, executive vice president for research and development from February 2000, and a director from March 1989 to May 2003; he had been an associate professor of orthopaedic surgery at the same college and, from 1989 to 1992, a consultant to the FDA. Betty Petty, William Petty's wife, was company secretary from inception and treasurer and a director until March 1996; David W. Petty is their son.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d5", "s-d101" ], "entity_ids": [ "e-exac", "e-wpetty", "e-miller", "e-bpetty", "e-dpetty" ] }, { "id": "c-pre-ipo", "kind": "fact", "text": "The registration statement for the 1996 initial public offering (amended Form S-1) shows the Petty family in control before the listing. William Petty held 1,323,271 shares, 44.6% before the offering, including 1,318,699 shares held jointly with Betty Petty; the same table lists Gary J. Miller with 285,002 shares (9.6%), David W. Petty, Mark A. Petty, Julie A. Petty and director R. Wynn Kearney, Jr. among the holders. A shareholders agreement with William, Betty, David, Julie and Mark Petty gave William and Betty Petty, and then the company, a first right to buy any family member's shares; William Petty had also advanced funds to the company, repaid with interest in 1995 ($46,353). Timothy J. Seese had been president and chief operating officer since March 1991 and a director since April 1991, and Joel C. Phillips, a former Arthur Andersen accountant, had been treasurer since March 1996. The company paid royalties to the Hospital for Special Surgery under a licence for the Optetrak knee system, to Accumed, Inc. for a bipolar hip prosthesis, and to members of its design team, including William Petty and Gary J. Miller.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d101" ], "entity_ids": [ "e-exac", "e-wpetty", "e-bpetty", "e-miller", "e-dpetty", "e-kearney", "e-seese", "e-phillips", "e-hss", "e-accumed" ] }, { "id": "c-early-suits", "kind": "fact", "text": "The 1996 registration statement disclosed two early lawsuits. On 13 December 1994 Marilyn Evans and Phillips Evans sued Exactech in the Circuit Court for Pinellas County, Florida, alleging personal injury from deterioration of the acetabular components of its total hip system and seeking unspecified damages for breach of warranty; the company's insurer was defending it and the company said the action was without merit. On 3 April 1995 Joint Medical sued Exactech and many of its competitors for infringing a ball-and-socket patent; under a tolling agreement the action was dismissed without prejudice as against Exactech on 28 July 1995, pending a decision of the Board of Patent Appeals and Interferences.", "qualification": "", "response": "Exactech said the hip-component action was without merit and that, on its patent counsel's opinion, Joint Medical's claims were without merit.", "outcome": "The patent action was dismissed as against Exactech on 28 July 1995 under the tolling agreement; the outcome of the Pinellas County action is not in the record.", "source_ids": [ "s-d101" ], "entity_ids": [ "e-exac", "e-jointmedical" ] }, { "id": "c-2010-holders", "kind": "fact", "text": "Exactech's 2010 proxy statement showed the founders still holding the largest stakes. William and Betty Petty beneficially owned 3,868,439 shares (29.5%), including 3,517,498 shares (27.3%) held through Prima Investments, Limited Partnership; Gary J. Miller owned 518,535 shares (4.0%), including 411,212 shares (3.2%) held by Millerworks, Limited Partnership, a Nevada partnership whose general partner, Millerworks, Inc., was wholly owned by Miller and whose interests were held by Miller, his wife and children. Institutional holders above 5% were GAMCO Investors, Inc. (798,294 shares, 6.2%) and FMR LLC (707,500 shares, 5.5%); directors and executive officers as a group held 38.3%.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d137" ], "entity_ids": [ "e-exac", "e-wpetty", "e-bpetty", "e-miller", "e-prima-lp", "e-millerworks", "e-gamco", "e-fmr" ] }, { "id": "c-2010-board", "kind": "fact", "text": "In March 2010 William Petty was chief executive officer and chairman, David W. Petty president and a director, Joel C. Phillips chief financial officer and treasurer, Gary J. Miller executive vice president for research and development, Bruce Thompson senior vice president and general manager of the biologics and spine division, and Betty Petty vice president and corporate secretary. The other directors were Albert H. Burstein (since March 1996), R. Wynn Kearney, Jr. (since September 1989), Paul E. Metts (since April 1998), William B. Locander and James G. Binch, and Richard C. Smith was nominated. Burstein had been a senior scientist and associate attending orthopaedic surgeon in biomechanical engineering at the Hospital for Special Surgery in New York from 1976 to 1996. McGladrey & Pullen, LLP had been the independent auditor since 2007 (audit fees $476,000 for 2009 and $614,000 for 2008). The proxy also recorded an extra $33,075 paid to Metts in 2009 for work on a 'Department of Defense inquiry the company is involved in'; the subject of that inquiry is not described in the record.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d137" ], "entity_ids": [ "e-exac", "e-wpetty", "e-dpetty", "e-phillips", "e-miller", "e-thompson", "e-bpetty", "e-burstein", "e-kearney", "e-metts", "e-locander", "e-binch", "e-rsmith", "e-hss", "e-mcgladrey" ] }, { "id": "c-brighton", "kind": "fact", "text": "Brighton Partners, Inc., a Florida supplier of raw materials, equipment and licences used in Exactech's production, was partly owned by company insiders: according to the 2010 proxy, director Albert H. Burstein was deemed to own 24%, William and Betty Petty jointly 4.6% and Gary J. Miller 2.8%. Exactech's purchases from it were $1,559,000 in 2007, $2,155,000 in 2008 and $1,498,000 in 2009. The same proxy recorded royalties of $300,000 in total paid to William Petty and Miller for 2009 under product-design consulting agreements and $180,000 paid to Burstein for 2009 under a verbal consulting agreement. On 24 May 2010 Exactech bought all of Brighton Partners' shares for $5,500,000 under a stock purchase agreement filed as an exhibit to its SEC report; the sellers included Burstein and members of his family, Gary J. Miller, William, Betty, David, Julie and Mark Petty, Joel C. Phillips and Timothy J. Seese, with Burstein and William Petty acting as sellers' representatives. The sellers handed over production documentation, including tool design methods, a list of major suppliers and the quality manual, and Burstein's consulting company, AH Burstein, Ph. D., Consulting Engineer, Inc., agreed to provide transition services; Bruce Thompson signed for Exactech.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d137", "s-d232" ], "entity_ids": [ "e-exac", "e-brighton", "e-burstein", "e-wpetty", "e-bpetty", "e-miller", "e-dpetty", "e-phillips", "e-seese", "e-ahb", "e-thompson" ] }, { "id": "c-petty-companies", "kind": "fact", "text": "The Florida register's officer index also lists David W. Petty as an officer of Brighton Partners, Inc. and of ExactOrtho, Inc., and Betty Petty as an officer of Brighton Partners and ExactOrtho; the index gives no titles or dates. ExactOrtho, Inc. (document P17000096933) was filed on 7 December 2017 with an effective date of 1 January 2018, between the signing and the closing of the TPG merger; its record names Roy W. Petty as registered agent and an officer, Betty A. Petty as an officer and David W. Petty as chief executive officer, shows no annual report and an administrative dissolution on 27 September 2019, and does not describe any business. Prima Investments, Inc. (document P08000001367), the general partner of the Petty family partnership, filed a 2019 annual report signed by Roy William Petty as president and registered agent.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d313", "s-d315", "s-d314", "s-d341" ], "entity_ids": [ "e-dpetty", "e-bpetty", "e-wpetty", "e-brighton", "e-exactortho", "e-prima-inc" ] }, { "id": "c-exhibit21", "kind": "fact", "text": "The subsidiary lists filed with Exactech's annual reports trace the international group. An earlier Exhibit 21.1 lists Exactech International Corporation (Florida), Exactech Asia (doing business as Exactech Medical (Shanghai), Ltd.), Exactech Taiwan (Taiwan), LTD, Exactech (UK), Ltd., Exactech KK (Tokyo) and Altiva Corporation (Delaware). The list filed in 2013 drops Altiva and adds Exactech U.S., Inc., Exactech International Operations, Ltd., Exactech France, SAS, Exactech Deutschland GmbH (spelt 'Exectech' in the exhibit) and Exactech Iberica, S.L.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d230", "s-d102" ], "entity_ids": [ "e-exac", "e-intl", "e-shanghai", "e-taiwan", "e-uk", "e-kk", "e-altiva", "e-exus", "e-eio", "e-fr", "e-de", "e-iberica" ] }, { "id": "c-intl-llc", "kind": "fact", "text": "The Florida subsidiary listed as 'Exactech International Corporation (Florida)' corresponds in the state register to Exactech International, LLC (document L10000132635, employer identification number 59-3699934), filed on 30 December 2010 with an effective date of 20 October 2000, c/o Exactech, Inc. in Gainesville, with Exactech, Inc. as its manager. It filed its last annual report on 27 April 2016, was voluntarily dissolved on 9 August 2016 and filed a statement of termination on 27 April 2017. The register search also shows an inactive Exactech International, Inc. (document P00000099153).", "qualification": "The match between the exhibit's name and the Florida LLC rests on the state, the Exactech address and Exactech, Inc.'s role as manager; the register does not use the exhibit's name.", "response": "", "outcome": "", "source_ids": [ "s-d132" ], "entity_ids": [ "e-exac", "e-intl" ] }, { "id": "c-exus", "kind": "fact", "text": "Exactech U.S., Inc. (Florida document P12000087578, employer identification number 46-1212089), filed on 16 October 2012, carried out the group's United States sales and distribution, according to the 2018 merger proxy. Its last Florida annual report (7 February 2023) listed Darin Johnson as president, Donna Edwards as secretary, Tony Collins as chief financial officer and Stuart Kleopfer and Bruce Thompson as directors; its West Virginia foreign registration (from 25 January 2013) also named Kerem Bolukbasi as treasurer in the 2022 report. On 2 February 2023 Corporation Service Company ordered the filing of articles of merger of 'Exactech U.S., Inc. into Exactech, Inc.'; the Florida register records the merger as filed on 8 February 2023 with effect from 8 October 2020 and shows Exactech U.S., Inc. as inactive. West Virginia revoked its registration on 2 January 2026 for failure to file an annual report.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5", "s-d52", "s-d26", "s-d138" ], "entity_ids": [ "e-exac", "e-exus", "e-johnson", "e-edwards", "e-collins", "e-kleopfer", "e-thompson", "e-bolukbasi" ] }, { "id": "c-barbados", "kind": "attributed", "text": "A database of offshore companies published by an investigative journalism consortium, drawn from Barbados corporate-registry data, lists Exactech International, Inc. as a Barbados company incorporated on 29 January 1999 and closed on 24 October 2003, registered through CITCO Corporate Management (Barbados) Ltd. Its recorded directors from 29 January 1999 were David W. Petty, Roy William Petty, Timothy J. Seese and Gary J. Miller, names matching Exactech's founders and senior executives, together with a fifth person. No shareholder is recorded.", "qualification": "The record shows only registration dates, the intermediary and directors; it states no owner or purpose, and its link to Exactech rests on the name and on four directors who were Exactech officers. Exactech's subsidiary lists in the record do not include it, and the dataset does not indicate any wrongdoing.", "response": "", "outcome": "The registry data record the company as closed, which the database defines as dissolved, on 24 October 2003.", "source_ids": [ "s-d228", "s-d289" ], "entity_ids": [ "e-exac", "e-barbados", "e-dpetty", "e-wpetty", "e-seese", "e-miller" ] }, { "id": "c-operations", "kind": "fact", "text": "According to its chief restructuring officer's 2024 declaration, Exactech was vertically integrated, making about 70% of its products in-house at four manufacturing facilities in Gainesville and Sarasota, Florida, and Gieres, France, with about 900 employees worldwide, about 580 of them in the United States. The 2016 annual report (Form 10-K) says that early on third-party vendors made all components while Exactech did design, quality assurance and packaging itself; by 2016 it machined metal and polyethylene parts in Gainesville and compression-moulded Optetrak knee inserts in two leased facilities in Sarasota, while packaged products were sterilised by gamma irradiation at an outside vendor. Its top three suppliers accounted for about 20% (2016), 23% (2015) and 24% (2014) of externally sourced components, compared with about 69%, 59% and 69% in 2002 and the two preceding years; it generally had no long-term supply contracts and bought on purchase orders. It also had strategic alliances with suppliers that made some components, distributed Tecres S.p.A. products under an exclusive agreement and RTI Surgical, Inc. and Biomatlante SARL products under non-exclusive agreements, and warned that some suppliers relied on a single source of raw materials. None of these filings names the packaging supplier.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d227", "s-d272", "s-d128" ], "entity_ids": [ "e-exac", "e-tecres", "e-rti", "e-biomatlante" ] }, { "id": "c-portfolio-2016", "kind": "fact", "text": "The 2018 merger proxy lists the group's transactions before the sale: a $150 million revolving credit facility from a syndicate led by J.P. Morgan Chase Bank (December 2015), the purchase of Exactech Australia, previously its independent distributor (February 2016), a 24.55% stake in Orthopedic Designs North America, Inc., a trauma-fixation company (October 2016), and the sale of the spine business (January 2017), of a majority interest in Exactech (Taiwan) (June 2017) and of the Chinese subsidiary (September 2017). Filings of the Taiwanese company BioGend Therapeutics (博晟生醫股份有限公司), summarised by a market-data site, say it acquired 81% of Exactech's Taiwanese subsidiary, which developed cartilage-repair technology, on 31 July 2017 and absorbed it by merger on 31 December 2017; a Taiwanese financial news report of June 2019 listed Exactech among BioGend's main shareholders with about 5%.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5", "s-d196", "s-d291" ], "entity_ids": [ "e-exac", "e-jpmchase", "e-au", "e-odna", "e-taiwan", "e-shanghai", "e-biogend" ] }, { "id": "c-dpa-2010", "kind": "fact", "text": "On 7 December 2010 the U.S. Attorney's Office for the District of New Jersey announced that Exactech had entered into a 12-month deferred prosecution agreement with a federal monitor. A criminal complaint filed the same day charged the company with conspiring to violate the federal anti-kickback statute, alleging that from 2002 through late 2008 it entered into consulting agreements with certain orthopaedic surgeons designed in part to induce them to use its hip and knee products. If Exactech met the agreement's requirements, the agreement would expire after 12 months and the complaint would be dismissed. Exactech also paid $2.99 million in a civil settlement with the Department of Justice and the HHS Office of Inspector General over claims that its marketing practices caused false claims to Medicare, and entered into a five-year Corporate Integrity Agreement with HHS-OIG. Exactech's board unanimously approved the resolution and authorised its outside counsel, Greenberg Traurig P.A., to sign the agreement.", "qualification": "A deferred prosecution agreement is not a conviction: the complaint was to be dismissed if the company complied for 12 months. The civil settlement resolved government claims without a judgment.", "response": "In the agreement the company undertook to acknowledge responsibility for its behaviour, to continue cooperating with the prosecutors and other agencies and to carry out further remediation; the prosecutors acknowledged that neither the agreement nor the criminal complaint alleged that the company's conduct had adversely affected patient health or patient care.", "outcome": "The record does not contain the dismissal order; the Settlement Trust's 2026 complaint refers to the agreement as having expired.", "source_ids": [ "s-d258", "s-d350" ], "entity_ids": [ "e-exac", "e-greenberg" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-donofrio", "kind": "fact", "text": "On the same day Douglas Donofrio, then Exactech's director of sales for the Northeast region, pleaded guilty before the chief district judge in Trenton to conspiring to violate the anti-kickback statute. According to the U.S. Attorney's Office he admitted entering into illegal financial arrangements with orthopaedic surgeons while employed by Exactech from about 2002 to 2008 and inflating entries in work reports used to justify consulting payments, and agreed to restitution of a $50,000 bonus he had received.", "qualification": "The plea concerns the individual; the charge carried a maximum of five years in prison and a $250,000 fine.", "response": "", "outcome": "The release gave a sentencing date of 14 March; the sentence is not in the record.", "source_ids": [ "s-d258" ], "entity_ids": [ "e-donofrio", "e-exac" ], "adverse_subject_ids": [ "e-donofrio" ] }, { "id": "c-trust-kickbacks", "kind": "attributed", "text": "The Settlement Trust's 2026 complaint alleges that the consulting arrangements continued after the deferred prosecution agreement expired: citing federal Open Payments data, it says Exactech's consulting payments to health-care providers peaked in 2018 and rose again for shoulder products from 2021, and that from 2017 to 2023 Exactech paid physicians nearly $60 million, including more than $16 million in consulting fees. It alleges that TPG and Jeffrey Binder used such arrangements to encourage physicians to use Exactech products or to discourage complaints about them.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The payment totals come from the complaint's reading of public payment data, which was not retrieved.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg", "e-binder" ] }, { "id": "c-deal-background", "kind": "fact", "text": "The merger proxy's account of the sale begins on 1 May 2017, when William Petty, David Petty and Bruce Thompson met at Exactech's Gainesville headquarters with Daniel Hann and Jeffrey Binder, the former president and chief executive of Biomet and a TPG adviser, who said TPG wished to explore a possible investment or strategic transaction; Exactech replied that it was not exploring a sale. The Pettys and the finance chief met Binder and Todd Sisitsky, managing partner of TPG Capital North America, on 21 June 2017, and the Pettys, Betty Petty and Joel Phillips met Sisitsky, Binder, Hann and Kendall Garrison, a TPG principal, in Atlanta on 24 July 2017. TPG said it wanted any talks to move promptly so as not to jeopardise Binder's availability to play a central role in the company. In late July the lead independent director, James G. Binch, contacted TPG about a confidentiality and standstill agreement; the merger agreement refers to a confidentiality agreement of 7 August 2017 between TPG Global, LLC and Exactech. On 29–30 August 2017 TPG's advisers met Exactech's finance, legal, regulatory, clinical, manufacturing and quality staff in Gainesville.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5" ], "entity_ids": [ "e-exac", "e-wpetty", "e-dpetty", "e-thompson", "e-hann", "e-binder", "e-sisitsky", "e-garrison", "e-tpg", "e-binch", "e-tpg-global" ] }, { "id": "c-merger-agreement", "kind": "fact", "text": "On 22 October 2017 Exactech agreed to merge with Osteon Merger Sub, Inc., a Florida company formed only for the merger and wholly owned by Osteon Holdings, L.P., a Delaware partnership ('Parent'); the proxy describes both as affiliates of the private-equity firm TPG Capital, L.P. and as jointly owned by the fund TPG Partners VII, L.P. Amendment No. 1 of 3 December 2017 raised the cash price from $42.00 to $49.25 per share, a premium of about 53.9% to the closing price of $32.00 on 20 October 2017 (the shares traded at $42.35 on 1 December 2017 and $50.45 on 11 January 2018). Under an equity commitment letter of 22 October 2017, amended on 3 December 2017, the fund committed to buy up to $737,057,000 of Parent equity to pay the merger price and costs, the same amount as Parent's maximum liability under the agreement. Exactech would owe Parent a $25,797,000 termination fee in specified cases, for example if it accepted a superior proposal. J.P. Morgan, engaged by Exactech on 13 October 2017, gave the board a fairness opinion on 2 December 2017. Exactech and Parent filed under the Hart-Scott-Rodino Act on 9 November 2017 and received early termination of the waiting period on 17 November 2017.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5" ], "entity_ids": [ "e-exac", "e-osteon-lp", "e-mergersub", "e-tpg", "e-tpg7", "e-jpm" ] }, { "id": "c-independent-directors", "kind": "fact", "text": "The merger was approved by a majority of the directors who were not company employees; William Petty and David W. Petty, as rollover investors, recused themselves. Independent directors were to receive additional cash compensation of up to $1,200,000 for their work on the sale ($400,000 for the lead independent director and $200,000 for each other independent director) and severance payments of up to $600,000, neither conditioned on the merger closing.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5" ], "entity_ids": [ "e-exac", "e-wpetty", "e-dpetty" ] }, { "id": "c-board-2018", "kind": "fact", "text": "At the time of the merger proxy (January 2018) William Petty was executive chairman and chairman of the board, David W. Petty chief executive officer (since March 2014), president (since November 2007) and a director, having joined the company in 1988, Joel C. Phillips executive vice president, chief financial officer and treasurer, Gary J. Miller executive vice president for research and development, Bruce Thompson senior vice president for strategic initiatives, Betty Petty vice president and corporate secretary and Donna Edwards vice president, legal, and general counsel; the independent directors were James G. Binch, William B. Locander, Richard C. Smith, Fern S. Watts and W. Andrew Krusen, Jr. Exactech's January 2015 release on the Blue Ortho purchase gave its chief financial officer's name as Jody Phillips.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5", "s-d128" ], "entity_ids": [ "e-exac", "e-wpetty", "e-dpetty", "e-phillips", "e-miller", "e-thompson", "e-bpetty", "e-edwards", "e-binch", "e-locander", "e-rsmith", "e-watts", "e-krusen" ] }, { "id": "c-rollover", "kind": "fact", "text": "A group of insiders kept a stake through Parent. Under a Rollover and Voting Agreement the 'rollover investors' — William Petty (executive chairman), David W. Petty (president and chief executive), Betty Petty (founding shareholder and corporate secretary), Prima Investments, Limited Partnership (owned and controlled by Dr and Mrs Petty), Miller Family Holdings, LLC (owned by Gary J. Miller's family), Bruce Thompson, Joel C. Phillips, Donna Edwards, Chris Roche and Steve Szabo — exchanged 2,711,584 Exactech shares for Parent shares just before the merger: Prima 2,300,000 shares for 130,757,376 Class B shares, William Petty 102,400 shares for 5,821,546 Class B shares, Betty Petty 75,400 shares for 3,713,450 Class A shares, David W. Petty 50,000 shares for 2,462,500 Class A shares, Miller Family Holdings 47,650, Phillips 82,000, Thompson 25,279, Edwards 18,052, Szabo 6,345 and Roche 4,458 shares. At the record date the founders, chief executive and other management holders owned 3,637,851 shares (about 25.1%) and agreed to vote them for the merger; the closing announcement put the exchanged shares at about 18.8% of the stock. The rollover investors waived appraisal rights, agreed to end their existing shareholder agreements with the company and, under the agreed terms for Parent's shareholders agreement, to vote in the same proportion as the TPG fund on director nominations, mergers and recapitalisations; the fund received drag-along rights on a sale of more than 50% of its interest.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5" ], "entity_ids": [ "e-exac", "e-osteon-lp", "e-tpg7", "e-wpetty", "e-dpetty", "e-bpetty", "e-prima-lp", "e-mfh-llc", "e-thompson", "e-phillips", "e-edwards", "e-roche", "e-szabo" ] }, { "id": "c-holders-2018", "kind": "fact", "text": "At the record date for the merger vote 14,423,864 shares were outstanding. William Petty beneficially owned 3,589,188 shares (24.3%), including 3,080,271 held by Prima Investments, Limited Partnership, a Florida partnership whose general partner, Prima Investments, Inc., was wholly owned by Dr and Mrs Petty and whose limited-partnership interests were held by them and their children. GAMCO Investors, Inc. and affiliates reported 1,863,658 shares (12.9%) as an investment adviser (Schedule 13D amendment of 21 November 2017), BlackRock, Inc. 800,197 (5.5%) and Dimensional Fund Advisors LP 751,750 (5.2%); directors and executive officers held 29.4%. Miller Family Holdings, LLC held 142,370 shares; its principal member was Miller Family Holdings, Inc., owned by Gary J. Miller, his wife and children. Valuing all their shares at $49.25 (without separating the rollover shares), the proxy's table of merger consideration for directors and named executives totalled $182,051,492, including $160,459,997 for William Petty's 3,258,071 shares, $8,769,406 for Gary J. Miller, $5,559,143 for Joel C. Phillips and $3,231,884 for David W. Petty.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5" ], "entity_ids": [ "e-exac", "e-wpetty", "e-bpetty", "e-prima-lp", "e-prima-inc", "e-gamco", "e-blackrock", "e-dfa", "e-mfh-llc", "e-mfh-inc", "e-miller", "e-phillips", "e-dpetty" ] }, { "id": "c-deal-suits", "kind": "fact", "text": "Two putative shareholder class actions over the merger were filed in the U.S. District Court for the Northern District of Florida: Anthony Pappalardo v. Exactech, Inc. et al. (No. 1:17-cv-00303-MW-GRJ, 14 December 2017) and Jordan Rosenblatt v. Exactech, Inc. et al. (No. 1:17-cv-00312, 22 December 2017). They named Exactech, its directors (William Petty, David W. Petty, James G. Binch, William B. Locander, Richard C. Smith, Fern S. Watts and W. Andrew Krusen, Jr., and in the second case also Albert H. Burstein), Parent, Merger Sub and TPG Capital, L.P., and asserted claims under sections 14(a) and 20(a) of the Securities Exchange Act.", "qualification": "The complaints' allegations were not adjudicated in the record.", "response": "Exactech and the director defendants denied the allegations and said they intended to defend the actions vigorously.", "outcome": "The outcome of the two federal actions is not in the record; the merger closed on 14 February 2018.", "source_ids": [ "s-d5" ], "entity_ids": [ "e-exac", "e-wpetty", "e-dpetty", "e-binch", "e-locander", "e-rsmith", "e-watts", "e-krusen", "e-burstein", "e-osteon-lp", "e-mergersub", "e-tpg" ] }, { "id": "c-arbitrage", "kind": "attributed", "text": "A shareholder, The Arbitrage Fund, also sued the Petty family and the outside directors in Florida state court for breach of fiduciary duty over the sale. On 22 July 2020 Florida's Third District Court of Appeal (No. 3D19-797) reversed the denial of class certification, holding that the shareholder could sue directly, and sent the case back to the trial court. The defendants were William, Betty and David Petty, Prima Investments, Inc., Prima Investments, L.P., James G. Binch, Andrew Krusen, Jr., William B. Locander, Richard C. Smith and Fern S. Watts. As summarised in the opinion, the plaintiff alleged that a competing bidder had offered $54 per share and reimbursement of any termination fee if the Pettys committed in writing to support its plan; the Pettys, holding about 26%, declined, the board rejected the offer and approved TPG's $49.25 deal, and the plaintiff alleged undisclosed negotiations between the Pettys and TPG over keeping their stake and positions.", "qualification": "The account of the competing bid and the negotiations is the plaintiff's, as summarised by the appeal court on the class-certification question; the court did not decide the merits.", "response": "", "outcome": "On 22 July 2020 the appeal court reversed the denial of class certification and remanded; the later outcome is not in the record.", "source_ids": [ "s-d241" ], "entity_ids": [ "e-arbfund", "e-wpetty", "e-bpetty", "e-dpetty", "e-prima-inc", "e-prima-lp", "e-binch", "e-krusen", "e-locander", "e-rsmith", "e-watts", "e-exac", "e-tpg" ], "adverse_subject_ids": [ "e-wpetty", "e-bpetty", "e-dpetty" ] }, { "id": "c-closing", "kind": "fact", "text": "Shareholders approved the merger on 13 February 2018. On 14 February 2018 articles of merger were filed with the Florida Department of State, merging Osteon Merger Sub, Inc. (document P17000084137), described in the plan as a wholly owned indirect subsidiary of Parent, into Exactech, Inc. (H85101), the surviving corporation; William Petty signed for Exactech as executive chairman and Michael LaGatta for Merger Sub as vice president. Exactech announced that TPG had acquired all of its common stock for $49.25 per share in a transaction valued at about $737 million, that its stock would stop trading on Nasdaq before the market opened on 15 February 2018, and that it would deregister its shares with the SEC. The final amendment to the going-private Schedule 13E-3 says that Exactech became an indirect wholly owned subsidiary of Parent, identified in that filing as Osteon Holdings, Inc., a Delaware corporation, rather than the partnership named in the proxy. Among the filing persons, TPG Partners VII, L.P., whose general partner is TPG Genpar VII, L.P., itself managed by its general partner TPG Genpar VII Advisors, LLC, signed through Michael LaGatta as vice president.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d21", "s-d10", "s-d175" ], "entity_ids": [ "e-exac", "e-mergersub", "e-osteon-lp", "e-osteon", "e-wpetty", "e-lagatta", "e-tpg", "e-tpg7", "e-tpg-genpar", "e-tpg-genpar-adv", "e-nasdaq" ] }, { "id": "c-form-d", "kind": "fact", "text": "On 28 February 2018 Osteon Holdings, Inc. (SEC Central Index Key 0001732417), a Delaware corporation formed in 2017 with its address at TPG's Fort Worth office (301 Commerce Street, Suite 3300), filed a Form D for an offering connected with a business combination, with the first sale on 14 February 2018, the closing day of the Exactech merger; $616,971,937 had been sold to 11 investors, all accredited. The filing lists as directors Kendall Garrison, Todd Sisitsky and John Schilling (c/o TPG Capital, L.P.), Jeffrey Binder (c/o Osteon Holdings, Inc.) and David Petty and William Petty (c/o Exactech, Inc.), and seven executive officers c/o TPG Capital, L.P., including Michael LaGatta and Adam Fliss, who signed the form as vice president.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d134" ], "entity_ids": [ "e-osteon", "e-garrison", "e-sisitsky", "e-schilling", "e-binder", "e-dpetty", "e-wpetty", "e-lagatta", "e-fliss", "e-tpg" ] }, { "id": "c-trust-deal", "kind": "attributed", "text": "The Settlement Trust's complaint gives its own account of the acquisition. It says TPG's first contact came on 4 April 2017 from Daniel Hann, a TPG consultant reporting to Michael Tepatti and Kendall Garrison, who approached Exactech's chief executive and that on 13 September 2017 TPG, led by Todd Sisitsky, Jeffrey Binder, John Schilling and Kendall Garrison, presented a non-binding offer of $39.00 per share at an Exactech board meeting. It alleges that TPG paid Binder a $1 million success fee for the acquisition, invoiced two days before the closing, and that at a deposition in the bankruptcy he at first said he did not recall the payment; that William Petty received more than $46 million and David Petty more than $2.8 million from the deal; and that TPG's due diligence had access to the results of the FDA's March 2017 inspection (seven critical observations, including the lack of complaint-handling procedures), identified the product-defect suit Talley v. Exactech, Inc. in the Northern District of Alabama, and did not interview or visit the critical packaging supplier, whose warehouse was about 15 minutes from Exactech's headquarters. It further alleges that the merger left Exactech with more than $200 million of secured debt, that by 2019 it had consistently negative cash flow and more than $380 million of liabilities, and that it was probably insolvent from the closing.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The deposition, invoice and inspection documents are under seal or were not retrieved.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg", "e-hann", "e-sisitsky", "e-binder", "e-schilling", "e-garrison", "e-wpetty", "e-dpetty", "e-tepatti" ] }, { "id": "c-chain-petition", "kind": "fact", "text": "Exactech's bankruptcy filings document the immediate ownership. Its corporate ownership statement lists Osteon Intermediate Holdings II, Inc. as its only shareholder (100%), and the special committees' resolutions list Osteon Intermediate Holdings II, Inc. and XpandOrtho, Inc. as Delaware corporations and Exactech, Inc. as a Florida corporation. Under the first-lien credit agreement of 14 February 2018 Exactech was the borrower, Osteon Intermediate Holdings II, Inc. acted as 'Holdings', and Goldman Sachs Bank USA was the agent until GLAS Trust Company LLC replaced it on 28 October 2024; the loans were guaranteed by Holdings and XpandOrtho, Inc. under a guaranty of the same date and secured by substantially all assets.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d20", "s-d7" ], "entity_ids": [ "e-exac", "e-osteon2", "e-xpand", "e-goldman", "e-glas-us" ] }, { "id": "c-trust-chain", "kind": "attributed", "text": "The Settlement Trust's complaint describes the chain above Exactech. It says Osteon Intermediate Holdings II, Inc. (Osteon II) was the direct parent, wholly owned by Osteon Intermediate Holdings I, Inc. (Osteon I), itself wholly owned by Osteon Holdings, Inc.; that Osteon I and II were Delaware corporations created by or at the direction of TPG at Exactech's Gainesville address, that Osteon I had no board or officers and Osteon II's board did not act until November 2023; and that XpandOrtho, Inc. was a wholly owned subsidiary of Exactech. According to the complaint, from 2018 to 2024 Osteon Holdings, Inc. was 88% owned by TPG VII Osteon Holdings, L.P. (the 'Sponsor'), 95% of which was owned and funded by the TPG fund TPG Partners VII, L.P., and its board was indistinguishable from Exactech's. It says that under the Osteon Holdings Shareholders' Agreement of 14 February 2018 the 'Majority Lead Investors' (the Sponsor) fixed the number of directors and Exactech had one representative, and that Jeffrey Binder, Todd Sisitsky, John Schilling, Kendall Garrison, William Petty and David Petty became directors of Osteon Holdings on that date; it relies on the agreement's forum clause (section 14.2) to sue Binder and the Pettys in Delaware.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The 88% and 95% figures appear only in the complaint; the shareholders agreement and partnership records are not public.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-osteon2", "e-osteon1", "e-osteon", "e-xpand", "e-sponsor", "e-tpg7", "e-tpg" ] }, { "id": "c-sponsor-loans", "kind": "fact", "text": "The 2024 restructuring support agreement defines the 'Sponsor' as TPG VII Osteon Holdings, LP and its affiliates in their capacities as direct or indirect equityholders, managers, consultants and lenders of the debtors. On 19 September 2023 Exactech signed a 'sidecar' credit agreement under which TPG VII Osteon Holdings, LP was agent and sole lender of $15,000,000 of term loans, with Osteon Intermediate Holdings II, Inc. as holdings; the chief restructuring officer said the Sponsor agreed in September 2023 to lend up to $15 million to support liquidity during settlement talks with product-liability plaintiffs and in April 2024 up to $20 million more, and that a mid-June 2024 Sponsor proposal for a restructuring with its own debtor-in-possession financing and a partial debt-for-equity exchange did not lead to agreement. At the petition date the sidecar loans totalled $28,525,064.59 ($17,600,993.96 of original loans and $10,924,070.63 under the first amendment), bearing 12% a year until 18 March 2024 and 18% afterwards, mostly paid in kind.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7" ], "entity_ids": [ "e-exac", "e-sponsor", "e-osteon2" ] }, { "id": "c-debt", "kind": "fact", "text": "At the 29 October 2024 petition date the debtors had about $352 million of funded debt ($352,169,400.47): $323,644,335.88 under the first-lien credit agreement — revolving loans of $52,180,116.32, the term loan of $264,917,930.82 and a 2024 incremental term loan of $6,546,288.74 at Term SOFR plus 8.00% — and $28,525,064.59 under the sidecar agreement. The first-lien agreement of 14 February 2018 had provided a $50,000,000 revolving facility and a $235,000,000 term loan; a first amendment on 17 December 2019 added a $35,000,000 incremental term loan and on 19 January 2022 the revolver's maturity was extended from 14 February 2023 to 15 November 2024. The chief restructuring officer said the recalls had cost about $20 million in the preceding twelve months, prevented a refinancing, and left the company with about $4 million of cash against weekly operating disbursements of about $4 million.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7" ], "entity_ids": [ "e-exac" ] }, { "id": "c-trust-fees", "kind": "attributed", "text": "The Settlement Trust's complaint alleges that on 14 February 2018 Exactech, Osteon Holdings, Osteon I and Osteon II signed a Management Services Agreement with TPG VII Management, LLC under which the TPG manager was paid an annual fee of $1 million quarterly, and that on 22 February 2018 TPG invoiced Exactech $5,909,935.00 for '2/14/18 Project Osteon Out of Pocket Expenses', which Exactech paid. The trust seeks to recover that payment as an actually and constructively fraudulent transfer under Florida and Delaware law and pleads waste of corporate assets of at least that amount. The complaint also states that the liabilities Exactech recognised for the polyethylene recalls rose from $16.8 million at the end of 2021 to $48.2 million at the end of 2022 and $135.8 million at the end of 2023, and that in 2022 it recorded a $138 million impairment writing off the remaining goodwill of its Large Joints (knee and hip) segment.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The financial figures are the complaint's account of Exactech's private accounts, which are not public.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg-mgmt", "e-osteon", "e-osteon1", "e-osteon2", "e-tpg", "e-trust" ] }, { "id": "c-board-2019", "kind": "fact", "text": "Exactech's 2019 annual report to the Florida register (18 March 2019) listed as directors William Petty, Jeffrey Binder, Kendall Garrison, John Schilling, Todd Sisitsky and David Petty (also president), and as officers Donna Edwards (vice president, legal), Joel C. Phillips (treasurer), Betty Petty (vice president, administration), Gary J. Miller (executive vice president, research and development), Daniel P. Hann (senior vice president, business development) and Bruce Thompson (senior vice president, strategic initiatives).", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d25" ], "entity_ids": [ "e-exac", "e-wpetty", "e-binder", "e-garrison", "e-schilling", "e-sisitsky", "e-dpetty", "e-edwards", "e-phillips", "e-bpetty", "e-miller", "e-hann", "e-thompson" ] }, { "id": "c-board-2023", "kind": "attributed", "text": "According to a written consent of 8 November 2023 quoted in the Settlement Trust's complaint, Exactech's board then consisted of Darin Johnson, David Petty, Jeff Binder, Todd Sisitsky, John Schilling, Kendall Garrison, Diana Nole, Gwen Bingham, Karen Golz and M. Elizabeth Abrams. The complaint says the boards of Osteon Holdings and Exactech were identical from February 2018 to November 2023, comprising four TPG representatives (Binder, Sisitsky, Schilling and Garrison) and David and William Petty, with Darin Johnson replacing William Petty in 2020; that Golz, Bingham and Nole joined as nominally independent directors in January 2021; that Abrams, appointed in November 2023, was the first Exactech director not also on the Osteon Holdings board; that Garrison and Schilling formed the audit and compliance committee from 2018 to the end of 2024; that TPG also placed its people in key posts, including chief executive (Binder), chief financial officer (Bolukbasi) and vice president for business development (Hann); and that TPG principal Michael Tepatti attended at least 28 board or audit committee meetings while TPG staff (Tepatti, Bennett Yasskin and John Lin) edited board agendas and draft minutes. Golz's own 2023 proxy biography at another listed company describes her as a board and audit committee member of 'Osteon Holdings/Exactech'.", "qualification": "The 2023 board list is quoted from a corporate consent in the complaint; the description of TPG's control and of meeting attendance is the Settlement Trust's allegation, not adjudicated.", "response": "", "outcome": "", "source_ids": [ "s-d24", "s-d306" ], "entity_ids": [ "e-exac", "e-osteon", "e-johnson", "e-dpetty", "e-binder", "e-sisitsky", "e-schilling", "e-garrison", "e-nole", "e-bingham", "e-golz", "e-abrams", "e-wpetty", "e-tepatti", "e-yasskin", "e-lin", "e-bolukbasi", "e-hann", "e-tpg" ] }, { "id": "c-executives", "kind": "attributed", "text": "The Settlement Trust's complaint sets out the executive succession. William Petty, chief executive from 1985 to 2014 and then executive chairman, was co-executive chairman of Exactech and Osteon Holdings with Jeffrey Binder after the acquisition until January 2020 and stepped back from day-to-day management around 6 January 2020. David Petty, the first employee in 1988, served as vice president of operations (1991–1993), vice president of marketing (1993–2000), executive vice president of sales and marketing (2000–2007), president (2007–2014) and chief executive from 2014 until January 2020, then as vice chairman, and sat on both boards from 14 February 2018 until the bankruptcy. Darin Johnson, vice president of marketing for extremities in 2002–2016, became president and chief executive in January 2020; Binder replaced him as chief executive in March 2022; Johnson became interim chief executive in March 2023 and chief executive again in September 2023. Binder was co-executive or executive chairman from February 2018 to about September 2023 and chief executive and executive chairman from March 2022 to March 2023, remaining a director afterwards. Kerem Bolukbasi, a TPG consultant from November 2014 to December 2018 and a field operations adviser in TPG Capital's operations group in 2020, became chief financial officer and an executive vice president in August 2020.", "qualification": "The dates come from the Settlement Trust's complaint; the earlier SEC proxy confirms David Petty as chief executive from March 2014 and president from November 2007, and the Florida and UK registers confirm Johnson as president and chief executive.", "response": "", "outcome": "", "source_ids": [ "s-d24", "s-d5" ], "entity_ids": [ "e-exac", "e-osteon", "e-wpetty", "e-dpetty", "e-johnson", "e-binder", "e-bolukbasi", "e-tpg" ] }, { "id": "c-officers-2024", "kind": "fact", "text": "Exactech's amended 2024 annual report to the Florida register (filed 19 August 2024) listed Darin Johnson as chief executive and president, Tony Collins as chief financial officer, Donna Edwards as secretary, Jessica Livingston as assistant secretary, Jeffrey Binder as chairman and David Petty, Timothy Pohl and Elizabeth Abrams as directors. Donna H. Edwards, general counsel and senior vice president, signed the bankruptcy petition, and Tony Collins, chief financial officer, certified the board resolutions.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d14", "s-d20" ], "entity_ids": [ "e-exac", "e-johnson", "e-collins", "e-edwards", "e-livingston", "e-binder", "e-dpetty", "e-pohl", "e-abrams" ] }, { "id": "c-binder-bio", "kind": "fact", "text": "Before Exactech, Jeffrey R. Binder was a director and the president and chief executive officer of Biomet, Inc. from February 2007, according to a 2014 information statement of Biomet's parent, and held that post until June 2015 according to the Settlement Trust's complaint; earlier he had held senior posts at a diagnostics division and two spine businesses.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d305", "s-d24" ], "entity_ids": [ "e-binder", "e-biomet" ] }, { "id": "c-binder-tpg", "kind": "attributed", "text": "The Settlement Trust's complaint says Binder has been a senior adviser to TPG since June 2015 under a Senior Advisor Agreement of 29 June 2015 with TPG Global, LLC, amended on 6 March 2018, reporting to Todd Sisitsky, Jeff Rhodes and John Schilling; that TPG rather than Exactech paid him more than $1 million for his Exactech work in 2018 and 2019; that by August 2019 he controlled all of Exactech's commercial activities; and that he had chaired Immucor, Inc., another TPG portfolio company, from June 2015. A national newspaper reported in May 2025 that Binder had a consulting relationship with TPG from 2015 to the present.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The agreement and payments are described only in the complaint.", "response": "", "outcome": "", "source_ids": [ "s-d24", "s-d301" ], "entity_ids": [ "e-binder", "e-tpg-global", "e-tpg", "e-exac" ] }, { "id": "c-tpg-people", "kind": "attributed", "text": "The complaint identifies the TPG individuals it sues: Todd Sisitsky, then president and co-managing partner of TPG Capital and managing partner of TPG Partners VII; John Schilling, a partner and head of operations at TPG Capital; Kendall Garrison, a TPG Capital principal; Michael Tepatti, a TPG Capital principal; and Bennett Yasskin and John Lin of TPG's health-care team, who it says took part in the recall process. Sisitsky, Schilling and Garrison sat on the Exactech and Osteon Holdings boards. TPG Inc.'s current report of September 2026 states that on 6 September 2026 Sisitsky stepped down as president of TPG Inc. and from its board with immediate effect.", "qualification": "Titles other than Sisitsky's 2026 departure come from the Settlement Trust's complaint.", "response": "", "outcome": "", "source_ids": [ "s-d24", "s-d97" ], "entity_ids": [ "e-sisitsky", "e-schilling", "e-garrison", "e-tepatti", "e-yasskin", "e-lin", "e-tpg", "e-exac", "e-osteon" ] }, { "id": "c-trust-exit", "kind": "attributed", "text": "The Settlement Trust's complaint alleges that TPG planned to exit Exactech in 2023 but from 2019 explored an earlier exit through a sale or a stock-market listing; that on or about 30 April 2021 Exactech confidentially submitted a 235-page draft Form S-1 to the SEC that did not mention the Alabama whistle-blower case or the loss of the Hospital for Special Surgery knee business; and that neither the sale nor the listing happened because of the recalls and the loss of that customer. Quoting the draft, it says the registrant described itself as controlled by investment funds affiliated with TPG, and it adds that the 2018 Form D listed 11 of Osteon Holdings' 13 directors and officers as TPG employees or affiliates.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The confidential draft registration statement is not public and was not retrieved.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg", "e-osteon", "e-hss" ] }, { "id": "c-tpg-identity", "kind": "attributed", "text": "The Settlement Trust's complaint describes TPG, Inc. as a Delaware corporation listed on Nasdaq with its address at 301 Commerce Street, Suite 3300, Fort Worth, Texas, formerly known as TPG Capital, LP and TPG Partners, LLC; it says TPG Partners, LLC converted into TPG, Inc. in or around December 2021, and that the firm was known as TPG Capital L.P. from 2018 to 2022, before it went public. The 2018 merger documents refer to the sponsor as TPG Capital, L.P., at the same Fort Worth address.", "qualification": "The name history is the complaint's description; this dossier treats references to TPG Capital, L.P. in the 2017–2022 records as the same TPG firm and keeps its separately named funds and vehicles as distinct participants.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-tpg" ] }, { "id": "c-recalls-overview", "kind": "fact", "text": "Exactech's chief restructuring officer summarised the recalls in the 2024 bankruptcy declaration. From June 2021 the company recalled its Connexion GXL hip liners and later expanded the recall to all hip liners and to knee and ankle implants; in early 2024 it also recalled shoulder replacement devices and knee patella components. The recalls were voluntary and coordinated with the FDA, and were caused by a vendor supplying non-conforming bags used to package the affected products: the bags, made and supplied by outside vendors, lacked one of the seven specified layers, an oxygen barrier meant to protect the polyethylene from oxidation. The recalled polyethylene components had been made between 2004 and August 2021. The declaration does not name the vendor.", "qualification": "This is the company's own description in a sworn bankruptcy declaration; the regulator's characterisation is in its safety communications and recall records.", "response": "In the same declaration the company said that, placing patients' interests first, it had proactively implemented the voluntary recall although internal and outside materials-science experts had confirmed through industry-standard laboratory testing that the packaging would not affect the clinical performance of most of the recalled components; and that, although it initiated the recalls in an abundance of caution, it has consistently maintained that the non-conforming bags have not led to overall higher rates of revision surgery beyond industry averages (5–10% at ten years of follow-up), a position it believes scientific and clinical data support. It did not answer a national newspaper's questions on the subject in May 2025.", "outcome": "", "source_ids": [ "s-d7", "s-d301" ], "entity_ids": [ "e-exac" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-fda-sc-2023", "kind": "fact", "text": "The FDA's safety communication of 23 March 2023 (updated 5 August 2024) warned patients and providers about Exactech knee, ankle and hip replacements made between 2004 and August 2021 and recalled in 2021 and 2022: many were packaged in defective bags missing one of the oxygen-barrier layers, which could lead to oxidation, accelerated wear, component cracking or fracture and revision surgery. The FDA said that in June 2021 Exactech recalled some GXL liners for Novation, AcuMatch and MCS hips for excessive and premature wear whose root cause was then unknown (classified Class II on 22 July 2021), and that on 7 February 2022 it expanded a recall to all Optetrak, Logic and Truliant knees and Vantage ankles packaged in defective bags regardless of label or shelf life, because about 80% of the knee and ankle devices made since 2004 had been packaged in such bags (Class II from 4 October 2021; updated correction notice of 7 April 2022). In August 2022 the hip recall was expanded to all hip devices with polyethylene packaged in defective bags (Class II from 9 September 2022). The FDA said it was evaluating Exactech's other devices and working with foreign regulators.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d255" ], "entity_ids": [ "e-exac" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-fda-sc-shoulder", "kind": "fact", "text": "On 16 January 2024 the FDA issued a separate safety communication on the Equinoxe Shoulder System: shoulder implants made between 2004 and August 2021 had also been packaged in the defective bags, and the FDA stated that 'to date, Exactech has declined to initiate a voluntary recall' of them. In an update of 19 April 2024 the FDA reported that Exactech had initiated a recall to remove Equinoxe shoulder devices packaged in the defective bags from facilities' unused inventory.", "qualification": "", "response": "", "outcome": "Exactech initiated the shoulder recall in 2024: the FDA's update of 19 April 2024 reports it, and the FDA enforcement record dates the recall event (94092) from 6 March 2024.", "source_ids": [ "s-d260" ], "entity_ids": [ "e-exac" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-recall-records", "kind": "fact", "text": "The FDA's recall database and enforcement reports record the polyethylene recalls event by event, all Class II with Exactech, Inc. (FDA establishment 1038671, Gainesville) as recalling firm. Event 88126 (recall Z-2132-2021): Connexion GXL acetabular liners sold as Novation GXL and AcuMatch GXL, initiated 29 June 2021, 89,050 units, for a risk of edge-loading and premature wear in a subset of patients; the FDA recorded the root cause as not yet determined by the firm. Event 88570: tibial inserts initiated 30 August 2021 and classified 4 October 2021, including Optetrak Logic inserts (Z-0021-2022, 109,787 devices) and Truliant inserts (Z-0023-2022, 31,201 devices), packaged in vacuum bags without an additional oxygen-barrier layer, as expanded on 7 February 2022. Event 90279: GXL liners for AcuMatch and MCS (for example Z-1728-2022, 11,143 devices), initiated by e-mail on 11 August 2022; the panel that centralised the litigation put this expansion at about 40,000 hip liners. Event 94092: Equinoxe humeral liners (Z-1420-2024, 2,806 units) and glenoids, initiated 6 March 2024 for vacuum bags without the ethylene vinyl alcohol (EVOH) barrier. Event 94409: all ultra-high-molecular-weight polyethylene knee patella components in out-of-specification bags, initiated 18 April 2024. Event 94410: AcuMatch L-Series 22 mm bipolar liners (Z-2236-2024, 589 units), initiated 26 April 2024, where the firm stated that from 2004 to August 2021 two packaging configurations were used, one with and one without an EVOH layer. Event 96102: AcuMatch XLE (42 units), Novation XLE (87 units) and Alteon XLE (1,446 units) liners lacking the EVOH layer, initiated on 31 December 2024, during the bankruptcy.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d247", "s-d253", "s-d351", "s-d254" ], "entity_ids": [ "e-exac" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-recalls-other", "kind": "fact", "text": "The enforcement reports list other Exactech recalls. In 2012 (event 62566) Equinoxe plates and screws and Octane-C spinal devices were recalled because labels gave a ten-year shelf life while the packaging was qualified for five; the event covered 54,877 units and was terminated on 3 July 2013. In 2017 (event 78111, initiated 19 September 2017) Optetrak offset tibial trays and screws were recalled for a design incompatibility (terminated 21 June 2021), and in November 2023 an AcuMatch hip system item after three complaints about loss of vacuum in the innermost bag (event 93507). On 15 August 2025 Equinoxe reverse-shoulder humeral liners whose articular surface position was outside the labelled dimensional specification were recalled (event 97459: 61,334 and 11,542 units in two entries); on 5 September 2025 Equinoxe Ergo reamers and instruments released before design updates and performance testing were complete (event 97588); and on 3 February 2026 Equinoxe Ergo impactor handles (120 units) and core instrument kits (596 kits) that might lack a cross-pin (event 98376), still in the name of Exactech, Inc. Between 19 April 2024 and 16 October 2026 the enforcement database holds 11 recall records for the firm, all Class II, out of 211 records in total.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d253", "s-d254" ], "entity_ids": [ "e-exac" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-warning-2024", "kind": "fact", "text": "On 19 January 2024 the FDA's Center for Devices and Radiological Health sent Exactech a warning letter (CMS# 669904), addressed to its president and chief executive Darin B. Johnson, after an inspection of the Gainesville facility from 18 to 26 September 2023 that ended with a Form FDA 483. The FDA found the Equinoxe anatomic and reverse total shoulder systems and other orthopaedic implants adulterated because of quality-system violations: the firm had not identified the actions needed to correct polyethylene shoulder implants packaged in bags that did not meet material and oxygen-transmission specifications, and its health hazard evaluation HHE2021-08-06-02 counted only complaints coded as polyethylene wear (11 complaints from January 2008 to July 2021) (21 CFR 820.100(a) and 820.30(g)). It also found the implants misbranded under the medical device reporting rules: its reporting procedure was inadequate, and a report on accelerated wear of a GXL liner in non-conforming packaging — the defect behind recall Z-1734-2022 — reached the FDA on 4 January 2023 although the firm had learned of it on 1 September 2022, outside the 30-day limit.", "qualification": "", "response": "Exactech answered the Form 483 observations on 13 October 2023, describing systemic corrective actions: a retrospective review of complaints, revised procedures and staff training, an assessment under CAPA2023-042 of how historical complaints had been coded, and a revision of its medical-device-reporting procedure due by 31 December 2023. The FDA said the adequacy of the response could not yet be determined because the actions were still under way.", "outcome": "Exactech initiated the shoulder recall in March–April 2024.", "source_ids": [ "s-d246" ], "entity_ids": [ "e-exac", "e-johnson" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-warning-2025", "kind": "fact", "text": "On 19 December 2025 the FDA sent a warning letter (CMS 720250) to 'Exactech, Inc. dba Advita Ortho', addressed to Aurelio Sahagun as president and chief executive, after an inspection of the Sarasota, Florida, facility from 15 to 25 July 2025 that ended with a Form FDA 483. The FDA found the Equinoxe reverse shoulder compression screw and accessories adulterated under the quality-system regulation and noted that the sole supplier of a critical powder used to mould ultra-high-molecular-weight polyethylene parts had not received a required on-site audit, had last been evaluated in September 2020 and had no signed quality agreement. A trade publication reported in March 2026 that the inspection took place before the court approved the asset sale and before Advita Ortho launched, and that the letter also found incomplete documentation of production deviations between July 2023 and July 2025 and temperature and humidity outside limits at the site since March 2024. A local television investigation reported in September 2026 that the FDA had not listed recalls or penalties tied to the letter and that Advita Ortho continued to operate.", "qualification": "Which legal entity is behind the name 'Exactech, Inc. dba Advita Ortho' is not stated in the letter; the inspection preceded the sale of the business to Advita Ortho.", "response": "The firm told the FDA that it had suspended production, started a field action on humeral shoulder liners and opened a corrective action (CAPA 2025-30) for the Sarasota and Gainesville sites due for completion by March 2026; the FDA found the responses not adequate.", "outcome": "", "source_ids": [ "s-d30", "s-d264", "s-d294" ], "entity_ids": [ "e-exac", "e-advita", "e-sahagun" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-fda-registration", "kind": "fact", "text": "In the FDA's registration and listing database (data as of 5 October 2026), the Gainesville establishment at 2320 N.W. 66th Ct. (registration and FEI number 1038671; manufacturer and importer, registered through 2026) is still registered to Exactech, Inc., which is also recorded as owner-operator, with 173 product listings including the Equinoxe shoulder (K150458). FDA 510(k) decisions for the applicant Exactech run from 15 October 1986 to 14 April 2026. The most recent, K260583 for the Equinoxe Shoulder System (reverse shoulder prosthesis, product code PHX), was received on 20 February 2026 and cleared as substantially equivalent on 14 April 2026; it names Exactech, Inc. as applicant and Advita Ortho, at the same Gainesville address, as correspondent.", "qualification": "The FDA records keep the Exactech, Inc. name after the sale of the business; they do not state which legal entity now holds the registration.", "response": "", "outcome": "", "source_ids": [ "s-d329", "s-d262", "s-d51" ], "entity_ids": [ "e-exac", "e-advita" ] }, { "id": "c-trust-recall-strategy", "kind": "attributed", "text": "The Settlement Trust's complaint alleges that TPG decided Exactech should issue a series of recalls each covering only part of a product line, to keep revenue looking stable for TPG's planned listing. It says the 29 June 2021 GXL recall was initially limited to liners implanted after 2015; that in August 2021 only knee and ankle inserts with a shelf life of more than five years were recalled; that the shelf-life-based proposal submitted to the FDA on 24 August 2021 had been drafted under TPG's supervision (61 versions of a presentation, one described in an e-mail as the 'final from TPG blessed deck'), and that within four days the FDA said the approach might not rest on relevant and reliable data and did not cover all affected liners; that the knee and ankle recall of 30 August 2021 went to distributors and sales representatives rather than to surgeons or patients, as did an 'Urgent Field Safety Notice' of 15 September 2021, and that surgeons were first notified directly by the correction notice of 7 February 2022, after the FDA's intervention; and that only on 11 August 2022 was the GXL recall extended to all liners, with a letter to physicians acknowledging that GXL liners had been packed in out-of-specification bags since 2004, while XLE liners on the market from 2018 were recalled only in December 2024. The complaint also lists the January 2024 shoulder communication, the 18 April 2024 patella recall and further hip recalls.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The FDA's own records of these recalls are summarised separately; the internal e-mails are quoted from the complaint and were not retrieved.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg" ] }, { "id": "c-trust-tpg-recall-role", "kind": "attributed", "text": "The complaint alleges that by 22 July 2021 Exactech's chief quality and regulatory clinical officer, Michael Crader, had told colleagues that 20 years of supplier certifications did not confirm the EVOH barrier and that 'this will be a major event'; that by 18 August 2021 Jeffrey Binder and John Schilling, assisted by Kendall Garrison, Bennett Yasskin, Michael Tepatti and John Lin, had displaced key Exactech regulatory staff and taken charge of the recall response and dealings with the FDA; and that at a September 2021 meeting with the FDA Binder acknowledged that GXL liners were 'not state of the art' but pressed for the entire GXL inventory not to be recalled.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "Binder told a national newspaper in May 2025 that Exactech's investigation of product complaints led it to discover in 2021 a packaging non-conformity that had gone undetected since 2008, many years before TPG's ownership and his tenure, and that when it was discovered Exactech reported it to the FDA in a timely fashion and initiated a recall. TPG told the same newspaper that the packaging issues predated its ownership, that it learned of them only in 2021 and that it 'supported the company as it immediately launched an investigation, initiated a voluntary recall, and provided support programs for physicians and patients'.", "outcome": "", "source_ids": [ "s-d24", "s-d301" ], "entity_ids": [ "e-exac", "e-crader", "e-binder", "e-schilling", "e-garrison", "e-yasskin", "e-tepatti", "e-lin", "e-tpg" ] }, { "id": "c-trust-packaging", "kind": "attributed", "text": "The complaint names the packaging supplier. It alleges that from 2004 to 2021 Exactech bought its polyethylene vacuum bags from Hillman Supply Company, Inc., a local Florida company near Exactech's headquarters that specialised in janitorial supplies and had no experience with polyethylene liners; that Hillman did not make the bags but outsourced them to other manufacturers, some of which outsourced further; that the specification required layers of low-density polyethylene, nylon and EVOH, yet almost none of the more than 1.4 million bags supplied over 17 years contained the EVOH barrier, and about 80% of liners made since 2004 were packaged without it; and that Exactech never audited Hillman or the bag makers, never reviewed Hillman's performance and never checked whether it was qualified. According to the complaint, the polyethylene was made in Sarasota and Gainesville and sent after packaging to a third-party steriliser, some femoral knee components were made by outside contract manufacturers, and an FDA inspection found that the vacuum-sealing process used for about 1,405,000 finished devices since February 2007 had not been validated and that there were no acceptance procedures for the three-seal bags from the external supplier. Citing the FDA's March 2023 safety communication, it says all Exactech joint replacement devices contain a plastic component that should be packaged with multiple oxygen barriers. It also alleges that a lawyer acting for TPG and Exactech learned no later than September 2023 that Exactech had been on notice of non-compliant packaging certifications by 2012.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. Hillman is not a defendant in the trust's suit; the FDA's own records and the company's declaration refer only to an unnamed vendor.", "response": "In the Florida product-liability cases where it was named as a co-defendant, Hillman Supply Company filed an answer with affirmative defences and a jury demand on 26 December 2023.", "outcome": "", "source_ids": [ "s-d24", "s-d218" ], "entity_ids": [ "e-exac", "e-hillman", "e-tpg" ] }, { "id": "c-trust-inspections", "kind": "attributed", "text": "Quoting FDA inspection records, the complaint alleges a history of findings: the March 2017 inspection found that Exactech had received 24 complaints from November 2013 to February 2017 and had not adequately investigated 19 of them, after which the company began a Class II recall of an Optetrak tibial tray line extension on 19 September 2017; a January 2020 inspection (ID 1116804) cited purchasing controls and design transfer, validation and verification (21 CFR 820.50 and 820.30); and the inspection of 8–17 November 2021 (ID 1158246) cited four observations and found that Exactech had not implemented requirements to prevent device oxidation, had never validated its implant packaging and had no procedures for accepting supplier products, including the vacuum bags. The complaint quotes the FDA's December 2021 report and a 44-page inspection report as finding that the bags did not contain EVOH as the packaging drawing required, that non-conforming product had been shipped to Exactech for 17 years and that receiving inspectors accepted it without checking the certificates; that around 2007 Exactech had extended the stated shelf life of knee inserts from five to eight years without reporting the change; and that in September 2023 Exactech again failed an inspection. It lists 20 FDA citations from 2017 to 2023 under a dozen regulations, 13 of them after TPG's acquisition, from inspections ending on 10 March 2017, 31 January 2020, 17 November 2021 and 26 September 2023.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The FDA inspection forms and reports (Forms 483 and establishment inspection reports) are not published by the FDA and were not retrieved; the findings are as quoted in the complaint. The FDA's 2024 warning letter separately documents the September 2023 inspection.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg" ] }, { "id": "c-trust-knee", "kind": "attributed", "text": "The complaint, citing the creditors' committee's investigation in the bankruptcy, alleges a second manufacturing problem: from late 2004 until 17 November 2021 Exactech made femoral knee components (Optetrak, Optetrak Logic and Truliant) to an incorrect non-articulating surface-roughness specification, affecting up to 371,986 devices, while outside contractors had read the ambiguous specification correctly. It says an internal health hazard evaluation of 31 March 2021 linked cement debonding to a surface that was too smooth and counted 142 loosening complaints, that on 7 April 2021 the company concluded there was no patient risk, and that the issue was recorded in a memorandum to file in November 2021 without a recall, notice to the FDA or new 510(k). The complaint also says Exactech obtained clearance in March 2018 for vitamin-E-infused Novation and AcuMatch XLE hip liners but only in July 2023 for a vitamin E knee insert (Truliant), and continued selling GXL liners until December 2020.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The internal evaluation and memorandum are quoted from the complaint and were not retrieved; no recall record for the roughness issue appears in the FDA data reviewed.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac" ] }, { "id": "c-trust-hss", "kind": "attributed", "text": "The complaint describes the Hospital for Special Surgery in New York as Exactech's largest domestic customer, which had implanted more than 15,000 Exactech polyethylene inserts over 20 years. It alleges that on 4 August 2017 HSS told Gary Miller of a 'badly worn' and oxidised GXL hip insert, the first of its oxidation complaints, and that on 8 November 2017 a Maryland surgeon wrote to the founders that the Optetrak Logic polyethylene should be withdrawn; that in October 2018 Binder and William Petty tried to get HSS to withdraw a conference presentation reporting delamination in 27 of 86 retrieved Exactech components, with Petty, at Binder's direction, e-mailing HSS surgeons that presenting the data 'will result in significant damage to both our reputations'; that on 9 February 2019 HSS removed all Exactech PS knee implants from its inventory and on 17 February 2021 pulled the Equinoxe shoulder over 'perceived poly issues'; and that Binder, Schilling and others sought to keep from regulators what had been known since 2018.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. HSS is not a party to the trust's suit; it appears as an interested party in the bankruptcy.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-hss", "e-miller", "e-wpetty", "e-binder", "e-schilling", "e-tpg" ] }, { "id": "c-trust-recall-scale", "kind": "attributed", "text": "The complaint's tables put the scale of the polyethylene recalls as follows: more than 70 products were recalled in coordination with the FDA, covering nearly 800,000 units in commerce worldwide, and the seven polyethylene recall events, a small share of Exactech's 68 recall events, accounted for almost 90% of recalled units. By its figures, event 88126 (hip, 29 June 2021) covered 89,050 units; event 88570 (knee and ankle, 30 August 2021) 430,517 units in commerce, 147,732 of them implanted or sold in the United States; event 90279 (GXL hip, 11 August 2022) 107,529 units; and event 94092 (shoulder, 6 March 2024) 171,322 units, 124,231 in the United States; the other events were 94409 (18 April 2024), 94410 (26 April 2024) and 96102 (31 December 2024). The complaint lists the affected lines as the Equinoxe reverse and anatomic shoulders, the MCS, AcuMatch, Novation and Alteon hips, the Optetrak, Optetrak Logic and Truliant knees and the Vantage ankle, more than 500,000 implants in all.", "qualification": "These totals are the Settlement Trust's compilation from FDA recall data and company statements; they differ in scope from the per-entry quantities in the FDA enforcement reports.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac" ] }, { "id": "c-registry-revisions", "kind": "attributed", "text": "A national newspaper reported in May 2025 that annual reports of the Australian Orthopaedic Association National Joint Replacement Registry from 2011 to 2018 identified Exactech devices, made in US facilities, as having 'higher than anticipated' revision rates, and that the 2016 report found the ten-year revision rate of the Optetrak PS knee to be more than four times the industry average.", "qualification": "The registry reports themselves were not retrieved; the figures are as reported by the newspaper.", "response": "In its October 2024 bankruptcy declaration the company said it has consistently maintained that the non-conforming packaging has not led to overall higher rates of revision surgery beyond industry averages (5–10% at ten years of follow-up), and that scientific and clinical data support its position; the newspaper reported the same position from the company's court disclosures.", "outcome": "", "source_ids": [ "s-d301", "s-d7" ], "entity_ids": [ "e-exac" ] }, { "id": "c-mdl", "kind": "fact", "text": "On 7 October 2022 the Judicial Panel on Multidistrict Litigation centralised federal claims over Exactech's polyethylene hip, knee and ankle liners in the Eastern District of New York before Judge Nicholas G. Garaufis as MDL No. 3044 (27 actions in eleven districts and 48 potentially related actions), naming Exactech, Inc. and Exactech U.S., Inc. as defendants and citing the June 2021 GXL safety notice and the August 2021 knee and ankle recall. The docket, In re Exactech Polyethylene Orthopedic Products Liability Litigation (No. 1:22-md-03044, magistrate judge Marcia M. Henry), also lists TPG Capital, TPG Inc., TPG Partners VII, L.P., TPG Genpar VII, L.P., TPG Genpar VII Advisors, LLC, Osteon Holdings, Inc., Osteon Merger Sub, Inc. and Osteon Intermediate Holdings II, Inc. among defendants. An amended master personal-injury complaint was filed on 22 March 2023 against Exactech, Exactech U.S., Osteon Holdings, Osteon Intermediate Holdings II, Osteon Merger Sub and TPG Inc., and the court adopted the master and short-form complaint procedure on 14 April 2023. On 30 May 2023 the magistrate judge stayed discovery against the TPG and Osteon defendants pending their motion to dismiss.", "qualification": "The MDL consolidates plaintiffs' claims; the record contains no judgment on liability against Exactech.", "response": "Exactech defended the consolidated cases. Among its filings, it opposed the conditional transfer into the MDL of a class complaint brought by the Medicare-claims recovery firm MSP Recovery Claims, Series LLC, and on 20 April 2023 filed a fully briefed motion, with Exactech U.S., Inc., to dismiss that complaint for lack of jurisdiction and standing.", "outcome": "Under the plan confirmed in September 2025, personal-injury and wrongful-death claims against the debtors are to be resolved and paid by the Exactech Settlement Trust; the record contains no judgment in the MDL.", "source_ids": [ "s-d351", "s-d322" ], "entity_ids": [ "e-exac", "e-exus", "e-tpg", "e-tpg7", "e-tpg-genpar", "e-tpg-genpar-adv", "e-osteon", "e-mergersub", "e-osteon2" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-mdl-tpg-dismissal", "kind": "fact", "text": "On 7 March 2024 Judge Garaufis granted the motion of TPG Inc., Osteon Holdings, Inc., Osteon Merger Sub, Inc. and Osteon Intermediate Holdings II, Inc. to dismiss the claims against them, which rested on veil-piercing and successor-liability theories, and dismissed them from all personal-injury actions originally filed in 18 states (Memorandum and Order, Document 561). The order notes that more than 1,400 short-form complaints had been filed in the MDL, that Exactech became a wholly owned subsidiary of Osteon Holdings when TPG Capital, LP's purchase closed on 14 February 2018, and that Osteon Intermediate Holdings II and Exactech were joint policyholders on a product-liability insurance certificate with a $10 million limit and a $250,000 self-insured retention per claim.", "qualification": "", "response": "TPG Inc., Osteon Holdings, Osteon Merger Sub and Osteon Intermediate Holdings II moved to dismiss for failure to state a claim of indirect liability on a veil-piercing theory (motion fully briefed on 28 July 2023); the plaintiffs opposed it as premature because the choice-of-law analysis was fact-intensive.", "outcome": "The dismissal removed TPG and its affiliates from the MDL personal-injury actions; the alter-ego and veil-piercing claims later passed to the Settlement Trust under the bankruptcy plan.", "source_ids": [ "s-d219", "s-d322" ], "entity_ids": [ "e-exac", "e-tpg", "e-osteon", "e-mergersub", "e-osteon2" ] }, { "id": "c-trust-mdl", "kind": "attributed", "text": "The Settlement Trust's complaint alleges that TPG had been named with Exactech in several pre-MDL suits and in the MDL master complaint on a veil-piercing theory, with TPG, Inc., Osteon Merger Sub, Inc. and the Osteon holding companies among the product-liability defendants; that in early March 2023 Kirkland & Ellis appeared for the TPG entities, including Osteon Holdings and Osteon Intermediate II, but not for Exactech, while, according to the trust, TPG directed the firm to represent TPG and Exactech jointly without disclosing this to the court or the plaintiffs; and that TPG obtained the March 2024 dismissal without disclosing that it had controlled four of six board seats from 2018 to early 2021 and directed the recalls.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg", "e-kirkland", "e-osteon", "e-osteon2", "e-mergersub" ] }, { "id": "c-suit-counts", "kind": "fact", "text": "By the 29 October 2024 petition date about 2,600 patients — 1.7% of the US patients potentially affected by a recalled device — had sued Exactech, according to its chief restructuring officer: about 1,840 cases in the MDL and more than 740 in Florida state courts, where cases had been coordinated before Judge Donna M. Keim in the Circuit Court of the Eighth Judicial Circuit, Alachua County, after an attempt to have them dismissed on forum non conveniens grounds was denied. Exactech made its most recent offer to settle the MDL in mid-July 2024; no settlement was reached.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7" ], "entity_ids": [ "e-exac" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-trust-suits", "kind": "attributed", "text": "The Settlement Trust's complaint counts more than 2,500 suits against the Exactech companies at the petition date: about 1,840 in the MDL, at least 740 in the Florida master case approved in 2022, more than 55 unconsolidated cases in other state courts by July 2024 and more than 60 outside the United States. It says the first hip bellwether trial in the Florida master case, set for December 2024 after the close of discovery, did not go ahead because of the bankruptcy. A local television investigation reported in September 2026, citing court records, that 1,812 patients had joined the MDL and 718 cases were pending in Florida.", "qualification": "The counts are the trust's and the broadcaster's; they differ slightly from the company's own figures.", "response": "", "outcome": "", "source_ids": [ "s-d24", "s-d294" ], "entity_ids": [ "e-exac" ] }, { "id": "c-florida-suits", "kind": "fact", "text": "Dockets of individual Florida cases, viewed through a court-docket aggregator, show who was sued alongside Exactech. Leanna Marceaux v. Exactech, Inc. et al. (Alachua County, No. 2022 CA 2702, filed 31 August 2022), Johnnie Starling v. Exactech Inc et al. (No. 01-2023-CA-000306, filed 24 January 2023, over an Optetrak knee) and Brenda Sindicich et al. v. Exactech Inc et al. (No. 01-2023-CA-004680, filed 28 November 2023), all part of the master case 2022 CA 002670, name Exactech, Inc., Exactech U.S., Inc., William, Betty and David Petty, Gary Miller, Miller Family Holdings, LLC and Miller Family Holdings, Inc., and the packaging supplier Hillman Supply Company, Inc. as defendants.", "qualification": "These are plaintiffs' claims; no ruling on liability appears in the dockets reviewed.", "response": "On 9 June 2023 the Petty and Miller defendants and the Miller family holding companies moved to dismiss the Starling case; the Exactech defendants answered the Sindicich complaint on 19 December 2023 and Hillman Supply Company filed an answer with affirmative defences and a jury demand on 26 December 2023.", "outcome": "The Starling and Sindicich cases were closed on 29 October 2024 because of the bankruptcy filed in the Exactech master case.", "source_ids": [ "s-d293", "s-d349", "s-d218" ], "entity_ids": [ "e-exac", "e-exus", "e-wpetty", "e-bpetty", "e-dpetty", "e-miller", "e-mfh-llc", "e-mfh-inc", "e-hillman" ], "adverse_subject_ids": [ "e-exac", "e-hillman", "e-wpetty", "e-bpetty", "e-dpetty", "e-miller" ] }, { "id": "c-arkansas", "kind": "attributed", "text": "In an interview with a legal-news website in November 2023, a plaintiffs' lawyer described Wilson et al. v. Exactech, Inc. (U.S. District Court for the Eastern District of Arkansas, No. 4:22-cv-136-BRW), a case over a Novation Crown Cup hip with a Connexion GXL liner alleging design and manufacturing defects, failure to warn and misleading claims of reduced wear, and said that Exactech was blaming the packaging supplier, Hillman.", "qualification": "This is the plaintiffs' lawyer's account of the case and of Exactech's position.", "response": "", "outcome": "", "source_ids": [ "s-d307" ], "entity_ids": [ "e-exac", "e-hillman" ] }, { "id": "c-australia-class", "kind": "fact", "text": "In Australia, Simon Harrold brought a class action in the Federal Court (Harrold v Exactech Australia Pty Ltd, NSD 1224 of 2024, filed 5 September 2024) against Exactech Australia Pty Ltd, the subsidiary that imported, distributed and sponsored the devices on the Australian Register of Therapeutic Goods, and Exactech, Inc., the US parent responsible for their design, manufacture, packaging and export, on behalf of about 5,000 people implanted between 1 January 2003 and 5 September 2024 with listed Equinoxe shoulder, Optetrak knee, Novation and AcuMatch hip and ankle components (several register entries were cancelled on 24 December 2024). The claim alleged a manufacturing defect in polyethylene without vitamin E and a packaging defect in out-of-specification vacuum bags. The proceeding against Exactech, Inc. was stayed on 23 December 2024 after the Chapter 11 case was recognised as a foreign proceeding; recognition orders of 6 February 2025 stayed proceedings against it in Australia without the consent of Jesse York as its foreign representative. After mediations on 20 December 2024 and 3 March 2025 the parties signed a deed of settlement on 29 May 2025.", "qualification": "", "response": "The respondents denied liability; the settlement was made without admission of liability.", "outcome": "The Federal Court approved the settlement on 13 November 2025 (see the settlement record).", "source_ids": [ "s-d197", "s-d214" ], "entity_ids": [ "e-exac", "e-au", "e-harrold", "e-york" ], "adverse_subject_ids": [ "e-exac", "e-au" ] }, { "id": "c-australia-settlement", "kind": "fact", "text": "On 13 November 2025 Justice Jackman approved the settlement (Harrold v Exactech Australia Pty Ltd (No 2) [2025] FCA 1412). Under the deed of 29 May 2025 the respondents pay about A$8.7 million without admitting liability, funded by insurance proceeds paid in US dollars, a contribution from Exactech Australia, an amount from consenting lenders and a foreign-exchange top-up capped at A$400,000; the court noted that Exactech Australia had limited assets and insurance and that the respondents had written in November and December 2024 that insurance cover was being exhausted. The orders allow the applicant's costs of A$2,185,491.25, A$100,000 to the applicant and A$800,000 to the administrator, with the balance to group members, who released Exactech's US and Australian companies. On 15 September 2025 the US Bankruptcy Court for the District of Delaware had authorised Exactech, Inc. to perform the deed and use the insurance proceeds and lender funding.", "qualification": "", "response": "The settlement was made without admission of liability.", "outcome": "Approved by the Federal Court of Australia on 13 November 2025; the remaining proceeding was otherwise dismissed without costs.", "source_ids": [ "s-d214", "s-d197" ], "entity_ids": [ "e-exac", "e-au", "e-harrold" ], "adverse_subject_ids": [ "e-exac", "e-au" ] }, { "id": "c-quitam-alabama", "kind": "fact", "text": "In June 2018 a former Exactech employee and two former sales representatives filed a whistle-blower (qui tam) suit under the False Claims Act in the Northern District of Alabama on behalf of the United States and several states (United States ex rel. Wallace v. Exactech, Inc., No. 7:18-cv-01010, later 2:18-cv-1010, filed 29 June 2018), alleging the sale of misbranded and defective knee implants; the relators are named on the docket as Brooks Wallace, Roberta Farley and Manuel Fuentes. The United States declined to intervene in August 2019 and the complaint was unsealed on 8 August 2019; the relators continued the case, and Jessica Livingston appeared for Exactech, for example on a motion to dismiss filed on 30 March 2020. In early 2023 the Justice Department served a civil investigative demand on another generation of the knee implant, according to the chief restructuring officer, who also referred to a separate investigation begun in 2023. The docket shows the case terminated on 10 July 2026.", "qualification": "The relators' allegations were resolved by settlement without a finding of liability; the Justice Department's release spells the second relator 'Robert Farley'.", "response": "Exactech contested the suit. It moved to dismiss the complaint in December 2019, attaching an expert report and its earlier corporate integrity and deferred prosecution agreements; on 14 February 2020 the court struck the complaint as an impermissible shotgun pleading and denied that motion as moot. On 5 August 2020 the court granted in part and denied in part Exactech's motion to dismiss the amended complaint, dismissing the state-law claims without prejudice and leaving the federal claims pending, and Exactech answered the amended complaint on 19 August 2020.", "outcome": "Resolved by the $8 million False Claims Act settlement announced on 16 September 2025.", "source_ids": [ "s-d7", "s-d220" ], "entity_ids": [ "e-exac", "e-wallace", "e-farley", "e-fuentes", "e-livingston" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-trust-quitam", "kind": "attributed", "text": "The Settlement Trust's complaint describes the Alabama relators as an orthopaedic surgeon employed by Exactech from 2006 to 2011 and two former sales representatives, and says their suit alleged a defect in the finned tibial tray of the knee, the refusal of the then finance chief to recall it and improper payments to surgeons through consulting agreements, under management led by William Petty; it says TPG learned of the unsealed complaint in 2019, that the case was ready for trial at the petition date and that it was settled during the bankruptcy.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-wpetty", "e-tpg" ] }, { "id": "c-quitam-maryland", "kind": "fact", "text": "A second qui tam suit, United States et al. ex rel. Dr. Pasquale Petrera v. Exactech, Inc. and TPG Capital, L.P. (U.S. District Court for the District of Maryland, Civil Action No. 21-cv-3325-SAG), was brought on behalf of the United States and several states. On 12 March 2026 the United States notified the court that it declined to intervene in the remaining claims against TPG Capital, L.P., and on 23 April 2026 the relator voluntarily dismissed all claims against TPG Capital, L.P. without prejudice.", "qualification": "", "response": "", "outcome": "The claims against Exactech were resolved by the September 2025 settlement; those against TPG Capital, L.P. were dismissed without prejudice on 23 April 2026.", "source_ids": [ "s-d143", "s-d142" ], "entity_ids": [ "e-exac", "e-petrera", "e-tpg" ] }, { "id": "c-fca-settlement", "kind": "fact", "text": "On 16 September 2025 the Justice Department announced that Exactech had agreed to pay $8 million to resolve allegations that it caused false claims to Medicare, Medicaid and the Department of Veterans Affairs. The government alleged that as early as January 2008 Exactech knew its finned tibial tray failed prematurely at a higher than acceptable rate, yet sold it from 1 January 2008 to 31 December 2018, and that from January 2019 it knew of problems with the polyethylene components of its Logic and Truliant knees, sold from 1 January 2019 to 7 February 2022. The federal share is $7,640,000, with $360,000 for states under separate agreements; the amount was based on Exactech's financial condition. The settlement resolved the Alabama action (relators Brooks Wallace, Robert Farley and Dr. Manuel Fuentes, who receive $1,329,360) and the Maryland action (Dr. Pasquale Petrera, $565,360). The HHS Office of Inspector General lists Exactech in its 'heightened scrutiny' category: on 22 May 2025 the company refused to enter a ten-year Corporate Integrity Agreement, and the OIG reserved its right to exclude it from federal health-care programmes.", "qualification": "The Justice Department states that the claims resolved by the settlement are allegations only and that there has been no determination of liability.", "response": "", "outcome": "Settled for $8 million in September 2025; Exactech declined the Corporate Integrity Agreement and remains on the OIG's heightened-scrutiny list.", "source_ids": [ "s-d256", "s-d146" ], "entity_ids": [ "e-exac", "e-wallace", "e-farley", "e-fuentes", "e-petrera" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-dischargeability", "kind": "fact", "text": "On 3 February 2025 the United States ex rel. Brooks Wallace, Robert Farley and Manuel Fuentes filed an adversary proceeding in the Delaware bankruptcy court (No. 1:25-ap-50076) asking for a determination that Exactech's debt to them was not dischargeable under section 523(a)(2) of the Bankruptcy Code (false pretences, false representation, actual fraud). The court repeatedly extended Exactech's time to answer, most recently by an order of 21 October 2025.", "qualification": "", "response": "", "outcome": "The record shows extensions of the answer deadline to October 2025 and the $8 million settlement of the underlying claims; no ruling on dischargeability appears.", "source_ids": [ "s-d172" ], "entity_ids": [ "e-exac", "e-wallace", "e-farley", "e-fuentes" ] }, { "id": "c-petition", "kind": "fact", "text": "On 29 October 2024 Exactech, Inc. and four affiliates — Osteon Holdings, Inc., Osteon Intermediate Holdings I, Inc., Osteon Intermediate Holdings II, Inc. and XpandOrtho, Inc. — filed for Chapter 11 in the US Bankruptcy Court for the District of Delaware. The cases were jointly administered under No. 24-12441 (LSS) before Judge Laurie Selber Silverstein (affiliate cases 24-12438, 24-12439, 24-12440 and 24-12442). The first-day declaration (Docket 18) was made by Jesse York, the company's chief restructuring officer. The petition put the number of creditors at 25,001–50,000 and both assets and liabilities in the $100,000,001–$500 million range. The list of the 30 largest unsecured creditors includes suppliers and other trade creditors such as Signature Orthopaedics (Australia, $1,819,697), Marle International Holdings (France, $1,039,100), Blackhawk Industrial ($975,776), the licensor Advata, Inc. ($886,716), Jarvis Surgical ($740,170), Orchid MPS Holdings ($704,989), Regeneration Technologies ($638,367), Methods Machine Tools ($594,657), Titanium Industries ($485,986), Hammill Manufacturing ($415,990), Autocam Medical Devices ($366,370), Donson Machine ($298,818), In'Tech Medical (France, $282,274) and WuXi AppTec ($267,756).", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d162", "s-d20" ], "entity_ids": [ "e-exac", "e-osteon", "e-osteon1", "e-osteon2", "e-xpand", "e-york" ], "adverse_subject_ids": [ "e-exac", "e-osteon", "e-osteon1", "e-osteon2", "e-xpand" ] }, { "id": "c-advisers", "kind": "fact", "text": "Exactech retained Centerview as investment banker in July 2023 and continued to use Ropes & Gray LLP as legal counsel to review its capital structure; on 25 April 2024 it engaged Riveron RTS, LLC, whose managing director Jesse York became chief restructuring officer, and from 27 August 2024 Young Conaway Stargatt & Taylor, LLP acted as co-counsel. The company appointed M. Elizabeth Abrams as an independent director of certain group boards in November 2023 to review refinancing and settlement options. On 24 July 2024 it formed a special committee with general authority over restructuring transactions, added Timothy Pohl as an independent director of Exactech, Inc., Osteon Intermediate Holdings II, Inc. and XpandOrtho, Inc., and added Abrams to the XpandOrtho board; with White & Case LLP as its independent counsel the committee investigated historical transactions between the sponsor and the company, including the sidecar loans. Riveron's website describes York as a senior managing director who served as chief restructuring officer of a global orthopaedic implant manufacturer, and a 2026 proxy statement of another listed company lists Exactech, Inc. among the boards on which Pohl, the founder of TRP Advisors, LLC, has served.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d319", "s-d317" ], "entity_ids": [ "e-exac", "e-centerview", "e-ropes", "e-riveron", "e-york", "e-ycst", "e-abrams", "e-pohl", "e-osteon2", "e-xpand", "e-whitecase", "e-sponsor" ] }, { "id": "c-adhoc-rsa", "kind": "fact", "text": "In mid-July 2024 Exactech signed confidentiality agreements with an ad hoc group of its first-lien lenders, advised by Milbank LLP and Evercore; on 16 August 2024 the group proposed new-money debtor-in-possession (DIP) financing and a stalking-horse credit bid. Exactech did not pay about $6 million of interest due by 31 August 2024; the lenders agreed to forbear until 2 October and then, on 9 October, until 27 October 2024. A restructuring support agreement, backed by about 95% of first-lien lenders and dated 28 October 2024, was signed with a stalking-horse asset purchase agreement on 29 October 2024. Its parties were the 'HoldCo' companies (Osteon Holdings, Inc. and Osteon Intermediate Holdings I, Inc.) and the 'OpCo' companies (Osteon Intermediate Holdings II, Inc., Exactech, Inc. and XpandOrtho, Inc.), for all of which Donna Edwards signed as secretary; the lenders' signature pages and the schedule naming the backstop lenders are 'on file' and not public. It provided for the sale of substantially all OpCo assets, including the debtors' equity in non-US subsidiaries, to the winning bidder through a plan, with entities formed by or for the first-lien lenders as stalking-horse purchaser credit-bidding the DIP and prepetition claims; an $85 million DIP facility, all new money, from the first-lien and sidecar lenders; a $500,000 reserve for general unsecured creditors and a wind-down amount; and, if the stalking horse won, $130 million of new 'takeback' debt of the buyer maturing in September 2029 and a planned new $50 million revolving facility.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7" ], "entity_ids": [ "e-exac", "e-osteon", "e-osteon1", "e-osteon2", "e-xpand", "e-milbank", "e-edwards", "e-eibidco" ] }, { "id": "c-rsa-milestones", "kind": "fact", "text": "The restructuring support agreement also set conditions for the foreign subsidiaries. Within 35 days of the petition the companies were to begin talks with proposed voluntary administrators of Exactech Australia Pty Ltd about an Australian corporate restructuring, involving Exactech International Operations AG as well; failure to resolve the Federal Court of Australia proceeding NSD 1224/2024 or to appoint an administrator within 75 days allowed the lenders to terminate the agreement. A plan for restructuring Exactech UK Limited was to be agreed within 60 days. The plan was to take effect within 14 days of the confirmation and sale order, extendable up to three times by a month to transfer regulatory approvals in the European Union.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7" ], "entity_ids": [ "e-exac", "e-au", "e-eio", "e-uk" ] }, { "id": "c-apa", "kind": "fact", "text": "The stalking-horse asset purchase agreement of 29 October 2024 was made between EI Bidco, LLC, a Delaware limited liability company, as purchaser and Exactech, Inc. with its signing subsidiaries as sellers. The purchased assets included the sellers' shares in the transferred subsidiaries listed in a schedule and their claims against third parties, including suppliers and manufacturers, relating to the assets. The excluded liabilities, which the buyer would not assume, included product-liability claims (including those based on improper packaging), claims relating to recalls or design defects and False Claims Act claims; liabilities of the acquired subsidiaries stayed with them. Notices to the purchaser go to EI Bidco, LLC c/o Watiga Trust Ltd, 600 North Bridge Road, Parkview Square, Singapore, for the attention of Matthew Richards, with a copy to Milbank LLP in New York. Matthew Richards signed for EI Bidco as authorised person and Tony Collins, chief financial officer, for the sellers Osteon Intermediate Holdings II, Exactech and XpandOrtho.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d135" ], "entity_ids": [ "e-exac", "e-eibidco", "e-watiga", "e-richards", "e-milbank", "e-collins", "e-osteon2", "e-xpand" ] }, { "id": "c-watiga", "kind": "fact", "text": "The Singapore company named in the purchaser's notice address is recorded in the global LEI register (LEI 9845003CBE1I61ECAE37, validated against the Singapore register) as company 201539173Z, incorporated on 29 October 2015, formerly Watiga Trust Pte. Ltd. and renamed GLAS Trust (Singapore) Ltd. on 3 July 2025, at 600 North Bridge Road, Parkview Square; for its parents the record gives a reporting exception. The Global Loan Agency Services Group (GLAS), a London-based loan-agency and trustee firm, announced on 16 December 2024 that it had completed the acquisition of Watiga Trust, a trust company licensed by the Monetary Authority of Singapore, and Watiga Asia after regulatory approval in late November 2024, describing Matt Richards as Watiga's founder and managing director.", "qualification": "The records describe a corporate trust and agency provider used as a notice address; they do not identify who owns EI Bidco, LLC.", "response": "", "outcome": "", "source_ids": [ "s-d221", "s-d223" ], "entity_ids": [ "e-watiga", "e-glas", "e-richards" ] }, { "id": "c-bidding", "kind": "fact", "text": "By an order of 10 December 2024 (Docket 321) the bankruptcy court approved bidding procedures for selling substantially all of the debtors' assets through the plan, with EI Bidco, LLC as stalking-horse bidder; an auction was planned for 3 March 2025 and a sale hearing for 27 March 2025, with Centerview Partners and Ropes & Gray as contacts for bidders.", "qualification": "", "response": "", "outcome": "The plan was confirmed in September 2025 rather than on the March 2025 timetable.", "source_ids": [ "s-d140", "s-d7" ], "entity_ids": [ "e-exac", "e-eibidco", "e-centerview", "e-ropes" ] }, { "id": "c-jointmedica", "kind": "fact", "text": "The restructuring support agreement records that Exactech, Inc. held rights and interests, including membership interests, in JointMedica Limited, a UK company shown on the 2024 group chart, and an amended and restated exclusive distribution agreement with it dated 24 August 2023; transferring them to the buyer required the consent of JointMedica Investment Holdings, L.P. (and/or the Sponsor) or a ruling by the bankruptcy court. Exactech and the ad hoc lender group sued JointMedica Limited and JointMedica Investment Holdings, L.P. in an adversary proceeding (No. 1:24-ap-50297, filed 13 December 2024), which was dismissed with prejudice on a joint stipulation on 5 November 2025 and closed. In the main case TPG VII Osteon Holdings, LP, Joint Medica Investment Holdings, L.P. and Joint Medica Ltd. appear together as one interested party represented by Kirkland & Ellis LLP and other firms.", "qualification": "The record does not state the percentage held by Exactech or who owns JointMedica Investment Holdings, L.P.; a shared representation in court does not by itself establish common ownership.", "response": "", "outcome": "Dismissed with prejudice on a joint stipulation filed by the ad hoc lender group on 5 November 2025; the adversary case was closed the same day. The record does not show the terms.", "source_ids": [ "s-d7", "s-d171", "s-d162" ], "entity_ids": [ "e-exac", "e-jointmedica", "e-jm-inv", "e-sponsor", "e-kirkland" ] }, { "id": "c-case-parties", "kind": "fact", "text": "The parties listed on the case docket include William Petty, David Petty and Gary Miller (represented by Baker & Hostetler LLP), the Hospital for Special Surgery, the special committee of the boards of Osteon Intermediate Holdings II, Exactech and XpandOrtho (White & Case LLP), the ad hoc group of first-lien lenders (Milbank LLP), GLAS USA LLC as DIP agent and first-lien agent, the US Department of Justice, selected plaintiffs in the polyethylene MDL and the official committee of unsecured creditors. Creditors and other interested parties also include suppliers and service providers such as Alkem Medtech Private Ltd., Jarvis Surgical, Sonoco Products Company and RTI Surgical, Inc. (doing business as Evergen); the docket does not describe their claims.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d162" ], "entity_ids": [ "e-exac", "e-wpetty", "e-dpetty", "e-miller", "e-hss", "e-ucc", "e-rti" ] }, { "id": "c-plans", "kind": "fact", "text": "The debtors filed their first joint plan and disclosure statement on 31 December 2024 (Dockets 390 and 391) and amended them on 3 February, 20 and 24 March and 1 and 3 April 2025; the court approved the disclosure statement on 3 April 2025 (Docket 829). The plan supplement for the third amended plan included the schedule of assumed contracts, the list of retained causes of action, a restructuring transactions memorandum and a wind-down trust agreement, and confirmation was set for 28 May 2025.", "qualification": "", "response": "", "outcome": "The plan eventually confirmed was the Fifth Amended Joint Plan, on 17 September 2025.", "source_ids": [ "s-d170" ], "entity_ids": [ "e-exac" ] }, { "id": "c-tpg-release", "kind": "attributed", "text": "Under the plan proposed in spring 2025 TPG would have been released from liability, including personal-injury claims, for $10 million, an amount the debtors' special committee investigation had found fair, a national newspaper reported on 27 May 2025; the creditors' committee disputed the committee's report and estimated the full value of the personal-injury claims as probably more than $1 billion. A news agency reported that at a hearing on 28 May 2025 Exactech's lawyers said the company was walking away from the effort to protect TPG, and that, faced with creditor opposition, its new plan would preserve claims against TPG; Ropes & Gray represented Exactech, Brown Rudnick the creditors' committee and Kirkland & Ellis TPG.", "qualification": "The amounts and the committee's estimate are as reported by the press; the special committee's report was not retrieved.", "response": "TPG told the national newspaper that it was 'categorically false' to allege that it had 'encouraged or engineered a bankruptcy filing to protect itself from liability'.", "outcome": "According to the confirmation order, the debtors moved on 7 May 2025 for approval of the settlement with the Sponsor, obtained on 28 May 2025 an adjournment of the confirmation hearing to negotiate with the creditors' committee, and withdrew that motion on 22 July 2025, when they filed the Fifth Amended Plan. The plan confirmed in September 2025 did not release TPG; the claims were transferred to the Settlement Trust.", "source_ids": [ "s-d301", "s-d278", "s-d142" ], "entity_ids": [ "e-exac", "e-tpg", "e-ucc", "e-ropes", "e-brownrudnick", "e-kirkland" ] }, { "id": "c-letter-ruling", "kind": "fact", "text": "In a letter ruling of 20 May 2025 on discovery disputes, Judge Silverstein held that Exactech and TPG shared a common legal interest in defending the product-liability claims but not in defending alter-ego and veil-piercing claims, and ordered disclosure of the parts of 56 contested documents dealing with those claims; Exactech's in-house and outside counsel (Faegre Drinker and Ropes & Gray) and TPG's counsel (Kirkland & Ellis) were on many of the e-mails. The Settlement Trust's complaint quotes the court's statement in that dispute (Docket 1183) that 'Exactech and TPG are and always have been adverse as to [alter ego and veil piercing] claims' and says that after a proposed settlement with TPG failed in June 2025 these claims were transferred to the trust.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d169", "s-d24" ], "entity_ids": [ "e-exac", "e-tpg", "e-ropes", "e-kirkland", "e-trust" ] }, { "id": "c-confirmation", "kind": "fact", "text": "By findings of fact, conclusions of law and an order entered on 17 September 2025 (Docket 1647), after a hearing on 15 September, the bankruptcy court approved a supplemental disclosure and confirmed the Fifth Amended Joint Chapter 11 Plan of Exactech, Inc. and its debtor affiliates (Docket 1501). The plan created the Exactech Settlement Trust to resolve and pay all allowed personal-injury and wrongful-death claims, as a qualified settlement fund under section 468B of the Internal Revenue Code: on the effective date it receives the trust assets and the debtors' liability for those claims and controls the trust's causes of action and insurance actions as representative of the estates. Ellen K. Reisman, selected by the unsecured creditors' committee, was named settlement trustee and Alan D. Halperin commercial unsecured-creditor (GUC) trustee and wind-down officer. In its announcement Exactech said the court had approved the sale of its assets to a new ownership group of Strategic Value Partners, LLC with its affiliates, Stellex Capital Management LLC and Greywolf Capital Management LP, which would acquire substantially all of its operations and assets, and that the new company would be led by incoming chief executive Aurelio Sahagun. The creditors' committee's counsel, Brown Rudnick, said that the revised plan approved on 15 September 2025 funds the trust with $2 million to pursue alter-ego and veil-piercing claims against TPG, whereas the original plan would have released TPG for $10 million.", "qualification": "", "response": "", "outcome": "The plan was confirmed on 17 September 2025. The notice of the plan's effective date was not retrieved, so the effective date is not stated from the record.", "source_ids": [ "s-d142", "s-d9", "s-d144" ], "entity_ids": [ "e-exac", "e-trust", "e-reisman", "e-halperin", "e-guc-trust", "e-ucc", "e-svp", "e-stellex", "e-greywolf", "e-sahagun", "e-tpg", "e-brownrudnick" ], "adverse_subject_ids": [ "e-exac" ] }, { "id": "c-wind-down", "kind": "fact", "text": "By October 2026 Matthew Dundon was acting in the case solely as trustee of the Exactech Commercial GUC Liquidating Trust and wind-down officer of the debtors, represented by Cole Schotz P.C.; on 5 October 2026 the court sustained his first and second omnibus objections to claims and appointed a new post-confirmation claims and noticing agent effective from 14 August 2026, and the outgoing agent filed the final claims register. Exactech, Inc.'s 2026 filing with the Florida register moved its principal address on 24 March 2026 from Gainesville to 10 Bank Street, Suite 1100, White Plains, New York, and lists Matthew Dundon as officer and Rick Wright with the title 'Other'; the register's officer index shows Dundon only at Exactech and at Dundon Advisers LLC, a New York company registered in Florida in 2022 of which he is managing member. The confirmation order had named Alan D. Halperin to these roles; the record does not show when or why Dundon succeeded him.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d162", "s-d326", "s-d4", "s-d96", "s-d345" ], "entity_ids": [ "e-exac", "e-dundon", "e-guc-trust", "e-coleschotz", "e-wright", "e-dundon-adv", "e-halperin" ] }, { "id": "c-advita-launch", "kind": "fact", "text": "Advita Ortho, LLC of Gainesville announced its launch on 3 November 2025 as the company that, in Exactech's restructuring, acquired its product lines — including the Equinoxe shoulder, Vantage ankle, Alteon hip, Truliant knee, Newton balancing technology and GPS navigation, and the distribution of the Spartan hip and Triverse knee — together with product data and Exactech's engineering, manufacturing and staff. It said it was owned by funds managed by affiliates of Strategic Value Partners, LLC (SVP), Stellex Capital Management, LLC and Greywolf Capital Management, LP, and that its board included Luigi Ferrari as chair (a senior adviser to SVP), chief executive Aurelio Sahagun, Andrew Ekdahl, Dave Demski and Steve C de Baca. By October 2026 its website also listed as directors Clara Anderson and Dave Richards, managing directors of SVP, Catherine DeMarco, a principal of Stellex, and Craig James, a managing director of Greywolf, and described Demski as a senior adviser to SVP. A 2026 proxy statement filed with the SEC by another medical-device company says that Demski has served on Advita Ortho's board since November 2025.", "qualification": "The owners, board and executives are as stated by Advita Ortho itself, except Demski's board seat, which another company's SEC filing also records; the owners' shares are not disclosed.", "response": "", "outcome": "", "source_ids": [ "s-d17", "s-d100", "s-d302" ], "entity_ids": [ "e-advita", "e-exac", "e-svp", "e-stellex", "e-greywolf", "e-ferrari", "e-sahagun", "e-ekdahl", "e-demski", "e-debaca", "e-anderson", "e-drichards", "e-demarco", "e-cjames" ] }, { "id": "c-advita-execs", "kind": "fact", "text": "Advita Ortho's other managers come partly from Exactech. Its website says Chris Roche, who joined the company in 2003 and designed the Equinoxe shoulder system, has been senior vice president for extremities since July 2021, a date when the business still belonged to Exactech; Roche was one of the 2018 rollover investors. A trade publication reported in March 2026, citing Advita's release of 5 March, that the company had appointed Jeffrey Figg as chief financial officer, Jorge Lopes as chief operating officer and Rebecca Young as chief human resources officer, after appointing a chief legal officer and a chief quality, regulatory and clinical officer in January 2026. According to Advita's website, Paul Haydock, formerly finance chief of Laborie Medical Technologies, became chief financial officer in September 2026. A local television investigation reported in September 2026 that many Exactech employees moved to Advita Ortho and that Exactech's former chief executive remained involved in an advisory role, while the new company did not take on most of Exactech's old liabilities.", "qualification": "The appointments are announced by Advita Ortho itself and reported by the trade press; the broadcaster does not name the former chief executive.", "response": "", "outcome": "", "source_ids": [ "s-d100", "s-d244", "s-d294" ], "entity_ids": [ "e-advita", "e-exac", "e-roche", "e-figg", "e-lopes", "e-ryoung", "e-haydock" ] }, { "id": "c-advita-registry", "kind": "fact", "text": "Advita Ortho, LLC is a Delaware limited liability company registered in Florida on 3 October 2025 as a foreign LLC (document M25000013975, employer identification number 39-3149966), active, with its address at 2311 NW 66th Court, Gainesville, C T Corporation System as registered agent and an amendment filed on 10 March 2026. The Florida record lists its members as Advita Holdings LLC and Advita Holdings II LLC, both at 100 West Putnam Avenue, Greenwich, Connecticut, and Jessica Livingston, formerly Exactech's assistant secretary, as authorised person. EDGAR records Strategic Value Partners, LLC (Central Index Key 0001301912) as a Delaware company at the same Greenwich address; a full-text search of EDGAR for 'Advita Ortho' returned only one filing, another company's 2026 proxy statement, so no Advita filings disclose its ownership structure.", "qualification": "A shared address does not by itself show who controls the two members; the members' owners are not disclosed in the records reviewed.", "response": "", "outcome": "", "source_ids": [ "s-d48", "s-d95", "s-d225", "s-d136" ], "entity_ids": [ "e-advita", "e-advita-h1", "e-advita-h2", "e-livingston", "e-svp" ] }, { "id": "c-trademarks", "kind": "fact", "text": "Trade-mark records show the transfer of the brands. In the Canadian register the EXACTECH mark (application 1456220, registration TMA814654, classes 5 and 10) was assigned by Exactech, Inc. to Advita Ortho, LLC with a date of change of 31 October 2025, registered on 10 March 2026; the current owner is Advita Ortho, LLC of 300 Fox Hill Street, Westwood, Massachusetts. A trade-mark aggregator's copy of the US record shows the ADVITA ORTHO mark (serial 99159324, registration 8360066, class 10) applied for on 28 April 2025 and registered on 21 July 2026 in the name of Exactech, Inc., with first use on 3 November 2025 and a docket entry of 25 February 2026 noting that an assignment of ownership was not updated automatically.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d45", "s-d27" ], "entity_ids": [ "e-exac", "e-advita" ] }, { "id": "c-italy", "kind": "fact", "text": "Exactech Italia S.p.A. (company number 02018520508, LEI 815600187F853BDAA941, Via C. G. Merlo 3, Milan) has been named ADVITA ORTHO ITALY S.P.A. since 11 November 2025 according to the global LEI register. The register's direct-parent record, as of 15 October 2026, still names Exactech, Inc. as parent, although Exactech's own identifier has lapsed.", "qualification": "The parent record appears not to have been updated after the sale of the business.", "response": "", "outcome": "", "source_ids": [ "s-d114", "s-d115" ], "entity_ids": [ "e-italia", "e-exac" ] }, { "id": "c-australia-sub", "kind": "fact", "text": "The Australian subsidiary (ACN 146 150 754, ABN 60 146 150 754, LEI 87550015Y6TSRR63XC35, Castle Hill, New South Wales) traded as Exactech Australia Pty Ltd from 9 September 2010 to 10 February 2026 and has since been named Advita Ortho Aus Pty Ltd; its ABN has been active continuously since 2010.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d216", "s-d114" ], "entity_ids": [ "e-au" ] }, { "id": "c-germany", "kind": "fact", "text": "Exactech Deutschland GmbH (Kiel local court HRB 11872 KI, previously Berlin-Charlottenburg HRB 125481 B; Werftstraße 193, Kiel) was renamed Advita Ortho Germany GmbH on 3 June 2026 after filing new articles of association in May 2026, according to a corporate-data aggregator's summary of the commercial register. Its managing directors were Alexander Kohtz from May 2010 to 3 August 2020, David Timm Backhuß from 3 August 2020 to 30 October 2025 and Nicolas Hohl from 30 October 2025. Another aggregator reproduces its 2023 accounts: a net loss of €219,377.68 (2022: €584,349.74), a deficit not covered by equity of €2,426,553.34, liabilities of €5,733,800.02, of which €5,557,797.73 owed to its shareholder, and 21 employees; on 1 April 2010 it had bought the business of another German company for €973,000, and it holds the word mark ENDON. The same aggregator names its sole shareholder as 'Exatech International' with a €25,000 (100%) holding.", "qualification": "These details come from aggregators' copies of the German register and filed accounts; the 'Exatech International' shareholder is not identified as a specific group company.", "response": "", "outcome": "", "source_ids": [ "s-d131", "s-d295", "s-d188", "s-d189", "s-d279" ], "entity_ids": [ "e-de", "e-kohtz", "e-backhuss", "e-hohl" ] }, { "id": "c-swiss", "kind": "fact", "text": "The Swiss operating subsidiary (UID CHE-115.564.269, entered in the commercial register on 31 March 2010, share capital CHF 100,000, seat Muri bei Bern, address Hintere Dorfgasse 9, Gümligen), whose former names include Exactech International Operation Ltd. AG, Exactech Switzerland Ltd., Exactech Schweiz AG and Exactech Suisse SA, amended its articles on 16 July 2026 and was renamed Advita International Ops AG (Swiss Official Gazette of Commerce, 31 July 2026), according to corporate-data aggregators' copies of the register. Its purpose is marketing orthopaedic products in Switzerland and Europe. Richard Edmund Andrews Jr. and Monica Rognoni are its board members with signing authority, and PricewaterhouseCoopers AG has been its auditor since 27 February 2024.", "qualification": "Board details come from aggregators' copies of the Swiss register; the registers do not show the shareholder.", "response": "", "outcome": "", "source_ids": [ "s-d54", "s-d233" ], "entity_ids": [ "e-eio", "e-andrews", "e-rognoni" ] }, { "id": "c-france", "kind": "fact", "text": "In the French business register the company with SIREN 433 701 166 (a simplified joint-stock company formed on 15 November 2000 in Mérignac, wholesale of medical goods; VAT FR24433701166), formerly Exactech France SAS, is now named Advita Ortho France SAS. Its president is Laurent Mouillac, in office since 13 January 2020 according to a corporate-data aggregator, and its auditor RSM France; for 2025 it reported no revenue and a net loss of €254,823, with one of its three establishments open.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d130", "s-d183" ], "entity_ids": [ "e-fr", "e-mouillac" ] }, { "id": "c-spain", "kind": "fact", "text": "The Spanish subsidiary listed in 2013 as Exactech Iberica, S.L. appears in a corporate-data aggregator's copy of the Spanish commercial gazette as Advita Ortho Iberica SL, at the Asturias Technology Park in Llanera, first registered on 22 February 2010, with its latest publication on 17 April 2026; the names of its officers are not shown.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d195" ], "entity_ids": [ "e-iberica" ] }, { "id": "c-austria", "kind": "fact", "text": "Exactech EÖG GmbH (company register FN 570674b, Commercial Court of Vienna, registered 22 December 2021, QBC 4 – am Belvedere 4, Vienna), which markets orthopaedic products and holds a trade licence for medical devices, had not changed its name as of 22 September 2026, according to an aggregator's copy of the Austrian register. Its sole managing director since 11 October 2023 is David Backhuß, the former managing director of the German subsidiary. Its 2024 balance sheet totalled about €353,350, with negative equity of €457,871 and liabilities of €769,618.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d236" ], "entity_ids": [ "e-eog", "e-backhuss" ] }, { "id": "c-uk", "kind": "fact", "text": "The UK register shows the change of control of the English subsidiary (company 05316864, formerly Exactech (UK) Ltd., now Advita Ortho UK Limited). Exactech Inc. was its person with significant control, holding more than 75% of shares and votes with the right to appoint directors, from 6 April 2016 to 21 December 2018; Osteon Holdings Inc. (Delaware, registration number 6581810) held that position from 21 December 2018 to 31 October 2025; from 31 October 2025 the company has stated that it has no registrable person or legal entity with significant control. Directors were David Petty and Joel Phillips from 1 July 2005 to 1 February 2020; Darin Johnson from 1 February 2020 to 21 October 2025; Bruce Thompson and Elliot Ness Cintron from 1 February 2020 to spring 2023; Richard Edmund Andrews Jr. and Nicolas Hohl from 1 April 2024; and Eric Astoin, Nathan Beckley and Andrew O'Hare from 5 February 2026.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d129", "s-d311", "s-d334", "s-d331", "s-d332", "s-d333" ], "entity_ids": [ "e-uk", "e-exac", "e-osteon", "e-dpetty", "e-phillips", "e-johnson", "e-thompson", "e-cintron", "e-andrews", "e-hohl", "e-astoin", "e-beckley", "e-ohare" ] }, { "id": "c-uk2", "kind": "fact", "text": "A second English company, Exactech (UK) 2 Limited (company 16540209), had Richard Edmund Andrews Jr., Nicolas Hohl and Darin Johnson as directors from 25 June 2025, Johnson leaving on 21 October 2025, and Eric Astoin, Nathan Beckley and Andrew O'Hare from 22 October 2025; Andrews and Hohl gave the Swiss subsidiary's address. The company has since been dissolved. Astoin, Beckley and O'Hare hold no UK appointments other than at the two English companies.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d266", "s-d268", "s-d331" ], "entity_ids": [ "e-uk2", "e-andrews", "e-hohl", "e-johnson", "e-astoin", "e-beckley", "e-ohare" ] }, { "id": "c-trust-suit", "kind": "attributed", "text": "Ellen K. Reisman, as trustee of the Exactech Settlement Trust, sued TPG in the Delaware Court of Chancery (C.A. No. 2026-0129-MTZ; case opened 30 January 2026, public version of the complaint filed 5 February 2026 and also lodged in the MDL on 10 February 2026). The defendants are TPG, Inc., TPG Partners VII L.P., TPG VII Management, LLC, TPG VII Osteon Holdings, L.P., TPG Operations, LLC, TPG Holdings II Sub, LP and TPG Capital – FO, LLC, and Jeffrey Binder, Kendall Garrison, John Schilling, Todd Sisitsky, Michael Tepatti, Bennett Yasskin, John Lin, William Petty and David Petty. The trust asks the court to find that TPG acted as the alter ego of Osteon Holdings, Inc. and Exactech and is liable for Exactech's defective-product liability, and that the individual defendants breached fiduciary duties; it claims damages of at least $1 billion. The counts include breach of fiduciary duty by William Petty, David Petty, Schilling, Garrison, Binder and Sisitsky as directors or officers of Exactech or Osteon Holdings (Count II); aiding and abetting by the TPG entities, Tepatti, Yasskin and Lin (Count V); a separate fiduciary claim against William and David Petty for conduct before the 2018 acquisition, including continuing to sell defective devices and delaying recalls (Count VI); fraudulent-transfer claims over the $5,909,935 expense payment (Counts VIII and IX) and waste (Count X). The trust also reserves claims to recover more than $600 million paid to Exactech's shareholders in the 2018 deal. The trust was created under the Fifth Amended Joint Chapter 11 Plan (Docket 1647-1) to take over the debtors' personal-injury and wrongful-death claims and pursue the estates' causes of action, and is run by the trustee with a trust advisory committee; Brown Rudnick LLP is co-counsel. The docket lists the case type as breach of fiduciary duty in the corporate context assigned to Morgan Zurn, with the case active in October 2026.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "TPG has denied wrongdoing, a local television investigation reported in September 2026; in a statement to a national newspaper in May 2025 TPG called it 'categorically false' that it had any prior knowledge of the packaging nonconformance, and in court filings TPG and its affiliates have said that Exactech and TPG maintained 'clearly separate businesses'.", "outcome": "Pending: the docket showed the case as active on 16 October 2026; a filing of 14 August 2026 attached the Maryland qui tam papers and the plan confirmation order as exhibits, but the filing itself is not in the record and no ruling is recorded.", "source_ids": [ "s-d24", "s-d166", "s-d294", "s-d301", "s-d142" ], "entity_ids": [ "e-trust", "e-exac", "e-reisman", "e-brownrudnick", "e-osteon", "e-tpg", "e-tpg7", "e-tpg-mgmt", "e-sponsor", "e-tpg-ops", "e-tpg-h2", "e-tpg-fo", "e-binder", "e-garrison", "e-schilling", "e-sisitsky", "e-tepatti", "e-yasskin", "e-lin", "e-wpetty", "e-dpetty" ], "adverse_subject_ids": [ "e-tpg", "e-tpg7", "e-tpg-mgmt", "e-sponsor", "e-tpg-ops", "e-tpg-h2", "e-tpg-fo", "e-binder", "e-garrison", "e-schilling", "e-sisitsky", "e-tepatti", "e-yasskin", "e-lin", "e-wpetty", "e-dpetty" ] }, { "id": "c-ucc-allegations", "kind": "attributed", "text": "Before the trust's suit, the official committee of unsecured creditors made similar allegations in the bankruptcy court. A national newspaper reported in May 2025 that the committee alleged that Exactech and certain officers and directors had known of product defects since 2005, engaged in practices designed to hide them, including giving inaccurate and misleading information to the FDA, and that TPG and Binder became aware of the full scope of the defects after the 2018 closing, Binder receiving 'multiple warnings' in March 2019.", "qualification": "These are the committee's allegations in bankruptcy-court filings, as reported; they were not adjudicated, and the claims passed to the Settlement Trust.", "response": "Exactech and its TPG affiliates disputed the allegations, saying in bankruptcy-court responses that the committee was merely speculating that directors and officers had acted with an actual intent to violate the law or neglect their duties.", "outcome": "", "source_ids": [ "s-d301" ], "entity_ids": [ "e-exac", "e-ucc", "e-tpg", "e-binder" ] }, { "id": "c-blueortho", "kind": "fact", "text": "On 15 January 2015 Exactech bought all the shares of BlueOrtho SAS of Grenoble, France, the developer and maker of the ExactechGPS computer-assisted surgery system and its partner since 2009, for up to €10 million: €2 million at closing and up to €8 million in earn-outs tied to the number of procedures using the technology, according to its release filed with the SEC. BlueOrtho was founded by its president and chief executive Anthony Boyer, the orthopaedic surgeon James Stiehl and Stéphane Lavallée, a computer-assisted surgery researcher. The French business register lists Blue Ortho SAS (SIREN 509 027 702, research and development in natural sciences and engineering, Meylan) as active, with Anthony Boyer as president (since 9 December 2008, according to a corporate-data aggregator) and a statutory auditor, and reports 2025 revenue of €11,728,231 and net profit of €478,496. Exactech's 2024 declaration names Blue Ortho as one of the foreign subsidiaries from which the debtors bought goods and services.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d128", "s-d55", "s-d56", "s-d139", "s-d7" ], "entity_ids": [ "e-exac", "e-blueortho", "e-boyer", "e-stiehl", "e-lavallee" ] }, { "id": "c-intercompany", "kind": "fact", "text": "In its 2024 declaration Exactech said the debtors manufactured products and sold them to non-debtor foreign subsidiaries for resale in local markets, bought goods and services from Exactech International Operation AG and Blue Ortho SAS, and made intercompany loans to the foreign subsidiaries. A simplified group chart attached to the declaration, legible only in part, shows the foreign group companies Exactech Italia S.p.A., Exactech International Operation AG (Switzerland), Blue Ortho SAS (France), Exactech Korea Jusik Hoesa (South Korea), JointMedica Limited (UK), Exactech Deutschland GmbH, Exactech UK Limited, Exactech France SAS, a Spanish S.L.U., Exactech KK (Japan), an Australian Pty Ltd, Exactech EOG GmbH (Austria) and Exactech Portugal, LDA. The 2018 merger proxy had described the Swiss company as the channel for international development, sales and distribution.", "qualification": "The chart's text was read by optical character recognition and the percentages and intermediate holders are only partly legible.", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d5" ], "entity_ids": [ "e-exac", "e-eio", "e-blueortho", "e-italia", "e-korea", "e-jointmedica", "e-de", "e-uk", "e-fr", "e-iberica", "e-kk", "e-au", "e-eog", "e-pt" ] }, { "id": "c-hillman-registry", "kind": "fact", "text": "The Florida register lists Hillman Supply Company, Inc. (document P93000005334, employer identification number 59-3157540), incorporated on 19 January 1993 and active, at 13935 NW US Highway 441, Alachua, Florida, near Gainesville; its 2026 annual report was filed on 16 January 2026 and it has three listed officers.", "qualification": "The match with the supplier named in the lawsuits rests on the name and location; the register does not describe its business.", "response": "", "outcome": "", "source_ids": [ "s-d198", "s-d217" ], "entity_ids": [ "e-hillman" ] }, { "id": "display-claim-796e02407f644b8386698a1f", "kind": "analysis", "text": "A founder-controlled implant maker, a private-equity owner and a packaging defect that spread across four product families: the dossier links Exactech's SEC filings, the FDA's safety communications, recall records and warning letters, the MDL, Florida, Australian and qui tam dockets, the Chapter 11 record and register entries from 1985 to October 2026, and keeps each allegation beside the response and outcome on record.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d4", "s-d19", "s-d114", "s-d20", "s-d18", "s-d7", "s-d5", "s-d101", "s-d227", "s-d272", "s-d128", "s-d21", "s-d10", "s-d175", "s-d301", "s-d255", "s-d246", "s-d258", "s-d350", "s-d256", "s-d146", "s-d162", "s-d142", "s-d9", "s-d144", "s-d17", "s-d100", "s-d302", "s-d278", "s-d24", "s-d166", "s-d294" ], "entity_ids": [ "e-exac", "e-wpetty", "e-miller", "e-bpetty", "e-dpetty", "e-tecres", "e-rti", "e-biomatlante", "e-kearney", "e-seese", "e-phillips", "e-hss", "e-accumed", "e-prima-lp", "e-prima-inc", "e-gamco", "e-blackrock", "e-dfa", "e-mfh-llc", "e-mfh-inc", "e-osteon-lp", "e-mergersub", "e-tpg", "e-tpg7", "e-jpm", "e-osteon", "e-lagatta", "e-tpg-genpar", "e-tpg-genpar-adv", "e-nasdaq", "e-thompson", "e-edwards", "e-roche", "e-szabo", "e-johnson", "e-greenberg", "e-wallace", "e-farley", "e-fuentes", "e-petrera", "e-osteon1", "e-osteon2", "e-xpand", "e-york", "e-trust", "e-reisman", "e-halperin", "e-guc-trust", "e-ucc", "e-svp", "e-stellex", "e-greywolf", "e-sahagun", "e-brownrudnick", "e-advita", "e-ferrari", "e-ekdahl", "e-demski", "e-debaca", "e-anderson", "e-drichards", "e-demarco", "e-cjames", "e-ropes", "e-kirkland", "e-tpg-mgmt", "e-sponsor", "e-tpg-ops", "e-tpg-h2", "e-tpg-fo", "e-binder", "e-garrison", "e-schilling", "e-sisitsky", "e-tepatti", "e-yasskin", "e-lin" ] }, { "id": "display-claim-9d4fdf2b1f482a3827f32f73", "kind": "analysis", "text": "Exactech, Inc. is a Florida corporation (document H85101) founded in 1985 by the orthopaedic surgeon William Petty, the biomedical engineer Gary J. Miller and Betty Petty, with its operating base at 2320 NW 66th Court, Gainesville. It began with a cemented hip system, developed its first knee implant in 1992, entered the shoulder market in 2005 and in 2014 acquired the computer-assisted surgery business behind ExactechGPS. In 2024 it made about 70% of its products in-house at plants in Gainesville and Sarasota, Florida, and Gieres, France, and employed about 900 people.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d4", "s-d19", "s-d114", "s-d20", "s-d18", "s-d7", "s-d5", "s-d101", "s-d227", "s-d272", "s-d128" ], "entity_ids": [ "e-exac", "e-wpetty", "e-miller", "e-bpetty", "e-dpetty", "e-tecres", "e-rti", "e-biomatlante" ] }, { "id": "display-claim-20f5e6bacb12c519c8a12d0f", "kind": "analysis", "text": "The Petty family controlled the company before and after its 1996 listing, and William Petty still beneficially owned about 24% when affiliates of the private-equity firm TPG agreed in October 2017 to buy it. After the price was raised to $49.25 a share, the merger closed on 14 February 2018 in a deal valued at about $737 million: Exactech left Nasdaq and became an indirect wholly owned subsidiary of Osteon Holdings, Inc., while the Pettys and other insiders exchanged part of their shares for shares in the new parent.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d101", "s-d5", "s-d21", "s-d10", "s-d175" ], "entity_ids": [ "e-exac", "e-wpetty", "e-bpetty", "e-miller", "e-dpetty", "e-kearney", "e-seese", "e-phillips", "e-hss", "e-accumed", "e-prima-lp", "e-prima-inc", "e-gamco", "e-blackrock", "e-dfa", "e-mfh-llc", "e-mfh-inc", "e-osteon-lp", "e-mergersub", "e-tpg", "e-tpg7", "e-jpm", "e-osteon", "e-lagatta", "e-tpg-genpar", "e-tpg-genpar-adv", "e-nasdaq", "e-thompson", "e-edwards", "e-roche", "e-szabo" ] }, { "id": "display-claim-e2d95f9abe56a4895df39c4d", "kind": "analysis", "text": "From June 2021 Exactech recalled polyethylene hip liners, then knee and ankle inserts and, in 2024, shoulder and patella components, most of them made between 2004 and August 2021 and packaged in bags missing an oxygen-barrier layer. The FDA warned patients in a safety communication of March 2023 and sent the company a warning letter in January 2024. By the October 2024 bankruptcy about 2,600 patients had sued, most of them in a federal multidistrict litigation in New York and in a coordinated Florida state case.", "qualification": "This is the company's own description in a sworn bankruptcy declaration; the regulator's characterisation is in its safety communications and recall records.", "response": "In the same declaration the company said that, placing patients' interests first, it had proactively implemented the voluntary recall although internal and outside materials-science experts had confirmed through industry-standard laboratory testing that the packaging would not affect the clinical performance of most of the recalled components; and that, although it initiated the recalls in an abundance of caution, it has consistently maintained that the non-conforming bags have not led to overall higher rates of revision surgery beyond industry averages (5–10% at ten years of follow-up), a position it believes scientific and clinical data support. It did not answer a national newspaper's questions on the subject in May 2025. Exactech answered the Form 483 observations on 13 October 2023, describing systemic corrective actions: a retrospective review of complaints, revised procedures and staff training, an assessment under CAPA2023-042 of how historical complaints had been coded, and a revision of its medical-device-reporting procedure due by 31 December 2023. The FDA said the adequacy of the response could not yet be determined because the actions were still under way.", "outcome": "Exactech initiated the shoulder recall in March–April 2024.", "source_ids": [ "s-d7", "s-d301", "s-d255", "s-d246" ], "entity_ids": [ "e-exac", "e-johnson" ] }, { "id": "display-claim-1539691537b4f31a44d92b4f", "kind": "analysis", "text": "In 2010 Exactech entered a deferred prosecution agreement with federal prosecutors over a charge that it had conspired to induce surgeons to use its products through consulting agreements, and paid $2.99 million in a related civil settlement. In September 2025 it agreed to pay $8 million to resolve whistle-blower and government allegations under the False Claims Act that it had sold knee implants while knowing of their premature failure.", "qualification": "A deferred prosecution agreement is not a conviction: the complaint was to be dismissed if the company complied for 12 months. The civil settlement resolved government claims without a judgment. The Justice Department states that the claims resolved by the settlement are allegations only and that there has been no determination of liability.", "response": "In the agreement the company undertook to acknowledge responsibility for its behaviour, to continue cooperating with the prosecutors and other agencies and to carry out further remediation; the prosecutors acknowledged that neither the agreement nor the criminal complaint alleged that the company's conduct had adversely affected patient health or patient care.", "outcome": "The record does not contain the dismissal order; the Settlement Trust's 2026 complaint refers to the agreement as having expired. Settled for $8 million in September 2025; Exactech declined the Corporate Integrity Agreement and remains on the OIG's heightened-scrutiny list.", "source_ids": [ "s-d258", "s-d350", "s-d256", "s-d146" ], "entity_ids": [ "e-exac", "e-greenberg", "e-wallace", "e-farley", "e-fuentes", "e-petrera" ] }, { "id": "display-claim-8139a59bcbafc4689174fa43", "kind": "analysis", "text": "On 29 October 2024 Exactech and four affiliates filed for Chapter 11 in Delaware. The plan confirmed on 17 September 2025 sold substantially all of the business to an ownership group of Strategic Value Partners, Stellex Capital Management and Greywolf Capital Management, which launched it as Advita Ortho, LLC in November 2025, and created the Exactech Settlement Trust to pay personal-injury and wrongful-death claims.", "qualification": "The owners, board and executives are as stated by Advita Ortho itself, except Demski's board seat, which another company's SEC filing also records; the owners' shares are not disclosed.", "response": "", "outcome": "The plan was confirmed on 17 September 2025. The notice of the plan's effective date was not retrieved, so the effective date is not stated from the record.", "source_ids": [ "s-d7", "s-d162", "s-d20", "s-d142", "s-d9", "s-d144", "s-d17", "s-d100", "s-d302" ], "entity_ids": [ "e-exac", "e-osteon", "e-osteon1", "e-osteon2", "e-xpand", "e-york", "e-trust", "e-reisman", "e-halperin", "e-guc-trust", "e-ucc", "e-svp", "e-stellex", "e-greywolf", "e-sahagun", "e-tpg", "e-brownrudnick", "e-advita", "e-ferrari", "e-ekdahl", "e-demski", "e-debaca", "e-anderson", "e-drichards", "e-demarco", "e-cjames" ] }, { "id": "display-claim-21c9c10d511246e90751dad6", "kind": "analysis", "text": "A plan proposed in spring 2025 would have released TPG from liability for $10 million; the debtors withdrew that settlement after creditors objected, and the claims passed to the Settlement Trust. In January 2026 the trust sued seven TPG entities, seven current or former TPG people and advisers, and William and David Petty in the Delaware Court of Chancery, alleging that TPG acted as Exactech's alter ego and that the individuals breached their fiduciary duties. TPG has denied wrongdoing, and the case was pending in October 2026 without a ruling.", "qualification": "The amounts and the committee's estimate are as reported by the press; the special committee's report was not retrieved. These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "TPG told the national newspaper that it was 'categorically false' to allege that it had 'encouraged or engineered a bankruptcy filing to protect itself from liability'.", "outcome": "", "source_ids": [ "s-d301", "s-d278", "s-d142", "s-d24", "s-d166", "s-d294" ], "entity_ids": [ "e-exac", "e-tpg", "e-ucc", "e-ropes", "e-brownrudnick", "e-kirkland", "e-trust", "e-reisman", "e-osteon", "e-tpg7", "e-tpg-mgmt", "e-sponsor", "e-tpg-ops", "e-tpg-h2", "e-tpg-fo", "e-binder", "e-garrison", "e-schilling", "e-sisitsky", "e-tepatti", "e-yasskin", "e-lin", "e-wpetty", "e-dpetty" ] }, { "id": "display-claim-40c76120eb1bacb1a9918791", "kind": "analysis", "text": "William Petty, an orthopaedic surgeon who taught at the University of Florida College of Medicine and chaired its orthopaedic surgery department from 1981 to 1996, founded Exactech in 1985 with the biomedical engineer Gary J. Miller and Betty Petty, his wife. He chaired the board from the start, was chief executive until 2014 and president from 2002 to 2007. Miller led research and development from 1986, as executive vice president from 2000, and sat on the board from 1989 to 2003; Betty Petty was company secretary and, until 1996, treasurer and a director. David W. Petty is their son.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d5", "s-d101" ], "entity_ids": [ "e-exac", "e-wpetty", "e-miller", "e-bpetty", "e-dpetty" ] }, { "id": "display-claim-32173b5c6bd406d45316559d", "kind": "analysis", "text": "Before the 1996 initial public offering William Petty held 1,323,271 shares, 44.6%, almost all jointly with Betty Petty, and Miller held 9.6%; a family shareholders agreement gave William and Betty Petty, and then the company, a first right to buy any family member's shares. The company paid royalties to the Hospital for Special Surgery for the Optetrak knee and to members of its design team, including Petty and Miller. In 2010 the couple still owned 29.5%, mostly through Prima Investments, Limited Partnership, Miller owned 4.0%, partly through Millerworks, Limited Partnership, and directors and officers together held 38.3%.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d101", "s-d137" ], "entity_ids": [ "e-exac", "e-wpetty", "e-bpetty", "e-miller", "e-dpetty", "e-kearney", "e-seese", "e-phillips", "e-hss", "e-accumed", "e-prima-lp", "e-millerworks", "e-gamco", "e-fmr" ] }, { "id": "display-claim-fcb7ce9ebb635fb96a80250a", "kind": "analysis", "text": "In March 2010 William Petty was chief executive and chairman, David W. Petty president, Joel C. Phillips finance chief, Miller head of research and development and Betty Petty corporate secretary. The outside directors included Albert H. Burstein, a former Hospital for Special Surgery scientist, R. Wynn Kearney, Jr., Paul E. Metts, William B. Locander and James G. Binch. The proxy recorded an extra payment to Metts for work on a Department of Defense inquiry whose subject it does not describe.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d137" ], "entity_ids": [ "e-exac", "e-wpetty", "e-dpetty", "e-phillips", "e-miller", "e-thompson", "e-bpetty", "e-burstein", "e-kearney", "e-metts", "e-locander", "e-binch", "e-rsmith", "e-hss", "e-mcgladrey" ] }, { "id": "display-claim-33fb4ccea7a343700cf2a48e", "kind": "analysis", "text": "Brighton Partners, Inc., which supplied raw materials, equipment and licences for Exactech's production, was partly owned by insiders — Burstein 24%, the Pettys 4.6% and Miller 2.8% — and sold Exactech between $1.5 million and $2.2 million of goods a year in 2007–2009. On 24 May 2010 Exactech bought all its shares for $5,500,000 from sellers including Burstein, the Petty family, Miller, Phillips and Timothy J. Seese. The Florida register also lists the Pettys as officers of ExactOrtho, Inc., a company filed in December 2017, between the signing and the closing of the TPG deal, and dissolved in 2019 without any described business.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d137", "s-d232", "s-d313", "s-d315", "s-d314", "s-d341" ], "entity_ids": [ "e-exac", "e-brighton", "e-burstein", "e-wpetty", "e-bpetty", "e-miller", "e-dpetty", "e-phillips", "e-seese", "e-ahb", "e-thompson", "e-exactortho", "e-prima-inc" ] }, { "id": "display-claim-96509467ca07f8eaa8d71753", "kind": "analysis", "text": "The 1996 registration statement disclosed a 1994 personal-injury suit in Pinellas County alleging deterioration of the acetabular components of Exactech's hip system, and a 1995 patent suit by Joint Medical against Exactech and many of its competitors.", "qualification": "", "response": "Exactech said the hip-component action was without merit and that, on its patent counsel's opinion, Joint Medical's claims were without merit.", "outcome": "The patent action was dismissed as against Exactech on 28 July 1995 under the tolling agreement; the outcome of the Pinellas County action is not in the record.", "source_ids": [ "s-d101" ], "entity_ids": [ "e-exac", "e-jointmedical" ] }, { "id": "display-claim-733f8b74bd8b009383e21501", "kind": "analysis", "text": "On 7 December 2010 the U.S. Attorney's Office for the District of New Jersey filed a criminal complaint charging Exactech with conspiring to violate the federal anti-kickback statute by entering, from 2002 to late 2008, into consulting agreements with orthopaedic surgeons designed in part to induce them to use its hip and knee products. The company entered a 12-month deferred prosecution agreement under a federal monitor, paid $2.99 million to settle related civil claims that its marketing caused false claims to Medicare, and signed a five-year Corporate Integrity Agreement with the HHS Office of Inspector General; its board authorised Greenberg Traurig to sign.", "qualification": "A deferred prosecution agreement is not a conviction: the complaint was to be dismissed if the company complied for 12 months. The civil settlement resolved government claims without a judgment.", "response": "In the agreement the company undertook to acknowledge responsibility for its behaviour, to continue cooperating with the prosecutors and other agencies and to carry out further remediation; the prosecutors acknowledged that neither the agreement nor the criminal complaint alleged that the company's conduct had adversely affected patient health or patient care.", "outcome": "The record does not contain the dismissal order; the Settlement Trust's 2026 complaint refers to the agreement as having expired.", "source_ids": [ "s-d258", "s-d350" ], "entity_ids": [ "e-exac", "e-greenberg" ] }, { "id": "display-claim-9ee030084327ff30486d8bb6", "kind": "analysis", "text": "The same day Douglas Donofrio, then director of sales for the Northeast region, pleaded guilty to conspiring to violate the statute, admitting illegal financial arrangements with surgeons and inflated work reports used to justify consulting payments, and agreed to repay a $50,000 bonus.", "qualification": "The plea concerns the individual; the charge carried a maximum of five years in prison and a $250,000 fine.", "response": "", "outcome": "The release gave a sentencing date of 14 March; the sentence is not in the record.", "source_ids": [ "s-d258" ], "entity_ids": [ "e-donofrio", "e-exac" ] }, { "id": "display-claim-2ad8d26daf368babac7d1373", "kind": "analysis", "text": "The Settlement Trust's 2026 complaint alleges that consulting payments continued after the agreement expired, peaking in 2018 and rising again for shoulder products from 2021, with nearly $60 million paid to physicians from 2017 to 2023, and that TPG and Jeffrey Binder used such arrangements to encourage the use of Exactech products or to discourage complaints.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The payment totals come from the complaint's reading of public payment data, which was not retrieved.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg", "e-binder" ] }, { "id": "display-claim-cb59c019754b937f43518f0c", "kind": "analysis", "text": "According to the merger proxy, TPG's approach began on 1 May 2017, when Daniel Hann and Jeffrey Binder, a former Biomet chief executive and TPG adviser, met William Petty, David Petty and Bruce Thompson in Gainesville, and Exactech said it was not exploring a sale. Meetings followed with Todd Sisitsky of TPG Capital in June and with Kendall Garrison in July. The lead independent director, James G. Binch, contacted TPG about a confidentiality and standstill agreement; a confidentiality agreement with TPG Global was dated 7 August 2017, and TPG's advisers met Exactech staff in Gainesville at the end of August.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5" ], "entity_ids": [ "e-exac", "e-wpetty", "e-dpetty", "e-thompson", "e-hann", "e-binder", "e-sisitsky", "e-garrison", "e-tpg", "e-binch", "e-tpg-global" ] }, { "id": "display-claim-818da279e13406cc48394787", "kind": "analysis", "text": "On 22 October 2017 Exactech agreed to merge with Osteon Merger Sub, Inc., wholly owned by Osteon Holdings, L.P. ('Parent'), both described as affiliates of TPG Capital and jointly owned by the fund TPG Partners VII, L.P., which committed up to $737,057,000 of equity. An amendment of 3 December raised the price from $42.00 to $49.25 a share, a premium of about 53.9% to the price before the announcement; J.P. Morgan gave a fairness opinion and the antitrust waiting period ended early on 17 November. The deal was approved by the directors who were not employees, with the Pettys recused as rollover investors; the independent directors were to receive up to $1.2 million for their work on the sale and up to $600,000 of severance.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5" ], "entity_ids": [ "e-exac", "e-osteon-lp", "e-mergersub", "e-tpg", "e-tpg7", "e-jpm", "e-wpetty", "e-dpetty" ] }, { "id": "display-claim-0119616a37b1d805de8bfdb7", "kind": "analysis", "text": "At the record date William Petty beneficially owned 24.3% of the shares, mostly through Prima Investments, Limited Partnership, owned by him, Betty Petty and their children, while GAMCO, BlackRock and Dimensional Fund Advisors each held more than 5%. Under a Rollover and Voting Agreement the three Pettys, Prima, Miller Family Holdings and five managers exchanged 2,711,584 Exactech shares for shares of Parent just before the merger — Prima alone 2,300,000 shares for 130,757,376 Class B shares — agreed to vote for the deal and to vote in line with the TPG fund on director nominations, mergers and recapitalisations. The proxy valued William Petty's shares at about $160 million at the merger price.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5" ], "entity_ids": [ "e-exac", "e-osteon-lp", "e-tpg7", "e-wpetty", "e-dpetty", "e-bpetty", "e-prima-lp", "e-mfh-llc", "e-thompson", "e-phillips", "e-edwards", "e-roche", "e-szabo", "e-prima-inc", "e-gamco", "e-blackrock", "e-dfa", "e-mfh-inc", "e-miller" ] }, { "id": "display-claim-f95b0121ac5afbf5b1070991", "kind": "analysis", "text": "Shareholders approved the merger on 13 February 2018, and on 14 February Osteon Merger Sub merged into Exactech; William Petty signed for Exactech and Michael LaGatta for the merger subsidiary and for the TPG fund through its general-partner chain. Exactech announced that TPG had acquired all its stock in a transaction valued at about $737 million and left Nasdaq. The final filings identified the new parent as Osteon Holdings, Inc., a Delaware corporation at TPG's Fort Worth office, whose Form D listed Garrison, Sisitsky, John Schilling, Binder and the two Pettys as directors.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d21", "s-d10", "s-d175", "s-d134" ], "entity_ids": [ "e-exac", "e-mergersub", "e-osteon-lp", "e-osteon", "e-wpetty", "e-lagatta", "e-tpg", "e-tpg7", "e-tpg-genpar", "e-tpg-genpar-adv", "e-nasdaq", "e-garrison", "e-sisitsky", "e-schilling", "e-binder", "e-dpetty", "e-fliss" ] }, { "id": "display-claim-58d57d6967ddeef39e429d8c", "kind": "analysis", "text": "Two federal class actions filed in December 2017 in the Northern District of Florida accused Exactech, its directors, Parent, the merger subsidiary and TPG Capital of violating the disclosure provisions of the Securities Exchange Act. In Florida state court The Arbitrage Fund sued the Pettys, their partnership and the outside directors for breach of fiduciary duty, alleging that the Pettys had declined a rival bidder's $54-a-share proposal and negotiated undisclosed terms with TPG; in July 2020 the appeal court reversed the denial of class certification and sent the case back to the trial court.", "qualification": "The complaints' allegations were not adjudicated in the record. The account of the competing bid and the negotiations is the plaintiff's, as summarised by the appeal court on the class-certification question; the court did not decide the merits.", "response": "Exactech and the director defendants denied the allegations and said they intended to defend the actions vigorously.", "outcome": "The outcome of the two federal actions is not in the record; the merger closed on 14 February 2018.", "source_ids": [ "s-d5", "s-d241" ], "entity_ids": [ "e-exac", "e-wpetty", "e-dpetty", "e-binch", "e-locander", "e-rsmith", "e-watts", "e-krusen", "e-burstein", "e-osteon-lp", "e-mergersub", "e-tpg", "e-arbfund", "e-bpetty", "e-prima-inc", "e-prima-lp" ] }, { "id": "display-claim-38859f43899adffc39e39d31", "kind": "analysis", "text": "The Settlement Trust's 2026 complaint gives a different account. It says TPG's first contact came on 4 April 2017 through Hann, that TPG first offered $39.00 a share in September 2017 and paid Binder a $1 million success fee, that William Petty received more than $46 million and David Petty more than $2.8 million, and that TPG's due diligence saw the FDA's 2017 inspection findings and a product-defect suit but did not visit the packaging supplier. It also alleges that the deal left Exactech with more than $200 million of secured debt and probably insolvent from the closing.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The deposition, invoice and inspection documents are under seal or were not retrieved.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg", "e-hann", "e-sisitsky", "e-binder", "e-schilling", "e-garrison", "e-wpetty", "e-dpetty", "e-tepatti" ] }, { "id": "display-claim-86de5ea5eb673ea3c12eb140", "kind": "analysis", "text": "Exactech's bankruptcy filings name Osteon Intermediate Holdings II, Inc. as its only shareholder and as 'Holdings' under the first-lien credit agreement of 14 February 2018, under which Goldman Sachs Bank USA was agent until GLAS Trust Company replaced it in October 2024 and XpandOrtho, Inc. was a guarantor. The Settlement Trust's complaint describes the chain above it: Osteon II was owned by Osteon Intermediate Holdings I, Inc. and that company by Osteon Holdings, Inc., which it says was 88% owned by TPG VII Osteon Holdings, L.P. (the 'Sponsor'), itself 95% owned and funded by TPG Partners VII, L.P.; under the Osteon Holdings shareholders' agreement the Sponsor set the size of the board, on which Exactech had one representative.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The 88% and 95% figures appear only in the complaint; the shareholders agreement and partnership records are not public.", "response": "", "outcome": "", "source_ids": [ "s-d20", "s-d7", "s-d24" ], "entity_ids": [ "e-exac", "e-osteon2", "e-xpand", "e-goldman", "e-glas-us", "e-osteon1", "e-osteon", "e-sponsor", "e-tpg7", "e-tpg" ] }, { "id": "display-claim-6e84d4fcbc0f8e3c7411349d", "kind": "analysis", "text": "The complaint describes TPG, Inc. as the Nasdaq-listed Delaware corporation at 301 Commerce Street, Fort Worth, formerly TPG Partners, LLC and known as TPG Capital L.P. before it went public; the 2018 merger documents name the sponsor as TPG Capital, L.P. at the same address.", "qualification": "The name history is the complaint's description; this dossier treats references to TPG Capital, L.P. in the 2017–2022 records as the same TPG firm and keeps its separately named funds and vehicles as distinct participants.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-tpg" ] }, { "id": "display-claim-c68e156094a31018400017bb", "kind": "analysis", "text": "The 2018 first-lien agreement provided a $50 million revolving facility and a $235 million term loan, increased by $35 million in 2019. In September 2023 the Sponsor became agent and sole lender of 'sidecar' term loans to support liquidity during settlement talks with product-liability plaintiffs, and it agreed to lend more in April 2024. At the 29 October 2024 petition the debtors owed about $352 million, including $28.5 million of sidecar loans, and the chief restructuring officer said the recalls had cost about $20 million in a year and prevented a refinancing.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7" ], "entity_ids": [ "e-exac", "e-sponsor", "e-osteon2" ] }, { "id": "display-claim-16efd1783ce0762beebdf9b8", "kind": "analysis", "text": "The trust alleges that a TPG manager was paid an annual fee of $1 million under a Management Services Agreement and that Exactech paid TPG $5,909,935 for deal expenses in February 2018, which it seeks to recover as a fraudulent transfer; it cites recall liabilities rising to $135.8 million by the end of 2023 and a $138 million goodwill impairment in 2022. It also alleges that TPG explored an earlier exit through a sale or a stock-market listing, including a confidential draft registration statement of April 2021 that omitted the Alabama whistle-blower case, and that neither happened because of the recalls and the loss of a major customer.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The financial figures are the complaint's account of Exactech's private accounts, which are not public. These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The confidential draft registration statement is not public and was not retrieved.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg-mgmt", "e-osteon", "e-osteon1", "e-osteon2", "e-tpg", "e-trust", "e-hss" ] }, { "id": "display-claim-3a5f71201a9073dfc09f46e9", "kind": "analysis", "text": "In January 2018 William Petty was executive chairman, David W. Petty president and chief executive, Joel C. Phillips finance chief, Gary J. Miller head of research and development, Bruce Thompson a senior vice president, Betty Petty corporate secretary and Donna Edwards general counsel; the independent directors were James G. Binch, William B. Locander, Richard C. Smith, Fern S. Watts and W. Andrew Krusen, Jr.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d5", "s-d128" ], "entity_ids": [ "e-exac", "e-wpetty", "e-dpetty", "e-phillips", "e-miller", "e-thompson", "e-bpetty", "e-edwards", "e-binch", "e-locander", "e-rsmith", "e-watts", "e-krusen" ] }, { "id": "display-claim-542c4b9ef6cd7e538590c117", "kind": "analysis", "text": "The 2019 report to the Florida register listed William Petty, Binder, Garrison, Schilling, Sisitsky and David Petty as directors, and Daniel P. Hann among the officers. According to a written consent of November 2023 quoted in the Settlement Trust's complaint, the board then comprised Darin Johnson, David Petty, Binder, Sisitsky, Schilling, Garrison, Diana Nole, Gwen Bingham, Karen Golz and M. Elizabeth Abrams. The complaint alleges that the Exactech and Osteon Holdings boards were identical until November 2023, that TPG placed its people in key posts and that the TPG principal Michael Tepatti attended at least 28 board or audit committee meetings.", "qualification": "The 2023 board list is quoted from a corporate consent in the complaint; the description of TPG's control and of meeting attendance is the Settlement Trust's allegation, not adjudicated.", "response": "", "outcome": "", "source_ids": [ "s-d25", "s-d24", "s-d306" ], "entity_ids": [ "e-exac", "e-wpetty", "e-binder", "e-garrison", "e-schilling", "e-sisitsky", "e-dpetty", "e-edwards", "e-phillips", "e-bpetty", "e-miller", "e-hann", "e-thompson", "e-osteon", "e-johnson", "e-nole", "e-bingham", "e-golz", "e-abrams", "e-tepatti", "e-yasskin", "e-lin", "e-bolukbasi", "e-tpg" ] }, { "id": "display-claim-ecebee9b27db79b5db20522c", "kind": "analysis", "text": "William Petty and Binder were co-executive chairmen after the acquisition; Petty stepped back in January 2020, when Darin Johnson succeeded David Petty as chief executive and David Petty became vice chairman. Binder was chief executive from March 2022 to March 2023, after which Johnson returned, and Kerem Bolukbasi, previously a TPG consultant, became finance chief in August 2020. The company's August 2024 report to the Florida register listed Johnson as chief executive, Tony Collins as finance chief, Edwards as secretary, Binder as chairman and David Petty, Timothy Pohl and Abrams as directors.", "qualification": "The dates come from the Settlement Trust's complaint; the earlier SEC proxy confirms David Petty as chief executive from March 2014 and president from November 2007, and the Florida and UK registers confirm Johnson as president and chief executive.", "response": "", "outcome": "", "source_ids": [ "s-d24", "s-d5", "s-d14", "s-d20" ], "entity_ids": [ "e-exac", "e-osteon", "e-wpetty", "e-dpetty", "e-johnson", "e-binder", "e-bolukbasi", "e-tpg", "e-collins", "e-edwards", "e-livingston", "e-pohl", "e-abrams" ] }, { "id": "display-claim-ecf9c5c805c6a2273618b4a7", "kind": "analysis", "text": "Binder had been president and chief executive of Biomet from February 2007, until June 2015 according to the trust. The trust alleges that he has been a senior adviser to TPG since June 2015, paid by TPG rather than Exactech for his Exactech work, and that by 2019 he controlled its commercial activities; a national newspaper reported his consulting relationship with TPG from 2015. The trust also sues Sisitsky, Schilling, Garrison, Tepatti and two members of TPG's health-care team, Bennett Yasskin and John Lin; Sisitsky stepped down as president of TPG Inc. on 6 September 2026.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The agreement and payments are described only in the complaint. Titles other than Sisitsky's 2026 departure come from the Settlement Trust's complaint.", "response": "", "outcome": "", "source_ids": [ "s-d305", "s-d24", "s-d301", "s-d97" ], "entity_ids": [ "e-binder", "e-biomet", "e-tpg-global", "e-tpg", "e-exac", "e-sisitsky", "e-schilling", "e-garrison", "e-tepatti", "e-yasskin", "e-lin", "e-osteon" ] }, { "id": "display-claim-2ca73705c719f073f215ce58", "kind": "analysis", "text": "In its 2024 bankruptcy declaration the company said that, in coordination with the FDA, it had voluntarily recalled Connexion GXL hip liners from June 2021, then all hip liners and knee and ankle implants, and in early 2024 shoulder devices and knee patella components, because a vendor had supplied packaging bags missing one of seven specified layers, an oxygen barrier protecting the polyethylene from oxidation.", "qualification": "This is the company's own description in a sworn bankruptcy declaration; the regulator's characterisation is in its safety communications and recall records.", "response": "In the same declaration the company said that, placing patients' interests first, it had proactively implemented the voluntary recall although internal and outside materials-science experts had confirmed through industry-standard laboratory testing that the packaging would not affect the clinical performance of most of the recalled components; and that, although it initiated the recalls in an abundance of caution, it has consistently maintained that the non-conforming bags have not led to overall higher rates of revision surgery beyond industry averages (5–10% at ten years of follow-up), a position it believes scientific and clinical data support. It did not answer a national newspaper's questions on the subject in May 2025.", "outcome": "", "source_ids": [ "s-d7", "s-d301" ], "entity_ids": [ "e-exac" ] }, { "id": "display-claim-47dd979442852d0fdf3926b2", "kind": "analysis", "text": "The FDA's safety communication of 23 March 2023 warned that knee, ankle and hip devices made between 2004 and August 2021 had been packaged in defective bags that could lead to oxidation, accelerated wear, cracking and revision surgery, and recorded the stages of the recalls: GXL liners in June 2021, all affected knees and ankles from February 2022 — about 80% of those made since 2004 — and all affected hip devices from August 2022. A second communication in January 2024 said that Equinoxe shoulder implants had been packaged in the same bags and that Exactech had so far declined to recall them.", "qualification": "", "response": "", "outcome": "Exactech initiated the shoulder recall in 2024: the FDA's update of 19 April 2024 reports it, and the FDA enforcement record dates the recall event (94092) from 6 March 2024.", "source_ids": [ "s-d255", "s-d260" ], "entity_ids": [ "e-exac" ] }, { "id": "display-claim-e832c39fd7ed36f78515a5a8", "kind": "analysis", "text": "The FDA's enforcement records list the polyethylene recalls as Class II events with Exactech, Inc. as recalling firm, among them 89,050 GXL hip liners from June 2021, 109,787 Optetrak Logic and 31,201 Truliant knee inserts from August 2021, shoulder liners and glenoids from March 2024, patella components from April 2024 and XLE hip liners from December 2024. They also record unrelated recalls, such as a 2012 shelf-life labelling error and, in 2025 and 2026, shoulder liners outside their dimensional specification and surgical instruments.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d247", "s-d253", "s-d351", "s-d254" ], "entity_ids": [ "e-exac" ] }, { "id": "display-claim-266fd14cffebd019e5a7a791", "kind": "analysis", "text": "After a September 2023 inspection in Gainesville the FDA's warning letter of 19 January 2024 found shoulder systems and other implants adulterated, because the firm had not identified the actions needed to correct shoulder implants in non-conforming bags and had counted only some complaints in its hazard evaluation, and misbranded, because a report of accelerated liner wear had reached the FDA late. A second letter of 19 December 2025, addressed to 'Exactech, Inc. dba Advita Ortho' after a July 2025 inspection in Sarasota, faulted the control of the sole supplier of a polyethylene powder and other quality-system failures.", "qualification": "Which legal entity is behind the name 'Exactech, Inc. dba Advita Ortho' is not stated in the letter; the inspection preceded the sale of the business to Advita Ortho.", "response": "Exactech answered the Form 483 observations on 13 October 2023, describing systemic corrective actions: a retrospective review of complaints, revised procedures and staff training, an assessment under CAPA2023-042 of how historical complaints had been coded, and a revision of its medical-device-reporting procedure due by 31 December 2023. The FDA said the adequacy of the response could not yet be determined because the actions were still under way. The firm told the FDA that it had suspended production, started a field action on humeral shoulder liners and opened a corrective action (CAPA 2025-30) for the Sarasota and Gainesville sites due for completion by March 2026; the FDA found the responses not adequate.", "outcome": "Exactech initiated the shoulder recall in March–April 2024.", "source_ids": [ "s-d246", "s-d30", "s-d264", "s-d294" ], "entity_ids": [ "e-exac", "e-johnson", "e-advita", "e-sahagun" ] }, { "id": "display-claim-71d7f847576f9b636fc45be0", "kind": "analysis", "text": "The FDA's registration database still lists the Gainesville plant under Exactech, Inc., and its most recent 510(k) clearance, of April 2026 for the Equinoxe shoulder, names Exactech, Inc. as applicant and Advita Ortho as correspondent. A national newspaper reported in 2025 that Australian joint-registry reports from 2011 to 2018 had found 'higher than anticipated' revision rates for Exactech devices.", "qualification": "The FDA records keep the Exactech, Inc. name after the sale of the business; they do not state which legal entity now holds the registration. The registry reports themselves were not retrieved; the figures are as reported by the newspaper.", "response": "In its October 2024 bankruptcy declaration the company said it has consistently maintained that the non-conforming packaging has not led to overall higher rates of revision surgery beyond industry averages (5–10% at ten years of follow-up), and that scientific and clinical data support its position; the newspaper reported the same position from the company's court disclosures.", "outcome": "", "source_ids": [ "s-d329", "s-d262", "s-d51", "s-d301", "s-d7" ], "entity_ids": [ "e-exac", "e-advita" ] }, { "id": "display-claim-d636173f6d2e67ac90d51385", "kind": "analysis", "text": "The complaint names the supplier of the vacuum bags from 2004 to 2021 as Hillman Supply Company, Inc., a local firm near Exactech's headquarters that it says specialised in janitorial supplies, had the bags made by others and supplied more than 1.4 million of them, almost none with the required EVOH barrier layer, without ever being audited by Exactech. The Florida register lists Hillman Supply Company, Inc. as an active company in Alachua, incorporated in 1993.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. Hillman is not a defendant in the trust's suit; the FDA's own records and the company's declaration refer only to an unnamed vendor. The match with the supplier named in the lawsuits rests on the name and location; the register does not describe its business.", "response": "In the Florida product-liability cases where it was named as a co-defendant, Hillman Supply Company filed an answer with affirmative defences and a jury demand on 26 December 2023.", "outcome": "", "source_ids": [ "s-d24", "s-d218", "s-d198", "s-d217" ], "entity_ids": [ "e-exac", "e-hillman", "e-tpg" ] }, { "id": "display-claim-48773d19a85e0a08a33b5409", "kind": "analysis", "text": "Quoting FDA inspection records that are not public, the complaint alleges that inspections in 2017, 2020, 2021 and 2023 found inadequate complaint investigations, unvalidated packaging and no acceptance checks on the bags, and that the company had extended the stated shelf life of knee inserts around 2007 without reporting it; it counts 20 FDA citations from 2017 to 2023, 13 of them after TPG's acquisition.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The FDA inspection forms and reports (Forms 483 and establishment inspection reports) are not published by the FDA and were not retrieved; the findings are as quoted in the complaint. The FDA's 2024 warning letter separately documents the September 2023 inspection.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-tpg" ] }, { "id": "display-claim-0ed54307ec3c0fd91186a88e", "kind": "analysis", "text": "The complaint alleges that by July 2021 Exactech's quality chief, Michael Crader, warned that 20 years of supplier certificates had not confirmed the oxygen barrier; that from August 2021 Binder and John Schilling, helped by other TPG staff, took charge of the recall response; and that TPG chose a series of partial recalls, notified distributors before surgeons and widened the recalls only after the FDA intervened, so as to keep revenue stable for a planned listing.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The FDA's own records of these recalls are summarised separately; the internal e-mails are quoted from the complaint and were not retrieved. These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "Binder told a national newspaper in May 2025 that Exactech's investigation of product complaints led it to discover in 2021 a packaging non-conformity that had gone undetected since 2008, many years before TPG's ownership and his tenure, and that when it was discovered Exactech reported it to the FDA in a timely fashion and initiated a recall. TPG told the same newspaper that the packaging issues predated its ownership, that it learned of them only in 2021 and that it 'supported the company as it immediately launched an investigation, initiated a voluntary recall, and provided support programs for physicians and patients'.", "outcome": "", "source_ids": [ "s-d24", "s-d301" ], "entity_ids": [ "e-exac", "e-tpg", "e-crader", "e-binder", "e-schilling", "e-garrison", "e-yasskin", "e-tepatti", "e-lin" ] }, { "id": "display-claim-f29d505c6c6efe92c5beb5dc", "kind": "analysis", "text": "The complaint alleges that the Hospital for Special Surgery, Exactech's largest domestic customer, reported a worn and oxidised hip insert in 2017, that in 2018 Binder and William Petty tried to have it withdraw a conference presentation on delaminated components, and that it removed Exactech knees in 2019 and the Equinoxe shoulder in 2021. Citing the creditors' committee, it also alleges that femoral knee components were made to a wrong surface-roughness specification from 2004 to 2021 without a recall.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. HSS is not a party to the trust's suit; it appears as an interested party in the bankruptcy. These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The internal evaluation and memorandum are quoted from the complaint and were not retrieved; no recall record for the roughness issue appears in the FDA data reviewed.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac", "e-hss", "e-miller", "e-wpetty", "e-binder", "e-schilling", "e-tpg" ] }, { "id": "display-claim-96575c2c9f48f5f11a3bbfe0", "kind": "analysis", "text": "By the complaint's count the seven polyethylene recall events covered nearly 800,000 units worldwide and more than 500,000 implants across the Equinoxe shoulder, several hip lines, the Optetrak, Optetrak Logic and Truliant knees and the Vantage ankle.", "qualification": "These totals are the Settlement Trust's compilation from FDA recall data and company statements; they differ in scope from the per-entry quantities in the FDA enforcement reports.", "response": "", "outcome": "", "source_ids": [ "s-d24" ], "entity_ids": [ "e-exac" ] }, { "id": "display-claim-f6d5b8b5bfdb040d77df9009", "kind": "analysis", "text": "On 7 October 2022 the Judicial Panel on Multidistrict Litigation centralised federal cases over Exactech's hip, knee and ankle polyethylene in the Eastern District of New York as MDL No. 3044 before Judge Nicholas G. Garaufis. The amended master complaint of March 2023 named Exactech, Exactech U.S., TPG Inc., Osteon Holdings, Osteon Intermediate Holdings II and Osteon Merger Sub, and discovery against the TPG and Osteon defendants was stayed pending their motion to dismiss.", "qualification": "The MDL consolidates plaintiffs' claims; the record contains no judgment on liability against Exactech.", "response": "Exactech defended the consolidated cases. Among its filings, it opposed the conditional transfer into the MDL of a class complaint brought by the Medicare-claims recovery firm MSP Recovery Claims, Series LLC, and on 20 April 2023 filed a fully briefed motion, with Exactech U.S., Inc., to dismiss that complaint for lack of jurisdiction and standing.", "outcome": "Under the plan confirmed in September 2025, personal-injury and wrongful-death claims against the debtors are to be resolved and paid by the Exactech Settlement Trust; the record contains no judgment in the MDL.", "source_ids": [ "s-d351", "s-d322" ], "entity_ids": [ "e-exac", "e-exus", "e-tpg", "e-tpg7", "e-tpg-genpar", "e-tpg-genpar-adv", "e-osteon", "e-mergersub", "e-osteon2" ] }, { "id": "display-claim-eca3946683876cdcaafc7f68", "kind": "analysis", "text": "On 7 March 2024 the court granted the motion of TPG Inc. and the Osteon companies to dismiss the claims against them, which rested on veil-piercing and successor-liability theories, removing them from the personal-injury actions filed from 18 states. The Settlement Trust alleges that TPG obtained this dismissal without disclosing its control of the board and of the recalls, and that it directed Kirkland & Ellis to represent TPG and Exactech jointly.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "TPG Inc., Osteon Holdings, Osteon Merger Sub and Osteon Intermediate Holdings II moved to dismiss for failure to state a claim of indirect liability on a veil-piercing theory (motion fully briefed on 28 July 2023); the plaintiffs opposed it as premature because the choice-of-law analysis was fact-intensive.", "outcome": "The dismissal removed TPG and its affiliates from the MDL personal-injury actions; the alter-ego and veil-piercing claims later passed to the Settlement Trust under the bankruptcy plan.", "source_ids": [ "s-d219", "s-d322", "s-d24" ], "entity_ids": [ "e-exac", "e-tpg", "e-osteon", "e-mergersub", "e-osteon2", "e-kirkland" ] }, { "id": "display-claim-e265c3eb134c415c3196c224", "kind": "analysis", "text": "By the 29 October 2024 petition about 2,600 patients had sued — some 1,840 in the MDL and more than 740 in Florida, where the cases were coordinated before Judge Donna M. Keim in Alachua County — and the company's last offer to settle the MDL, in July 2024, had not been accepted. The trust also counts more than 55 cases in other state courts and more than 60 abroad, and says the first Florida bellwether trial, set for December 2024, was halted by the bankruptcy.", "qualification": "The counts are the trust's and the broadcaster's; they differ slightly from the company's own figures.", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d24", "s-d294" ], "entity_ids": [ "e-exac" ] }, { "id": "display-claim-438eea78fe7baab39fcee89e", "kind": "analysis", "text": "Florida cases in the master case 2022 CA 002670 named not only Exactech but also William, Betty and David Petty, Gary Miller, the Miller family holding companies and Hillman Supply Company. In a federal case in Arkansas over a Connexion GXL hip liner, a plaintiffs' lawyer said in 2023 that Exactech was blaming the packaging supplier.", "qualification": "These are plaintiffs' claims; no ruling on liability appears in the dockets reviewed. This is the plaintiffs' lawyer's account of the case and of Exactech's position.", "response": "On 9 June 2023 the Petty and Miller defendants and the Miller family holding companies moved to dismiss the Starling case; the Exactech defendants answered the Sindicich complaint on 19 December 2023 and Hillman Supply Company filed an answer with affirmative defences and a jury demand on 26 December 2023.", "outcome": "The Starling and Sindicich cases were closed on 29 October 2024 because of the bankruptcy filed in the Exactech master case.", "source_ids": [ "s-d293", "s-d349", "s-d218", "s-d307" ], "entity_ids": [ "e-exac", "e-exus", "e-wpetty", "e-bpetty", "e-dpetty", "e-miller", "e-mfh-llc", "e-mfh-inc", "e-hillman" ] }, { "id": "display-claim-d462be3850b62fe315b2ae38", "kind": "analysis", "text": "In Australia Simon Harrold sued Exactech Australia and Exactech, Inc. in the Federal Court in September 2024 on behalf of about 5,000 patients, alleging manufacturing and packaging defects. The parties settled by a deed of 29 May 2025 for about A$8.7 million, funded by insurance, the Australian subsidiary and the lenders, and Justice Jackman approved the settlement on 13 November 2025.", "qualification": "", "response": "The respondents denied liability; the settlement was made without admission of liability. The settlement was made without admission of liability.", "outcome": "", "source_ids": [ "s-d197", "s-d214" ], "entity_ids": [ "e-exac", "e-au", "e-harrold", "e-york" ] }, { "id": "display-claim-c740c1aad2bb10598ba6b3e9", "kind": "analysis", "text": "On 29 June 2018 Brooks Wallace, Roberta Farley and Manuel Fuentes filed a qui tam suit in the Northern District of Alabama on behalf of the United States and several states, alleging that Exactech sold misbranded and defective knee implants. The government declined to intervene, and the complaint was unsealed in August 2019. The Settlement Trust's complaint says the suit concerned the finned tibial tray, that TPG learned of it in 2019 and that it was ready for trial when Exactech filed for bankruptcy.", "qualification": "The relators' allegations were resolved by settlement without a finding of liability; the Justice Department's release spells the second relator 'Robert Farley'. These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "Exactech contested the suit. It moved to dismiss the complaint in December 2019, attaching an expert report and its earlier corporate integrity and deferred prosecution agreements; on 14 February 2020 the court struck the complaint as an impermissible shotgun pleading and denied that motion as moot. On 5 August 2020 the court granted in part and denied in part Exactech's motion to dismiss the amended complaint, dismissing the state-law claims without prejudice and leaving the federal claims pending, and Exactech answered the amended complaint on 19 August 2020.", "outcome": "Resolved by the $8 million False Claims Act settlement announced on 16 September 2025.", "source_ids": [ "s-d7", "s-d220", "s-d24" ], "entity_ids": [ "e-exac", "e-wallace", "e-farley", "e-fuentes", "e-livingston", "e-wpetty", "e-tpg" ] }, { "id": "display-claim-0256f1b7a6d96d3cabf22ed1", "kind": "analysis", "text": "A second qui tam suit by Dr. Pasquale Petrera in the District of Maryland named both Exactech and TPG Capital, L.P.; in March 2026 the United States declined to intervene in the remaining claims against TPG Capital.", "qualification": "", "response": "", "outcome": "The claims against Exactech were resolved by the September 2025 settlement; those against TPG Capital, L.P. were dismissed without prejudice on 23 April 2026.", "source_ids": [ "s-d143", "s-d142" ], "entity_ids": [ "e-exac", "e-petrera", "e-tpg" ] }, { "id": "display-claim-a75beb966793d585c8db2ad3", "kind": "analysis", "text": "On 16 September 2025 the Justice Department announced that Exactech would pay $8 million, an amount based on its financial condition, to resolve allegations that it sold the finned tibial tray from 2008 to 2018 and the Logic and Truliant knees from 2019 to 2022 while knowing of their problems, causing false claims to Medicare, Medicaid and the Department of Veterans Affairs; the relators in both cases receive part of the sum. In May 2025 the company had refused a ten-year Corporate Integrity Agreement, and the HHS Office of Inspector General lists it in its heightened-scrutiny category.", "qualification": "The Justice Department states that the claims resolved by the settlement are allegations only and that there has been no determination of liability.", "response": "", "outcome": "", "source_ids": [ "s-d256", "s-d146" ], "entity_ids": [ "e-exac", "e-wallace", "e-farley", "e-fuentes", "e-petrera" ] }, { "id": "display-claim-b92c6fa850c4cb8fc3325190", "kind": "analysis", "text": "In February 2025 the Alabama relators and the United States asked the bankruptcy court to rule that Exactech's debt to them could not be discharged because it arose from fraud; the court repeatedly extended the company's time to answer.", "qualification": "", "response": "", "outcome": "The record shows extensions of the answer deadline to October 2025 and the $8 million settlement of the underlying claims; no ruling on dischargeability appears.", "source_ids": [ "s-d172" ], "entity_ids": [ "e-exac", "e-wallace", "e-farley", "e-fuentes" ] }, { "id": "display-claim-a0794d613c3a7a33cea71386", "kind": "analysis", "text": "Exactech hired Centerview as investment banker in July 2023 and Riveron in April 2024, whose Jesse York became chief restructuring officer, and added Young Conaway as co-counsel to Ropes & Gray. Independent directors M. Elizabeth Abrams, appointed in November 2023, and Timothy Pohl, appointed in July 2024, served on a special committee that, with White & Case, investigated past transactions between the sponsor and the company. After failing to pay about $6 million of interest due in August 2024, the company signed a restructuring support agreement with about 95% of its first-lien lenders on 28 October 2024, providing $85 million of new debtor-in-possession financing and a sale of the business to a lender vehicle.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d319", "s-d317" ], "entity_ids": [ "e-exac", "e-centerview", "e-ropes", "e-riveron", "e-york", "e-ycst", "e-abrams", "e-pohl", "e-osteon2", "e-xpand", "e-whitecase", "e-sponsor", "e-osteon", "e-osteon1", "e-milbank", "e-edwards", "e-eibidco" ] }, { "id": "display-claim-c6c27fbbeaa9ad2b3e95f395", "kind": "analysis", "text": "On 29 October 2024 Exactech, Osteon Holdings, Osteon Intermediate Holdings I and II and XpandOrtho filed for Chapter 11 in the District of Delaware; the cases were jointly administered under No. 24-12441 before Judge Laurie Selber Silverstein, with 25,001–50,000 creditors listed. The lender agreement also set deadlines for the Australian and UK subsidiaries, including resolving the Australian class action.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d162", "s-d20" ], "entity_ids": [ "e-exac", "e-osteon", "e-osteon1", "e-osteon2", "e-xpand", "e-york", "e-au", "e-eio", "e-uk" ] }, { "id": "display-claim-c2026844bfb3ed9afbc3acee", "kind": "analysis", "text": "The stalking-horse purchaser, EI Bidco, LLC, signed an asset purchase agreement on 29 October 2024 under which it would not assume product-liability, recall or False Claims Act liabilities; its notices go to Matthew Richards at a Singapore trust company, Watiga Trust, which GLAS acquired in December 2024. The court approved bidding procedures on 10 December 2024. Exactech and the lenders also sued the JointMedica parties, whose consent was needed to transfer Exactech's interest in the UK company JointMedica Limited.", "qualification": "The records describe a corporate trust and agency provider used as a notice address; they do not identify who owns EI Bidco, LLC. The record does not state the percentage held by Exactech or who owns JointMedica Investment Holdings, L.P.; a shared representation in court does not by itself establish common ownership.", "response": "", "outcome": "The plan was confirmed in September 2025 rather than on the March 2025 timetable. Dismissed with prejudice on a joint stipulation filed by the ad hoc lender group on 5 November 2025; the adversary case was closed the same day. The record does not show the terms.", "source_ids": [ "s-d7", "s-d135", "s-d221", "s-d223", "s-d140", "s-d171", "s-d162" ], "entity_ids": [ "e-exac", "e-eibidco", "e-watiga", "e-richards", "e-milbank", "e-collins", "e-osteon2", "e-xpand", "e-glas", "e-centerview", "e-ropes", "e-jointmedica", "e-jm-inv", "e-sponsor", "e-kirkland" ] }, { "id": "display-claim-54f555157f7b96753934f72c", "kind": "analysis", "text": "The plan proposed in spring 2025 would have released TPG from liability, including personal-injury claims, for $10 million, an amount the debtors' special committee had found fair; the creditors' committee disputed that finding and put the full value of the personal-injury claims at probably more than $1 billion. On 20 May 2025 Judge Silverstein ruled that Exactech and TPG shared a common legal interest in defending the product claims but not alter-ego and veil-piercing claims, on which the court said they had always been adverse; at a hearing on 28 May Exactech's lawyers said the company was walking away from the effort to protect TPG.", "qualification": "The amounts and the committee's estimate are as reported by the press; the special committee's report was not retrieved.", "response": "TPG told the national newspaper that it was 'categorically false' to allege that it had 'encouraged or engineered a bankruptcy filing to protect itself from liability'.", "outcome": "According to the confirmation order, the debtors moved on 7 May 2025 for approval of the settlement with the Sponsor, obtained on 28 May 2025 an adjournment of the confirmation hearing to negotiate with the creditors' committee, and withdrew that motion on 22 July 2025, when they filed the Fifth Amended Plan. The plan confirmed in September 2025 did not release TPG; the claims were transferred to the Settlement Trust.", "source_ids": [ "s-d301", "s-d278", "s-d142", "s-d169", "s-d24" ], "entity_ids": [ "e-exac", "e-tpg", "e-ucc", "e-ropes", "e-brownrudnick", "e-kirkland", "e-trust" ] }, { "id": "display-claim-a4ccff73472103aeee282f74", "kind": "analysis", "text": "After several amended plans, the court confirmed the Fifth Amended Joint Plan on 17 September 2025. The confirmation approved the sale of the operations to a group of Strategic Value Partners, Stellex Capital Management and Greywolf Capital Management, created the Exactech Settlement Trust, with Ellen K. Reisman as trustee, to pay injury claims and pursue claims against TPG, and named Alan D. Halperin commercial unsecured-creditor trustee and wind-down officer. Parties appearing in the case included the founders, the Hospital for Special Surgery, the lenders, the Justice Department and the creditors' committee.", "qualification": "", "response": "", "outcome": "The plan was confirmed on 17 September 2025. The notice of the plan's effective date was not retrieved, so the effective date is not stated from the record.", "source_ids": [ "s-d170", "s-d142", "s-d9", "s-d144", "s-d162" ], "entity_ids": [ "e-exac", "e-trust", "e-reisman", "e-halperin", "e-guc-trust", "e-ucc", "e-svp", "e-stellex", "e-greywolf", "e-sahagun", "e-tpg", "e-brownrudnick", "e-wpetty", "e-dpetty", "e-miller", "e-hss", "e-rti" ] }, { "id": "display-claim-aefdf0747ffb7759ab554f16", "kind": "analysis", "text": "By October 2026 Matthew Dundon had replaced Halperin as trustee of the commercial unsecured creditors' trust and wind-down officer, and Exactech, Inc.'s 2026 Florida filing moved its address to White Plains, New York.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d162", "s-d326", "s-d4", "s-d96", "s-d345" ], "entity_ids": [ "e-exac", "e-dundon", "e-guc-trust", "e-coleschotz", "e-wright", "e-dundon-adv", "e-halperin" ] }, { "id": "display-claim-9063ce27c1093f6b89a03c64", "kind": "analysis", "text": "Ellen K. Reisman, trustee of the Exactech Settlement Trust created under the bankruptcy plan, sued in the Delaware Court of Chancery (C.A. No. 2026-0129-MTZ) on 30 January 2026. The defendants are TPG, Inc., TPG Partners VII, TPG VII Management, TPG VII Osteon Holdings, TPG Operations, TPG Holdings II Sub and TPG Capital – FO, together with Jeffrey Binder, Kendall Garrison, John Schilling, Todd Sisitsky, Michael Tepatti, Bennett Yasskin, John Lin and William and David Petty. The trust asks the court to declare that TPG acted as the alter ego of Osteon Holdings and Exactech and is liable for its product liabilities, and claims damages of at least $1 billion for breach of fiduciary duty, aiding and abetting, fraudulent transfers and waste; it pleads a separate claim against the Pettys for their conduct before 2018 and reserves claims over more than $600 million paid to shareholders in the 2018 deal.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "TPG has denied wrongdoing, a local television investigation reported in September 2026; in a statement to a national newspaper in May 2025 TPG called it 'categorically false' that it had any prior knowledge of the packaging nonconformance, and in court filings TPG and its affiliates have said that Exactech and TPG maintained 'clearly separate businesses'.", "outcome": "Pending: the docket showed the case as active on 16 October 2026; a filing of 14 August 2026 attached the Maryland qui tam papers and the plan confirmation order as exhibits, but the filing itself is not in the record and no ruling is recorded.", "source_ids": [ "s-d24", "s-d166", "s-d294", "s-d301", "s-d142" ], "entity_ids": [ "e-trust", "e-exac", "e-reisman", "e-brownrudnick", "e-osteon", "e-tpg", "e-tpg7", "e-tpg-mgmt", "e-sponsor", "e-tpg-ops", "e-tpg-h2", "e-tpg-fo", "e-binder", "e-garrison", "e-schilling", "e-sisitsky", "e-tepatti", "e-yasskin", "e-lin", "e-wpetty", "e-dpetty" ] }, { "id": "display-claim-177a7b2cc2719f0c267bfc4a", "kind": "analysis", "text": "Before the suit, the official committee of unsecured creditors alleged in the bankruptcy court, as a national newspaper reported in May 2025, that Exactech and certain officers and directors had known of product defects since 2005 and engaged in practices designed to hide them, including giving misleading information to the FDA, and that TPG and Binder became aware of the full scope of the defects after the 2018 closing.", "qualification": "These are the committee's allegations in bankruptcy-court filings, as reported; they were not adjudicated, and the claims passed to the Settlement Trust.", "response": "Exactech and its TPG affiliates disputed the allegations, saying in bankruptcy-court responses that the committee was merely speculating that directors and officers had acted with an actual intent to violate the law or neglect their duties.", "outcome": "", "source_ids": [ "s-d301" ], "entity_ids": [ "e-exac", "e-ucc", "e-tpg", "e-binder" ] }, { "id": "display-claim-b77723b88747cab54425c880", "kind": "analysis", "text": "Advita Ortho, LLC announced on 3 November 2025 that it had acquired Exactech's product lines — among them the Equinoxe shoulder, Vantage ankle, Alteon hip and Truliant knee and the GPS navigation technology — together with its engineering, manufacturing and staff, and that it was owned by funds managed by affiliates of Strategic Value Partners, Stellex Capital Management and Greywolf Capital Management. Its board is chaired by Luigi Ferrari, a senior adviser to Strategic Value Partners, and includes chief executive Aurelio Sahagun, Dave Demski and directors from the three owners.", "qualification": "The owners, board and executives are as stated by Advita Ortho itself, except Demski's board seat, which another company's SEC filing also records; the owners' shares are not disclosed.", "response": "", "outcome": "", "source_ids": [ "s-d17", "s-d100", "s-d302" ], "entity_ids": [ "e-advita", "e-exac", "e-svp", "e-stellex", "e-greywolf", "e-ferrari", "e-sahagun", "e-ekdahl", "e-demski", "e-debaca", "e-anderson", "e-drichards", "e-demarco", "e-cjames" ] }, { "id": "display-claim-d9df5cfb166223b314e1fb50", "kind": "analysis", "text": "Several managers came from Exactech, among them Chris Roche, who designed the Equinoxe shoulder system and has led the extremities business since 2021; in 2026 the company named new finance, operations and human-resources chiefs. A local television investigation reported in September 2026 that many Exactech employees moved to Advita Ortho and that the new company did not take on most of Exactech's old liabilities.", "qualification": "The appointments are announced by Advita Ortho itself and reported by the trade press; the broadcaster does not name the former chief executive.", "response": "", "outcome": "", "source_ids": [ "s-d100", "s-d244", "s-d294" ], "entity_ids": [ "e-advita", "e-exac", "e-roche", "e-figg", "e-lopes", "e-ryoung", "e-haydock" ] }, { "id": "display-claim-83148c69d3445599b38c52fb", "kind": "analysis", "text": "Advita Ortho, LLC, a Delaware company, registered in Florida in October 2025; its record lists Advita Holdings LLC and Advita Holdings II LLC as members, both at the Greenwich, Connecticut, address that EDGAR gives for Strategic Value Partners, and Jessica Livingston, formerly Exactech's assistant secretary, as authorised person. In Canada the EXACTECH trade mark was assigned by Exactech, Inc. to Advita Ortho with a date of change of 31 October 2025, while the US ADVITA ORTHO mark was registered in July 2026 in Exactech, Inc.'s name.", "qualification": "A shared address does not by itself show who controls the two members; the members' owners are not disclosed in the records reviewed.", "response": "", "outcome": "", "source_ids": [ "s-d48", "s-d95", "s-d225", "s-d136", "s-d45", "s-d27" ], "entity_ids": [ "e-advita", "e-advita-h1", "e-advita-h2", "e-livingston", "e-svp", "e-exac" ] }, { "id": "display-claim-3a3af5c9d49cff80b47bb436", "kind": "analysis", "text": "An earlier subsidiary list filed with the SEC named Exactech International Corporation (Florida), Exactech Asia, trading as Exactech Medical (Shanghai), Exactech Taiwan, Exactech (UK), Exactech KK in Tokyo and Altiva Corporation; the 2013 list dropped Altiva and added Exactech U.S., Inc., Exactech International Operations, Exactech France, Exactech Deutschland and Exactech Iberica. The Florida company in the list corresponds in the state register to Exactech International, LLC, managed by Exactech, Inc. and dissolved in 2016. Exactech U.S., Inc., which handled US sales and distribution, was merged into Exactech, Inc. by articles filed in February 2023 with effect from October 2020.", "qualification": "The match between the exhibit's name and the Florida LLC rests on the state, the Exactech address and Exactech, Inc.'s role as manager; the register does not use the exhibit's name.", "response": "", "outcome": "", "source_ids": [ "s-d230", "s-d102", "s-d132", "s-d5", "s-d52", "s-d26", "s-d138" ], "entity_ids": [ "e-exac", "e-intl", "e-shanghai", "e-taiwan", "e-uk", "e-kk", "e-altiva", "e-exus", "e-eio", "e-fr", "e-de", "e-iberica", "e-johnson", "e-edwards", "e-collins", "e-kleopfer", "e-thompson", "e-bolukbasi" ] }, { "id": "display-claim-6e96ab132fd099b8ec1a021b", "kind": "analysis", "text": "In January 2015 Exactech bought Blue Ortho SAS of Grenoble, the developer of ExactechGPS founded by Anthony Boyer, James Stiehl and Stéphane Lavallée, for up to €10 million. The 2018 merger proxy records the purchase of the Australian distributor in February 2016, a 24.55% stake in Orthopedic Designs North America, and the 2017 sales of the spine business, of a majority of the Taiwanese subsidiary — to BioGend Therapeutics — and of the Chinese subsidiary. The chart attached to the 2024 bankruptcy declaration shows group companies in Italy, Switzerland, France, South Korea, Germany, the UK, Spain, Japan, Australia, Austria and Portugal and JointMedica Limited; the US debtors sold products to the foreign subsidiaries for resale and bought goods and services from the Swiss company and Blue Ortho.", "qualification": "The chart's text was read by optical character recognition and the percentages and intermediate holders are only partly legible.", "response": "", "outcome": "", "source_ids": [ "s-d128", "s-d55", "s-d56", "s-d139", "s-d7", "s-d5", "s-d196", "s-d291" ], "entity_ids": [ "e-exac", "e-blueortho", "e-boyer", "e-stiehl", "e-lavallee", "e-jpmchase", "e-au", "e-odna", "e-taiwan", "e-shanghai", "e-biogend", "e-eio", "e-italia", "e-korea", "e-jointmedica", "e-de", "e-uk", "e-fr", "e-iberica", "e-kk", "e-eog", "e-pt" ] }, { "id": "display-claim-bd13b503f0174eb6a724d3f0", "kind": "analysis", "text": "Most European subsidiaries took Advita names after the sale. Exactech Italia S.p.A. has been Advita Ortho Italy since November 2025, though the global LEI register still names Exactech, Inc. as its parent; the Swiss operating company became Advita International Ops AG in July 2026; Exactech Deutschland became Advita Ortho Germany in June 2026, with Nicolas Hohl as managing director since October 2025; the French company is now Advita Ortho France, presided over by Laurent Mouillac; and the Spanish company appears as Advita Ortho Iberica. The Austrian Exactech EÖG GmbH, managed by David Backhuß, had not changed its name in September 2026.", "qualification": "The parent record appears not to have been updated after the sale of the business. Board details come from aggregators' copies of the Swiss register; the registers do not show the shareholder. These details come from aggregators' copies of the German register and filed accounts; the 'Exatech International' shareholder is not identified as a specific group company.", "response": "", "outcome": "", "source_ids": [ "s-d114", "s-d115", "s-d54", "s-d233", "s-d131", "s-d295", "s-d188", "s-d189", "s-d279", "s-d130", "s-d183", "s-d195", "s-d236" ], "entity_ids": [ "e-italia", "e-exac", "e-eio", "e-andrews", "e-rognoni", "e-de", "e-kohtz", "e-backhuss", "e-hohl", "e-fr", "e-mouillac", "e-iberica", "e-eog" ] }, { "id": "display-claim-3090ccb79ef3e1b54d7198df", "kind": "analysis", "text": "In the UK register Exactech Inc. controlled the English subsidiary (company 05316864, now Advita Ortho UK Limited) until December 2018 and Osteon Holdings Inc. from then until 31 October 2025, after which the company has stated that it has no registrable controller. Its directors included David Petty and Joel Phillips until 2020 and Darin Johnson until October 2025. A second company, Exactech (UK) 2 Limited, formed in 2025 with directors overlapping those of the first, has been dissolved.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d129", "s-d311", "s-d334", "s-d331", "s-d332", "s-d333", "s-d266", "s-d268" ], "entity_ids": [ "e-uk", "e-exac", "e-osteon", "e-dpetty", "e-phillips", "e-johnson", "e-thompson", "e-cintron", "e-andrews", "e-hohl", "e-astoin", "e-beckley", "e-ohare", "e-uk2" ] }, { "id": "display-claim-9c63a3c6d7316e52f80bf30d", "kind": "analysis", "text": "The Australian subsidiary traded as Exactech Australia Pty Ltd from September 2010 until February 2026 and has since been named Advita Ortho Aus Pty Ltd.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d216", "s-d114" ], "entity_ids": [ "e-au" ] }, { "id": "display-claim-c5cf73212f2f25e9ad4d32c5", "kind": "analysis", "text": "An offshore-companies database built from Barbados registry data lists a company named Exactech International, Inc., incorporated in Barbados in January 1999 through CITCO Corporate Management and closed in October 2003, whose recorded directors bore the names of David W. Petty, Roy William Petty, Timothy J. Seese and Gary J. Miller; no shareholder or purpose is recorded.", "qualification": "The record shows only registration dates, the intermediary and directors; it states no owner or purpose, and its link to Exactech rests on the name and on four directors who were Exactech officers. Exactech's subsidiary lists in the record do not include it, and the dataset does not indicate any wrongdoing.", "response": "", "outcome": "", "source_ids": [ "s-d228", "s-d289" ], "entity_ids": [ "e-exac", "e-barbados", "e-dpetty", "e-wpetty", "e-seese", "e-miller" ] }, { "id": "display-claim-2e410fb8d54e52968b2aa275", "kind": "analysis", "text": "TPG's fund TPG Partners VII, L.P., acting through its general partners TPG Genpar VII and TPG Genpar VII Advisors, was among the filing persons of the February 2018 take-private, after which Exactech announced that TPG had acquired all its stock. The trust's complaint says Osteon Holdings was 88% owned by the fund's vehicle TPG VII Osteon Holdings and that the firm, formerly TPG Partners, LLC, was known as TPG Capital L.P. before becoming the listed TPG, Inc.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The 88% and 95% figures appear only in the complaint; the shareholders agreement and partnership records are not public. The name history is the complaint's description; this dossier treats references to TPG Capital, L.P. in the 2017–2022 records as the same TPG firm and keeps its separately named funds and vehicles as distinct participants.", "response": "", "outcome": "", "source_ids": [ "s-d21", "s-d10", "s-d175", "s-d24" ], "entity_ids": [ "e-exac", "e-mergersub", "e-osteon-lp", "e-osteon", "e-wpetty", "e-lagatta", "e-tpg", "e-tpg7", "e-tpg-genpar", "e-tpg-genpar-adv", "e-nasdaq", "e-osteon2", "e-osteon1", "e-xpand", "e-sponsor" ] }, { "id": "display-claim-32e5629ae73835ce2094e419", "kind": "analysis", "text": "From September 2023 the sponsor vehicle TPG VII Osteon Holdings lent Exactech 'sidecar' term loans, $28.5 million at the petition date, and in June 2024 it proposed a restructuring with its own financing that did not lead to agreement.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d7" ], "entity_ids": [ "e-exac", "e-sponsor", "e-osteon2" ] }, { "id": "display-claim-a374967b03d9c3b6490980dd", "kind": "analysis", "text": "TPG Inc. and the Osteon companies were named in the product-liability MDL on veil-piercing theories and dismissed from it in March 2024. A Maryland whistle-blower also sued TPG Capital, L.P. alongside Exactech; after the United States declined to intervene, the relator dismissed those claims without prejudice in April 2026.", "qualification": "", "response": "TPG Inc., Osteon Holdings, Osteon Merger Sub and Osteon Intermediate Holdings II moved to dismiss for failure to state a claim of indirect liability on a veil-piercing theory (motion fully briefed on 28 July 2023); the plaintiffs opposed it as premature because the choice-of-law analysis was fact-intensive.", "outcome": "The dismissal removed TPG and its affiliates from the MDL personal-injury actions; the alter-ego and veil-piercing claims later passed to the Settlement Trust under the bankruptcy plan.", "source_ids": [ "s-d219", "s-d322", "s-d143", "s-d142" ], "entity_ids": [ "e-exac", "e-tpg", "e-osteon", "e-mergersub", "e-osteon2", "e-petrera" ] }, { "id": "display-claim-9b7f8c6052473dd90ce2beca", "kind": "analysis", "text": "A plan proposed in spring 2025 would have released TPG for $10 million; the debtors withdrew that settlement after creditors objected, and the claims passed to the Settlement Trust, which in January 2026 sued seven TPG entities and TPG partners, staff and advisers in Delaware for at least $1 billion.", "qualification": "The amounts and the committee's estimate are as reported by the press; the special committee's report was not retrieved. These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "TPG told the national newspaper that it was 'categorically false' to allege that it had 'encouraged or engineered a bankruptcy filing to protect itself from liability'. TPG has denied wrongdoing, a local television investigation reported in September 2026; in a statement to a national newspaper in May 2025 TPG called it 'categorically false' that it had any prior knowledge of the packaging nonconformance, and in court filings TPG and its affiliates have said that Exactech and TPG maintained 'clearly separate businesses'.", "outcome": "Pending: the docket showed the case as active on 16 October 2026; a filing of 14 August 2026 attached the Maryland qui tam papers and the plan confirmation order as exhibits, but the filing itself is not in the record and no ruling is recorded.", "source_ids": [ "s-d301", "s-d278", "s-d142", "s-d24", "s-d166", "s-d294" ], "entity_ids": [ "e-exac", "e-tpg", "e-ucc", "e-ropes", "e-brownrudnick", "e-kirkland", "e-trust", "e-reisman", "e-osteon", "e-tpg7", "e-tpg-mgmt", "e-sponsor", "e-tpg-ops", "e-tpg-h2", "e-tpg-fo", "e-binder", "e-garrison", "e-schilling", "e-sisitsky", "e-tepatti", "e-yasskin", "e-lin", "e-wpetty", "e-dpetty" ] }, { "id": "display-claim-c79517878fad419097c2c86d", "kind": "analysis", "text": "Petty co-founded Exactech in 1985, chaired its board from inception, was chief executive until 2014 and president from 2002 to 2007. After the 2018 acquisition he was co-executive chairman of Exactech and Osteon Holdings with Jeffrey Binder until he stepped back from day-to-day management in January 2020.", "qualification": "The dates come from the Settlement Trust's complaint; the earlier SEC proxy confirms David Petty as chief executive from March 2014 and president from November 2007, and the Florida and UK registers confirm Johnson as president and chief executive.", "response": "", "outcome": "", "source_ids": [ "s-d7", "s-d5", "s-d101", "s-d24" ], "entity_ids": [ "e-exac", "e-wpetty", "e-miller", "e-bpetty", "e-dpetty", "e-osteon", "e-johnson", "e-binder", "e-bolukbasi", "e-tpg" ] }, { "id": "display-claim-50a3d0809fca24448f0c1fd6", "kind": "analysis", "text": "Before the 1996 listing he held 44.6% of the shares, almost all jointly with Betty Petty; at the 2018 record date he beneficially owned 24.3%, mostly through Prima Investments, Limited Partnership. In the sale he and Prima exchanged 2,402,400 shares for Class B shares of the new parent.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d101", "s-d5" ], "entity_ids": [ "e-exac", "e-wpetty", "e-bpetty", "e-miller", "e-dpetty", "e-kearney", "e-seese", "e-phillips", "e-hss", "e-accumed", "e-prima-lp", "e-prima-inc", "e-gamco", "e-blackrock", "e-dfa", "e-mfh-llc", "e-mfh-inc", "e-osteon-lp", "e-tpg7", "e-thompson", "e-edwards", "e-roche", "e-szabo" ] }, { "id": "display-claim-319f007d78f8f7270bbf5c4b", "kind": "analysis", "text": "He and Betty Petty jointly owned 4.6% of the supplier Brighton Partners, which Exactech bought in 2010 with him as one of the sellers' representatives, and he received royalties under a product-design consulting agreement.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d137", "s-d232" ], "entity_ids": [ "e-exac", "e-brighton", "e-burstein", "e-wpetty", "e-bpetty", "e-miller", "e-dpetty", "e-phillips", "e-seese", "e-ahb", "e-thompson" ] }, { "id": "display-claim-af1c0cac311197502539affc", "kind": "analysis", "text": "He was a defendant in The Arbitrage Fund's fiduciary-duty suit over the sale and in Florida product-liability cases. The Settlement Trust alleges that in 2018 he e-mailed Hospital for Special Surgery surgeons, at Binder's direction, to discourage a presentation of data on damaged components, and sues him for breach of fiduciary duty, including over his conduct before the acquisition.", "qualification": "The account of the competing bid and the negotiations is the plaintiff's, as summarised by the appeal court on the class-certification question; the court did not decide the merits. These are plaintiffs' claims; no ruling on liability appears in the dockets reviewed. These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. HSS is not a party to the trust's suit; it appears as an interested party in the bankruptcy. These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "On 9 June 2023 the Petty and Miller defendants and the Miller family holding companies moved to dismiss the Starling case; the Exactech defendants answered the Sindicich complaint on 19 December 2023 and Hillman Supply Company filed an answer with affirmative defences and a jury demand on 26 December 2023. TPG has denied wrongdoing, a local television investigation reported in September 2026; in a statement to a national newspaper in May 2025 TPG called it 'categorically false' that it had any prior knowledge of the packaging nonconformance, and in court filings TPG and its affiliates have said that Exactech and TPG maintained 'clearly separate businesses'.", "outcome": "On 22 July 2020 the appeal court reversed the denial of class certification and remanded; the later outcome is not in the record. The Starling and Sindicich cases were closed on 29 October 2024 because of the bankruptcy filed in the Exactech master case. Pending: the docket showed the case as active on 16 October 2026; a filing of 14 August 2026 attached the Maryland qui tam papers and the plan confirmation order as exhibits, but the filing itself is not in the record and no ruling is recorded.", "source_ids": [ "s-d241", "s-d293", "s-d349", "s-d218", "s-d24", "s-d166", "s-d294", "s-d301", "s-d142" ], "entity_ids": [ "e-arbfund", "e-wpetty", "e-bpetty", "e-dpetty", "e-prima-inc", "e-prima-lp", "e-binch", "e-krusen", "e-locander", "e-rsmith", "e-watts", "e-exac", "e-tpg", "e-exus", "e-miller", "e-mfh-llc", "e-mfh-inc", "e-hillman", "e-hss", "e-binder", "e-schilling", "e-trust", "e-reisman", "e-brownrudnick", "e-osteon", "e-tpg7", "e-tpg-mgmt", "e-sponsor", "e-tpg-ops", "e-tpg-h2", "e-tpg-fo", "e-garrison", "e-sisitsky", "e-tepatti", "e-yasskin", "e-lin" ] }, { "id": "display-claim-1220698ebf03fa3dfc96215e", "kind": "analysis", "text": "Binder was president and chief executive of Biomet from February 2007, and in 2017, as a TPG adviser, took part in TPG's first meetings with the Petty family.", "qualification": "", "response": "", "outcome": "", "source_ids": [ "s-d305", "s-d24", "s-d5" ], "entity_ids": [ "e-binder", "e-biomet", "e-exac", "e-wpetty", "e-dpetty", "e-thompson", "e-hann", "e-sisitsky", "e-garrison", "e-tpg", "e-binch", "e-tpg-global" ] }, { "id": "display-claim-80c431c92e1056a9b8d64228", "kind": "analysis", "text": "He was co-executive chairman, then executive chairman, of Exactech and Osteon Holdings from February 2018 to about September 2023 and chief executive from March 2022 to March 2023, and the company's August 2024 Florida report listed him as chairman.", "qualification": "The dates come from the Settlement Trust's complaint; the earlier SEC proxy confirms David Petty as chief executive from March 2014 and president from November 2007, and the Florida and UK registers confirm Johnson as president and chief executive.", "response": "", "outcome": "", "source_ids": [ "s-d24", "s-d5", "s-d14", "s-d20" ], "entity_ids": [ "e-exac", "e-osteon", "e-wpetty", "e-dpetty", "e-johnson", "e-binder", "e-bolukbasi", "e-tpg", "e-collins", "e-edwards", "e-livingston", "e-pohl", "e-abrams" ] }, { "id": "display-claim-c81a21075f1a272256eef7f6", "kind": "analysis", "text": "The trust alleges that he has been a TPG senior adviser since 2015, that TPG rather than Exactech paid him more than $1 million for his Exactech work in 2018 and 2019, and that TPG paid him a $1 million success fee for the acquisition.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The agreement and payments are described only in the complaint. These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them. The deposition, invoice and inspection documents are under seal or were not retrieved.", "response": "", "outcome": "", "source_ids": [ "s-d24", "s-d301" ], "entity_ids": [ "e-binder", "e-tpg-global", "e-tpg", "e-exac", "e-hann", "e-sisitsky", "e-schilling", "e-garrison", "e-wpetty", "e-dpetty", "e-tepatti" ] }, { "id": "display-claim-fa8201a08f0f00a3292ee9de", "kind": "analysis", "text": "The trust alleges that from August 2021 he and John Schilling took charge of the recall response and dealings with the FDA, and that he pressed the FDA not to recall the entire GXL inventory.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "Binder told a national newspaper in May 2025 that Exactech's investigation of product complaints led it to discover in 2021 a packaging non-conformity that had gone undetected since 2008, many years before TPG's ownership and his tenure, and that when it was discovered Exactech reported it to the FDA in a timely fashion and initiated a recall. TPG told the same newspaper that the packaging issues predated its ownership, that it learned of them only in 2021 and that it 'supported the company as it immediately launched an investigation, initiated a voluntary recall, and provided support programs for physicians and patients'.", "outcome": "", "source_ids": [ "s-d24", "s-d301" ], "entity_ids": [ "e-exac", "e-crader", "e-binder", "e-schilling", "e-garrison", "e-yasskin", "e-tepatti", "e-lin", "e-tpg" ] }, { "id": "display-claim-e11a9360e02d8437eb66bcfe", "kind": "analysis", "text": "He is a defendant in the Settlement Trust's suit for breach of fiduciary duty as a director or officer of Exactech or Osteon Holdings.", "qualification": "These are allegations in the Settlement Trust's complaint, which was pending in the Delaware Court of Chancery in October 2026; no court has ruled on them.", "response": "TPG has denied wrongdoing, a local television investigation reported in September 2026; in a statement to a national newspaper in May 2025 TPG called it 'categorically false' that it had any prior knowledge of the packaging nonconformance, and in court filings TPG and its affiliates have said that Exactech and TPG maintained 'clearly separate businesses'.", "outcome": "Pending: the docket showed the case as active on 16 October 2026; a filing of 14 August 2026 attached the Maryland qui tam papers and the plan confirmation order as exhibits, but the filing itself is not in the record and no ruling is recorded.", "source_ids": [ "s-d24", "s-d166", "s-d294", "s-d301", "s-d142" ], "entity_ids": [ "e-trust", "e-exac", "e-reisman", "e-brownrudnick", "e-osteon", "e-tpg", "e-tpg7", "e-tpg-mgmt", "e-sponsor", "e-tpg-ops", "e-tpg-h2", "e-tpg-fo", "e-binder", "e-garrison", "e-schilling", "e-sisitsky", "e-tepatti", "e-yasskin", "e-lin", "e-wpetty", "e-dpetty" ] } ], "sources": [ { "id": "s-d4", "title": "Florida corporation record: Exactech, Inc. (H85101)", "publisher": "Florida Department of State, Division of Corporations", "date": "2026-03-24", "locator": "Retained parts s0003", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/corporationsearch/SearchResultDetail?inquirytype=EntityName&directionType=ForwardList&searchNameOrder=EXACTECH+H851010&aggregateId=domp-h85101-1ad7a3f8-8bc3-491f-9584-767722f48023&searchTerm=EXACT+BOOKS,+LLC.&listNameOrder=EXACTCOUPONCOM+P160000388320" }, { "id": "s-d5", "title": "Definitive merger proxy statement (DEFM14A) of Exactech, Inc. for the merger with Osteon Merger Sub, Inc.", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2018-01-16", "locator": "Retained parts s0002, s0006, s0009, s0012, s0013, s0014, s0018, s0019, s0028, s0029, s0030, s0059, s0062, s0068, s0069, s0079, s0103, s0104, s0105, s0110, s0111, s0161, s0205, s0206", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/913165/000119312518010291/d497992ddefm14a.htm" }, { "id": "s-d7", "title": "Court record source · s-d7", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d9", "title": "Company statement source · s-d9", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "company_statement", "publisher_type": "corporate", "url": "" }, { "id": "s-d10", "title": "Exhibit 99.1 to Form 8-K: Exactech completes merger with TPG Capital", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2018-02-14", "locator": "Retained parts s0001, s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/913165/000091316518000015/exh9912018specmeet.htm" }, { "id": "s-d14", "title": "Exactech, Inc.: amended 2024 annual report", "publisher": "Florida Department of State, Division of Corporations", "date": "2024-08-19", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/CorporationSearch/GetDocument?aggregateId=domp-h85101-1ad7a3f8-8bc3-491f-9584-767722f48023&transactionId=h85101-02ddfc1d-c6b5-42e0-a202-1c481613784e&formatType=PDF" }, { "id": "s-d17", "title": "Company statement source · s-d17", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "company_statement", "publisher_type": "corporate", "url": "" }, { "id": "s-d18", "title": "Florida register name search: EXACTECH", "publisher": "Florida Department of State, Division of Corporations", "date": "2026-10-16", "locator": "Retained parts s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/corporationsearch/SearchResults?inquiryType=EntityName&searchTerm=EXACTECH" }, { "id": "s-d19", "title": "EDGAR submissions record: Exactech Inc (CIK 0000913165)", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2026-10-16", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "regulator", "url": "https://data.sec.gov/submissions/CIK0000913165.json" }, { "id": "s-d20", "title": "Court record source · s-d20", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d21", "title": "Articles of merger: Osteon Merger Sub, Inc. into Exactech, Inc.", "publisher": "Florida Department of State, Division of Corporations", "date": "2018-02-14", "locator": "Retained parts s0001, s0003", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "" }, { "id": "s-d24", "title": "Court record source · s-d24", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d25", "title": "Exactech, Inc.: 2019 annual report", "publisher": "Florida Department of State, Division of Corporations", "date": "2019-03-18", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/CorporationSearch/GetDocument?aggregateId=domp-h85101-1ad7a3f8-8bc3-491f-9584-767722f48023&transactionId=h85101-ae25d387-04a4-4907-89aa-9e7242be467a&formatType=PDF" }, { "id": "s-d26", "title": "Exactech, Inc.: filing order for articles of merger of Exactech U.S., Inc. into Exactech, Inc.", "publisher": "Florida Department of State, Division of Corporations", "date": "2023-02-02", "locator": "Retained parts s0004", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "" }, { "id": "s-d27", "title": "Other source · s-d27", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "other", "publisher_type": "corporate", "url": "" }, { "id": "s-d30", "title": "Warning letter CMS 720250 to Exactech, Inc. dba Advita Ortho", "publisher": "U.S. Food and Drug Administration", "date": "2025-12-19", "locator": "Retained parts s0002, s0009, s0018", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/exactech-inc-dba-advita-ortho-720250-12192025" }, { "id": "s-d45", "title": "Canadian trade-mark record 1456220 (EXACTECH, TMA814654)", "publisher": "Canadian Intellectual Property Office", "date": "2026-03-10", "locator": "Retained parts s0002, s0003", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "other", "publisher_type": "government", "url": "https://ised-isde.canada.ca/cipo/trademark-search/1456220" }, { "id": "s-d48", "title": "Florida record: Advita Ortho, LLC (M25000013975)", "publisher": "Florida Department of State, Division of Corporations", "date": "2026-03-10", "locator": "Retained parts s0003", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=CurrentList&searchNameOrder=ADVITAORTHO+M250000139750&aggregateId=forl-m25000013975-64122630-e40f-434c-a695-d655291af413&searchTerm=ADVOCATE+BROKERAGE,+INC&listNameOrder=ADVISTA+L190000507310" }, { "id": "s-d51", "title": "510(k) premarket notification K260583: Equinoxe Shoulder System", "publisher": "U.S. Food and Drug Administration", "date": "2026-04-14", "locator": "Retained parts s0005", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K260583" }, { "id": "s-d52", "title": "Florida corporation record: Exactech U.S., Inc. (P12000087578)", "publisher": "Florida Department of State, Division of Corporations", "date": "2023-02-08", "locator": "Retained parts s0003", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/corporationsearch/SearchResultDetail?inquirytype=EntityName&directionType=PreviousList&searchNameOrder=EXACTECHUS+P120000875780&aggregateId=domp-p12000087578-3b6156b2-02fd-45f8-98b6-f64dd9c1a5b8&searchTerm=EXACTED3000+LLC&listNameOrder=EXACTDATA+L080001010380" }, { "id": "s-d54", "title": "Corporate registry source · s-d54", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d55", "title": "Corporate registry source · s-d55", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d56", "title": "French business directory record: Blue Ortho SAS (SIREN 509027702)", "publisher": "French government business directory (recherche-entreprises.api.gouv.fr)", "date": "2026-09-24", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "government", "url": "https://recherche-entreprises.api.gouv.fr/search?q=509027702" }, { "id": "s-d95", "title": "Florida register officer search: Livingston, Jessica", "publisher": "Florida Department of State, Division of Corporations", "date": "2026-10-16", "locator": "Retained parts s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?inquiryType=OfficerRegisteredAgentName&searchTerm=LIVINGSTON%20JESSICA" }, { "id": "s-d96", "title": "Florida register officer search: Dundon, Matthew", "publisher": "Florida Department of State, Division of Corporations", "date": "2026-10-16", "locator": "Retained parts s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?inquiryType=OfficerRegisteredAgentName&searchTerm=DUNDON%20MATTHEW" }, { "id": "s-d97", "title": "TPG Inc. current report on Form 8-K: departure of Todd Sisitsky", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2026-09-06", "locator": "Retained parts s0003", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/1880661/000188066126000051/tpg-20260906.htm" }, { "id": "s-d100", "title": "Company statement source · s-d100", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "company_statement", "publisher_type": "corporate", "url": "" }, { "id": "s-d101", "title": "Amended registration statement (Form S-1/A) of Exactech, Inc. for its 1996 initial public offering", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "1996-05-01", "locator": "Retained parts s0010, s0036, s0037, s0042, s0043", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/0000913165/000095017096000256/0000950170-96-000256.txt" }, { "id": "s-d102", "title": "Exhibit 21.1 to the Exactech annual report: subsidiaries of the registrant", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2013-03-01", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/913165/000091316513000006/exhibit211.htm" }, { "id": "s-d114", "title": "Global LEI register search: Exactech", "publisher": "Global Legal Entity Identifier Foundation (GLEIF)", "date": "2026-10-16", "locator": "Retained parts s0001, s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://api.gleif.org/api/v1/lei-records?filter[fulltext]=Exactech&page[size]=50" }, { "id": "s-d115", "title": "Global LEI register: direct parent of ADVITA ORTHO ITALY S.P.A.", "publisher": "Global Legal Entity Identifier Foundation (GLEIF)", "date": "2026-10-15", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://api.gleif.org/api/v1/lei-records/815600187F853BDAA941/direct-parent" }, { "id": "s-d128", "title": "Exhibit 99.1 to Form 8-K: Exactech acquires BlueOrtho", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2015-01-20", "locator": "Retained parts s0002, s0003, s0005", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/913165/000091316515000002/exacform8-kblueorthoex991.htm" }, { "id": "s-d129", "title": "Persons with significant control: company 05316864", "publisher": "Companies House (United Kingdom)", "date": "2026-10-16", "locator": "Retained parts s0002, s0003, s0004", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://find-and-update.company-information.service.gov.uk/company/05316864/persons-with-significant-control" }, { "id": "s-d130", "title": "French business directory record: Advita Ortho France SAS (SIREN 433701166)", "publisher": "French government business directory (recherche-entreprises.api.gouv.fr)", "date": "2026-09-23", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "government", "url": "https://recherche-entreprises.api.gouv.fr/search?q=433701166" }, { "id": "s-d131", "title": "Corporate registry source · s-d131", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d132", "title": "Florida record: Exactech International, LLC (L10000132635)", "publisher": "Florida Department of State, Division of Corporations", "date": "2017-04-27", "locator": "Retained parts s0003", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/corporationsearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=EXACTECHINTERNATIONAL%20L100001326350&aggregateId=flal-l10000132635-bcbb484a-e39e-4189-9d6e-8c16a4e5f1ea&searchTerm=EXACTECH&listNameOrder=EXACTECH%20H851010" }, { "id": "s-d134", "title": "Form D notice of exempt offering: Osteon Holdings, Inc.", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2018-02-28", "locator": "Retained parts s0001, s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/1732417/000173241718000001/primary_doc.xml" }, { "id": "s-d135", "title": "Court record source · s-d135", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d136", "title": "EDGAR full-text search: \"Advita Ortho\"", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2026-10-16", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "regulator", "url": "https://efts.sec.gov/LATEST/search-index?q=%22Advita%20Ortho%22" }, { "id": "s-d137", "title": "Definitive proxy statement (DEF 14A) of Exactech, Inc. for the 2010 annual meeting", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2010-03-26", "locator": "Retained parts s0006, s0007, s0009, s0011, s0012, s0018, s0042", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/913165/000119312510067974/ddef14a.htm" }, { "id": "s-d138", "title": "West Virginia business record: Exactech U.S., Inc.", "publisher": "West Virginia Secretary of State", "date": "2026-01-02", "locator": "Retained parts s0006, s0007", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://apps.sos.wv.gov/business/corporations/organization.aspx?org=316068" }, { "id": "s-d139", "title": "Corporate registry source · s-d139", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d140", "title": "Court record source · s-d140", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d142", "title": "Court record source · s-d142", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d143", "title": "Court record source · s-d143", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d144", "title": "Company statement source · s-d144", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "company_statement", "publisher_type": "corporate", "url": "" }, { "id": "s-d146", "title": "Corporate Integrity Agreements: Exactech, Inc. (heightened scrutiny)", "publisher": "U.S. Department of Health and Human Services, Office of Inspector General", "date": "2025-09-16", "locator": "Retained parts s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "government", "url": "https://oig.hhs.gov/compliance/corporate-integrity-agreements/browse-cias/exactech/" }, { "id": "s-d162", "title": "Court record source · s-d162", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d166", "title": "Court record source · s-d166", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d169", "title": "Court record source · s-d169", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "government", "url": "" }, { "id": "s-d170", "title": "Court record source · s-d170", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d171", "title": "Court record source · s-d171", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d172", "title": "Court record source · s-d172", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d175", "title": "Schedule 13E-3, final amendment, filed by Exactech, Inc., Osteon Holdings, Inc. and others", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2018-02-14", "locator": "Retained parts s0005, s0010", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/913165/000091316518000016/schedule13e-3a1.htm" }, { "id": "s-d183", "title": "Corporate registry source · s-d183", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d188", "title": "Corporate registry source · s-d188", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d189", "title": "Corporate registry source · s-d189", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d195", "title": "Corporate registry source · s-d195", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d196", "title": "Other source · s-d196", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "other", "publisher_type": "corporate", "url": "" }, { "id": "s-d197", "title": "Court record source · s-d197", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d198", "title": "Florida register name search: Hillman Supply", "publisher": "Florida Department of State, Division of Corporations", "date": "2026-10-16", "locator": "Retained parts s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?inquiryType=EntityName&searchTerm=HILLMAN%20SUPPLY" }, { "id": "s-d214", "title": "Harrold v Exactech Australia Pty Ltd (No 2) [2025] FCA 1412", "publisher": "Federal Court of Australia", "date": "2025-11-13", "locator": "Retained parts s0013, s0016, s0018, s0020, s0021", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "court_record", "publisher_type": "government", "url": "https://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/single/2025/2025fca1412" }, { "id": "s-d216", "title": "ABN history: 60 146 150 754", "publisher": "Australian Business Register", "date": "2026-10-16", "locator": "Retained parts s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://abr.business.gov.au/AbnHistory/View?id=60146150754" }, { "id": "s-d217", "title": "Florida corporation record: Hillman Supply Company, Inc. (P93000005334)", "publisher": "Florida Department of State, Division of Corporations", "date": "2026-01-16", "locator": "Retained parts s0003", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=HILLMANSUPPLY%20P930000053340&aggregateId=domp-p93000005334-1e15f63a-36d7-477b-8e49-bff143137e25&searchTerm=HILLMAN%20SUPPLY&listNameOrder=HILLMANSUPPLY%20P930000053340" }, { "id": "s-d218", "title": "Court record source · s-d218", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d219", "title": "Memorandum and Order, In re Exactech Polyethylene Orthopedic Products Liability Litigation, No. 22-MD-3044 (E.D.N.Y.)", "publisher": "U.S. Government Publishing Office (GovInfo), U.S. Courts collection", "date": "2024-03-07", "locator": "Retained parts s0001, s0007, s0009, s0017, s0049", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "court_record", "publisher_type": "government", "url": "https://www.govinfo.gov/content/pkg/USCOURTS-nyed-1_22-md-03044/pdf/USCOURTS-nyed-1_22-md-03044-3.pdf" }, { "id": "s-d220", "title": "Court record source · s-d220", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "nonprofit", "url": "" }, { "id": "s-d221", "title": "Global LEI register record: 9845003CBE1I61ECAE37", "publisher": "Global Legal Entity Identifier Foundation (GLEIF)", "date": "2025-07-03", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://api.gleif.org/api/v1/lei-records/9845003CBE1I61ECAE37" }, { "id": "s-d223", "title": "Company statement source · s-d223", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "company_statement", "publisher_type": "corporate", "url": "" }, { "id": "s-d225", "title": "EDGAR submissions record: Strategic Value Partners, LLC (CIK 0001301912)", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2026-10-16", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "regulator", "url": "https://data.sec.gov/submissions/CIK0001301912.json" }, { "id": "s-d227", "title": "Annual report on Form 10-K of Exactech, Inc. for 2016", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2017-03-01", "locator": "Retained parts s0004, s0008, s0009, s0018", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/913165/000091316517000006/exac2016123110k.htm" }, { "id": "s-d228", "title": "Research source · s-d228", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "research", "publisher_type": "nonprofit", "url": "" }, { "id": "s-d230", "title": "Exhibit 21.1 to an earlier Exactech annual report: subsidiaries of the registrant", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2008-03-01", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/913165/000119312508057269/dex211.htm" }, { "id": "s-d232", "title": "Company statement source · s-d232", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "company_statement", "publisher_type": "corporate", "url": "" }, { "id": "s-d233", "title": "Corporate registry source · s-d233", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d236", "title": "Corporate registry source · s-d236", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d241", "title": "Court record source · s-d241", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d244", "title": "Media source · s-d244", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "media", "publisher_type": "media", "url": "" }, { "id": "s-d246", "title": "Warning letter CMS 669904 to Exactech, Inc.", "publisher": "U.S. Food and Drug Administration", "date": "2024-01-19", "locator": "Retained parts s0002, s0006, s0007, s0013, s0014", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/exactech-inc-669904-01192024" }, { "id": "s-d247", "title": "Medical device recall record Z-2132-2021 (Connexion GXL liners)", "publisher": "U.S. Food and Drug Administration", "date": "2021-07-22", "locator": "Retained parts s0005", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=188104" }, { "id": "s-d253", "title": "openFDA device enforcement reports: recalling firm Exactech", "publisher": "U.S. Food and Drug Administration", "date": "2026-10-07", "locator": "Retained parts s0003, s0009, s0032, s0039, s0305, s0346", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://api.fda.gov/device/enforcement.json?search=recalling_firm%3A%22Exactech%22&limit=100" }, { "id": "s-d254", "title": "openFDA device enforcement reports: recalling firm Exactech, 19 April 2024 – 16 October 2026", "publisher": "U.S. Food and Drug Administration", "date": "2026-10-07", "locator": "Retained parts s0001, s0002, s0003, s0004, s0006, s0007", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://api.fda.gov/device/enforcement.json?search=recalling_firm%3A%22Exactech%22+AND+recall_initiation_date%3A%5B20240419+TO+20261016%5D&limit=100" }, { "id": "s-d255", "title": "Safety communication: risks with Exactech joint replacement devices in defective packaging", "publisher": "U.S. Food and Drug Administration", "date": "2023-03-23", "locator": "Retained parts s0002, s0007, s0008", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://www.fda.gov/medical-devices/safety-communications/risks-exactech-joint-replacement-devices-defective-packaging-fda-safety-communication" }, { "id": "s-d256", "title": "Press release: Exactech agrees to pay $8 million to resolve False Claims Act allegations", "publisher": "U.S. Attorney's Office, Northern District of Alabama (U.S. Department of Justice)", "date": "2025-09-16", "locator": "Retained parts s0004, s0005, s0006, s0007", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "government", "url": "https://www.justice.gov/usao-ndal/pr/medical-device-company-exactech-inc-agrees-pay-8-million-selling-allegedly-defective" }, { "id": "s-d258", "title": "Press release: Exactech enters deferred prosecution agreement; sales director pleads guilty", "publisher": "U.S. Attorney's Office, District of New Jersey (U.S. Department of Justice)", "date": "2010-12-07", "locator": "Retained parts s0001, s0002, s0003, s0004", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "government", "url": "https://www.justice.gov/sites/default/files/usao-nj/legacy/2014/09/02/Exactech%20DPA%20-%20Donofrio%2C%20Douglas%20Plea%20PR_0.pdf" }, { "id": "s-d260", "title": "Safety communication: risks with the Exactech Equinoxe shoulder system in defective packaging", "publisher": "U.S. Food and Drug Administration", "date": "2024-01-16", "locator": "Retained parts s0002, s0010", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://www.fda.gov/medical-devices/safety-communications/risks-exactech-equinoxe-shoulder-system-defective-packaging-fda-safety-communication" }, { "id": "s-d262", "title": "openFDA 510(k) decisions by date: applicant Exactech", "publisher": "U.S. Food and Drug Administration", "date": "2026-10-05", "locator": "Retained parts s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://api.fda.gov/device/510k.json?search=applicant%3A%22Exactech%22&count=decision_date" }, { "id": "s-d264", "title": "Media source · s-d264", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "media", "publisher_type": "media", "url": "" }, { "id": "s-d266", "title": "Officers: company 16540209", "publisher": "Companies House (United Kingdom)", "date": "2026-10-16", "locator": "Retained parts s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://find-and-update.company-information.service.gov.uk/company/16540209/officers" }, { "id": "s-d268", "title": "Corporate registry source · s-d268", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "" }, { "id": "s-d272", "title": "Annual report on Form 10-K of Exactech, Inc. for 2002", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2003-03-01", "locator": "Retained parts s0009", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/0000913165/000093176303000631/d10k.htm" }, { "id": "s-d278", "title": "Media source · s-d278", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "media", "publisher_type": "media", "url": "" }, { "id": "s-d279", "title": "Corporate registry source · s-d279", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d289", "title": "Research source · s-d289", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "research", "publisher_type": "nonprofit", "url": "" }, { "id": "s-d291", "title": "Media source · s-d291", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "media", "publisher_type": "media", "url": "" }, { "id": "s-d293", "title": "Court record source · s-d293", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d294", "title": "Media source · s-d294", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "media", "publisher_type": "media", "url": "" }, { "id": "s-d295", "title": "Corporate registry source · s-d295", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "corporate", "url": "" }, { "id": "s-d301", "title": "Media source · s-d301", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "media", "publisher_type": "media", "url": "" }, { "id": "s-d302", "title": "Definitive proxy statement (DEF 14A) of Alphatec Holdings, Inc. for 2026", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2026-04-29", "locator": "Retained parts s0010", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/1350653/000119312526191867/atec-20260429.htm" }, { "id": "s-d305", "title": "Information statement (DEF 14C) of LVB Acquisition, Inc.", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2014-09-11", "locator": "Retained parts s0004", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/1402366/000119312514338999/d783544ddef14c.htm" }, { "id": "s-d306", "title": "Proxy statement of Aspen Technology, Inc. (2023)", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2023-10-24", "locator": "Retained parts s0018", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/1897982/000189798223000065/azpn-20231024.htm" }, { "id": "s-d307", "title": "Media source · s-d307", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "media", "publisher_type": "media", "url": "" }, { "id": "s-d311", "title": "Officers: company 05316864", "publisher": "Companies House (United Kingdom)", "date": "2026-10-16", "locator": "Retained parts s0003, s0005", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://find-and-update.company-information.service.gov.uk/company/05316864/officers" }, { "id": "s-d313", "title": "Florida register officer search: Petty, David", "publisher": "Florida Department of State, Division of Corporations", "date": "2026-10-16", "locator": "Retained parts s0003", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?inquiryType=OfficerRegisteredAgentName&searchTerm=PETTY%20DAVID" }, { "id": "s-d314", "title": "Corporate registry source · s-d314", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "" }, { "id": "s-d315", "title": "Florida register officer search: Petty, Betty", "publisher": "Florida Department of State, Division of Corporations", "date": "2026-10-16", "locator": "Retained parts s0002", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?inquiryType=OfficerRegisteredAgentName&searchTerm=PETTY%20BETTY" }, { "id": "s-d317", "title": "Definitive proxy statement (DEF 14A) of GoHealth, Inc. for 2026", "publisher": "U.S. Securities and Exchange Commission (EDGAR)", "date": "2026-04-01", "locator": "Retained parts s0006", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "company_statement", "publisher_type": "regulator", "url": "https://www.sec.gov/Archives/edgar/data/1808220/000114036126018208/ny20066632x1_def14a.htm" }, { "id": "s-d319", "title": "Company statement source · s-d319", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "company_statement", "publisher_type": "corporate", "url": "" }, { "id": "s-d322", "title": "Court record source · s-d322", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d326", "title": "Court record source · s-d326", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d329", "title": "openFDA registration and listing: establishment 1038671", "publisher": "U.S. Food and Drug Administration", "date": "2026-10-05", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "regulatory_record", "publisher_type": "regulator", "url": "https://api.fda.gov/device/registrationlisting.json?search=registration.fei_number:1038671&limit=1" }, { "id": "s-d331", "title": "Corporate registry source · s-d331", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "" }, { "id": "s-d332", "title": "Corporate registry source · s-d332", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "" }, { "id": "s-d333", "title": "Corporate registry source · s-d333", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "" }, { "id": "s-d334", "title": "Corporate registry source · s-d334", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "" }, { "id": "s-d341", "title": "Prima Investments, Inc.: 2019 annual report", "publisher": "Florida Department of State, Division of Corporations", "date": "2019-03-08", "locator": "Retained parts s0001", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "https://search.sunbiz.org/Inquiry/CorporationSearch/GetDocument?aggregateId=domp-p08000001367-5b2e6dc5-a1a1-43b2-bee6-b79f7a091ed1&transactionId=p08000001367-93101a26-5c07-447a-83f6-16e671367bef&formatType=PDF" }, { "id": "s-d345", "title": "Corporate registry source · s-d345", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "corporate_registry", "publisher_type": "registry_operator", "url": "" }, { "id": "s-d349", "title": "Court record source · s-d349", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d350", "title": "Court record source · s-d350", "publisher": "", "date": "", "locator": "", "basis": "Source classification retained; identifying metadata omitted.", "source_type": "court_record", "publisher_type": "corporate", "url": "" }, { "id": "s-d351", "title": "Transfer order, MDL No. 3044", "publisher": "United States Judicial Panel on Multidistrict Litigation", "date": "2022-10-07", "locator": "Retained parts s0001, s0004", "basis": "Retained copy of the document collected on 2026-10-16; the cited parts were read.", "source_type": "court_record", "publisher_type": "government", "url": "https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3044-Initial-Transfer-Order-9-22.pdf" } ], "atlas": { "version": "1.0", "reference": "dudil-report-assembler/2.19.0", "default_view": "target_overview", "hypotheses_default": true, "path_policy": "evidence_first", "context_entity_ids": [] }, "case_id": "exactech", "version": "1.0", "as_of": "2026-10-16" }